Product Name | CAS | MF | MW | Synonyms |
---|---|---|---|---|
Dehydrovomifoliol | 39763-33-2 | C13H18O3 | 222.284 | (6S)-dehydrovomifoliol; (6S)-6-hydroxy-3-oxo-alpha-ionone; (+)-Dehydrovomifoliol; (4S)-4-hydroxy-3,5,5-trimethyl-4-[(E)-3-oxobut-1-enyl]cyclohex-2-en-1-one |
Dehydrotumulosic acid | 6754-16-1 | C31H48O4 | 484.721 | (2R)-2-[(3S,5R,10S,13R,14R,16R,17R)-3,16-dihydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methyl-5-methylideneheptanoic acid |
Dehydrotrametenolic acid | 29220-16-4 | C30H46O3 | ||
Dehydrotomatine | 157604-98-3 | C50H81NO21 | 1032.2 | |
Dehydroritonavir (M-9) | 1156504-13-0 | C37H46N6O5S2 | 718.94 | (3S,4S,6S,9S)-4-Hydroxy-12-methyl-13-[2-(1-methylethenyl)-4-thiazolyl]-9-(1-methylethyl)-8,11-dioxo-3,6-bis(phenylmethyl)-2,7,10,12-tetraazatridecanoic Acid 5-Thiazolylmethyl Ester |
dehydroretronecine | 26400-45-3 | C8H11NO2 | 0 | dehydroretronecine; 6,7-DIHYDRO-7-HYDROXY-1-HYDROXYMETHYL-5H-PYRROLIZINE; 2,3-Dihydro-1-hydroxy-1H-pyrrolizine-7-methanol; Dehdroheliotridine |
dehydropodophyllotoxin | 42123-27-3 | C22H18O8 | 410.37 | Tetradehydropodophyllotoxin |
Dehydroperilloxin | 263241-09-4 | C16H16O4 | 272.3 | 2-(5-methoxyfuro[3,2-i][3]benzoxepin-2-yl)propan-2-ol |
Dehydropachymic acid | 77012-31-8 | C33H50O5 | 526.8 | (3beta,16alpha)-3-(Acetyloxy)-16-hydroxy-24-methylenelanosta-7,9(11)-dien-21-oic acid; 9-Dehydropachymic acid; delta9(11)-Dehydropachymic acid |
Dehydronuciferine | 7630-74-2 | C19H19NO2 | 293.36 | |
Dehydronitroso Nifedipine | 50428-14-3 | C17H16N2O5 | 328.33 | 2,6-Dimethyl-4-(2-nitrosophenyl)-3,5-pyridinedicarboxylic Acid 3,5-Dimethyl Ester 2,6-Dimethyl-3,5-dicarbomethoxy-4-(2-nitrosophenyl)pyridine; |
Dehydronifedipine-d6 | 125464-52-0 | C17H10D6N2O6 | 350.36 | 2,6-Dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic Acid 3,5-Di(methyl-d3) Ester; Dimethyl 2,6-Dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylate-d6 |
Dehydronifedipine | 67035-22-7 | C17H16N2O6 | 344.33 | Dehydro Nifedipine; 2,6-Dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic Acid 3,5-Dimethyl Ester; Dimethyl 2,6-Dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylate; |
Dehydroleucodine | 36150-07-9 | C15H16O3 | 244.29 | Dehydroleucodin; (3aS,9aS,9bS)-6,9-dimethyl-3-methylidene-4,5,9a,9b-tetrahydro-3aH-azuleno[4,5-b]furan-2,7-dione |
Dehydrojuncusol | 117824-04-1 | C18H16O2 | 264.324 | |
Dehydrojuncuenin B | 1161681-28-2 | C18H16O2 | 264.324 | |
Dehydrojuncuenin A | 1161681-26-0 | C18H16O | 248.324 | |
Dehydroherbarin | 36379-74-5 | C16H14O5 | 286.283 | 7,9-dimethoxy-3-methyl-1H-benzo[g]isochromene-5,10-dione |
Dehydroheliobuphthalmin | 103001-05-4 | C22H20O8 | 412.4 | (E)-(1,3-Benzodioxol-5-ylmethyl)(1,3-benzodioxol-5-ylmethylene)butanedioic acid dimethyl ester |
Dehydroevodiamine | 67909-49-3 | C19H15N3O | 14-Methyl-5-oxo-7,8,8a,13a-tetrahydro-5H-indolo[2',3':3,4]pyrido[2,1-b]quinazolin-14-ium-13-ide; indolo[2',3':3,4]pyrido[2,1-b]quinazolinium, 5,7,8,8a,13,13a-hexahydro-14-methyl-5-oxo-, inner salt; Dehydroevodiamine; Dehydroevodiamine Hydrochloride | |
Dehydroespeletone | 51995-99-4 | C14H16O3 | 232.3 | 4-Methoxy-3-(3-methyl-2-butenoyl)acetophenone |
Dehydroemetine | 4914-30-1 | C29H38N2O4 | 478.629 | |
Dehydroeffusol | 137319-34-7 | C17H14O2 | 250.297 | 5-Ethenyl-1-methylphenanthrene-2,7-diol |
Dehydroeburicoic acid monoacetate | 77035-42-8 | C33H50O4 | 510.7 | 3-O-Acetyldehydroeburicoic acid |
Dehydrodivanillin | 2092-49-1 | C16H14O6 | 302.2788 | 5,5'-Bivanillin; Divanillin; 3-(5-formyl-2-hydroxy-3-methoxyphenyl)-4-hydroxy-5-methoxybenzaldehyde; 3,3-Biphenyldicarboxaldehyde, 6,6-dihydroxy-5,5-dimethoxy- (8CI) |
Dehydrodiconiferyl alcohol | 4263-87-0 | C20H22O6 | 358.39 | 4-[3-(hydroxymethyl)-5-[(E)-3-hydroxyprop-1-enyl]-7-methoxy-2,3-dihydro-1-benzofuran-2-yl]-2-methoxyphenol |
Dehydrodicentrine | 19843-03-9 | C20H19NO4 | 337.37 | 5H-Benzo(g)-1,3-benzodioxolo(6,5,4-de)quinoline, 6,7-dihydro-10,11-dimethoxy-7-methyl- |
Dehydrodeguelin | 3466-23-7 | C23H20O6 | 392.4 | 6a,12a-Dehydrodeguelin;9,10-Dimethoxy-3,3-dimethyl-3H-bis[1]benzopyrano[3,4-b:6',5'-e]pyran-7(13H)-one |
Dehydrocyclopeptine | 31965-37-4 | C17H14N2O2 | 278.3 | |
Dehydrocurdione | 38230-32-9 | C15H22O2 | 234.33 | |
Dehydrocrenatine | 26585-13-7 | C14H12N2O | 224.3 | 1-ethenyl-4-methoxy-9H-pyrido[3,4-b]indole |
Dehydrocrenatidine | 65236-62-6 | C15H14N2O2 | 254.3 | 1-ethenyl-4,8-dimethoxy-9H-pyrido[3,4-b]indole |
Dehydrocrebanine | 77784-22-6 | C20H19NO4 | 337.4 | 5H-Benzo(g)-1,3-benzodioxolo(6,5,4-de)quinoline, 6,7-dihydro-9,10-dime thoxy-7-methyl- |
Dehydrocostus lactone | 477-43-0 | C15H18O2 | 230.3 | (3aS,6aR,9aR,9bS)-3,6,9-trimethylidene-3a,4,5,6a,7,8,9a,9b-octahydroazuleno[4,5-b]furan-2-one; |
Decahydro-6-isopropyl-2-naphthol | 34131-99-2 | C13H24O | 196.33 | Decahydro-6-isopropyl-2-naphthol; Decahydro-6-(1-methylethyl)-2-naphthalenol; Decatol; 6-Isopropyldecahydronaphthalen-2-ol |
Decahydro-2-hydroxy-2,5,5,8a-tetramethylnaphthalene-1-ethanol | 55881-96-4 | C16H30O2 | 254.41 | Decahydro-2-hydroxy-2,5,5,8a-tetramethylnaphthalene-1-ethanol; Sclareol glycol |
Zopolrestat | 110703-94-1 | C19H12F3N3O3S | 419.38 | 3-[(5-Trifluoromethyl-2-benzothiazolyl)methyl]-3,4-dihydro-4-oxophthalazine-1-acetic acid;CP-73850;3,4-Dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl]methyl]-1-phthalazineacetic acid;Alond;Xedia;2-[4-Oxo-3-[[5-(trifluoromethyl)-1,3-benzothiazol-2- |
Zopiclone Impurity A | 43200-96-0 | C17H17ClN6O4 | 404.82 | Zopiclone N-Oxide; 1-Piperazine-carboxylic Acid 4-Methyl-4-oxide 6-(5-Chloro-pyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5yl Ester; RP 29753; Eszopiclone Impurity A |
Zopiclone Deschloro Impurity | 1348046-61-6 | C17H18N6O3 | 354.37 | Deschloro-Zopiclone |
Zolmitriptan Impurity 1 | 187975-62-8 | C10H13N3O2 | 207.23 | (S)-4-(4-Hydrazinylbenzyl)-2-oxazolidinone; (4S)-4-[(4-hydrazinylphenyl)methyl]-2-Oxazolidinone |
Zolmitriptan 2-Carboxylic Acid Ethyl Ester Hydrochloride | 868622-23-5 | C19H25N3O4.HCl | 395.884 | (S)-3-(2-Dimethylaminoethyl)-5-(2-oxo-1,3- oxazolidin-4-ylmethyl)-1H-indol-2-carboxylic Acid Ethyl Ester Hydrochloride; Zolmitriptan ethyl carboxylate hydrochloride; ZYT69J5HCM |
Zolmitriptan | 139264-17-8 | C16H21N3O2 | 287.36 | (4S)-4-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl-2-oxazolidinone; BW-311C90; Zomig |
Z-Gly-Gly-Val | 34152-86-8 | C17H23N3O6 | 365.38 | AC1OEE67; SCHEMBL9556695; 34152-86-8; ZINC4029401; (2S)-3-methyl-2-[[2-[[2-(phenylmethoxycarbonylamino)acetyl]amino]acetyl]amino]butanoicacid |
Uvarigranol E | 176598-10-0 | C23H22O8 | 426.42 | |
Uniprofen | 51234-28-7 | C16H12ClNO3 | 301.72438;g/mol | 2-[2-(4-chlorophenyl)-1,3-benzoxazol-5-yl]propanoicacid; Benoxaprofen; Oraflex; Coxigon; Inflamid; Opren |
Zafirlukast Related Compound E | 1159195-70-6 | C31H33N3O6S | 575.69 | Zafirlukast p-Tolyl Isomer; N-[3-[[2-Methoxy-4-[[[(4-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]carbamic Acid Cyclopentyl Ester; Cyclopentyl 3-[2-Methoxy-4-(p-tolylsulfonylcarbamoyl)benzyl]-1-methylindol-5-ylcarbamate |
Zafirlukast Related Compound D | 1794760-52-3 | C31H33N3O6S | 575.69 | Zafirlukast m-Tolyl Isomer-d7; N-[3-[[2-Methoxy-4-[[[(3-methylphenyl-d7)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]carbamic Acid Cyclopentyl Ester |
Zafirlukast Related Compound C | 1159195-67-1 | C27H27N3O6S | 521.6 | Decyclopentyl Zafirlukast Methyl Ester; N-[3-[[2-methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]carbamic Acid Methyl Ester; Methyl 3-[2-Methoxy-4-(o-tolylsulfonylcarbamoyl)benzyl]-1-methylindol-5-ylcarbamate |
Zafirlucast | 107753-78-6 | C31H33N3O6S | 575.68 | ICI-204219; ICI204219; ICI 204219; ICI-204,219; ICI 204,219; ICI204,219; Zafirlukast; brand names Accolate, Accoleit, and Vanticon. |
Z-AEVD-FMK | 1135688-47-9 | C28H39FN4O10 | 610.64 | Z-A-E(OMe)-V-Asp(OMe)-FMK; Z-Ala-Glu(OMe)-Val-Asp(OMe)-FMK; Z-Ala-Glu(OMe)-Val-Asp(OMe)-Fluoromethylketone; methyl (4S)-5-[[(2S)-1-[[(3S)-5-fluoro-1-methoxy-1,4-dioxopentan-3-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-oxo-4-[[(2S)-2-(phenylmethoxycarbony |
Zacopride hydrochloride | 101303-98-4 | C15H20ClN3O2.HCl | 346.26 | (±)-4-Amino-N-1-azabicyclo[2.2.2]oct-3-yl-5-chloro-2-methoxybenzamide hydrochloride |
Dehydrochromolaenin | 20013-76-7 | C15H14O | 210.3 | 1,5,8-Trimethylnaphtho[2,1-b]furan; |
Dehydrocholic Acid | 81-23-2 | C24H34O5 | 402.53 | Decholin;Dehystolin;Oxycholin;Ketocholanic acid;(4R)-4-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-3,7,12-trioxo-1,2,4,5,6,8,9,11,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid;5b-Cholan-24-oic acid,3,7,12-trioxo- (8CI);3,7,12-Tri-ket |
Dehydrocavidine | 83218-34-2 | C21H18NO4 | 348.4 | |
DEHYDROCARNITINE HYDROCHLORIDE | 94291-69-7 | C7H14ClNO3 | 195.64 | DEHYDROCARNITINE HYDROCHLORIDE; (3-carboxy-2-oxopropyl)trimethylammonium chloride; Dehydrocarnitine hydrochloride,96% |
Dehydrobruceine A | 73435-47-9 | C26H32O11 | 520.52 | Dehydrobrucein A; Picrasa-1,4-dien-21-oic acid, 13,20-epoxy-2,11,12-trihydroxy-15-(3-methyl-1-oxobutoxy)-3,16-dioxo-, methyl ester, (11beta,12alpha,15beta) |
Dehydrobruceantinol | 99132-99-7 | C30H36O13 | 604.59 | |
Dehydroborapetoside B | 1221178-16-0 | C27H34O12 | 550.552 | (2S,6S,6aR,9R,10aS,10bS)-2-(3-Furanyl)-6-(beta-D-glucopyranosyloxy)-1,4,6,6a,9,10,10a,10b-octahydro-9-hydroxy-6a,10b-dimethyl-4-oxo-2H-naphtho[2,1-c]pyran-7-carboxylic acid methyl ester; methyl (2S,6S,6aR,9R,10aS,10bS)-2-(furan-3-yl)-9-hydroxy-6a,10b-dime |
Dehydroandrographolide succinate potasium salt | 76958-99-1 | C28H35O10·K | 570.67 | Ddhads; 14-Deoxy-11,12-didehydroandrographolide 3,19-disuccinate; C28H35O10.K; 8093AH |
Dehydroandrographolide succinate | 786593-06-4 | C28H36O10 | 532.58 | |
Dehydroandrographolide | 134418-28-3 | C20H28O4 | 332.43 | Andrographolide, dehydro-;Deoxy-11,12-didehydroandrographolide;(3E)-3-[2-[(1S,4aS,5R,6R,8aS)-Decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl]ethylidene]-2(3H)-furanone;14-Deoxy-11-dehydroandrographolide |
Dehydro-alpha-lapachone | 15297-92-4 | C15H12O3 | 240.3 | 2,2-dimethylbenzo[g]chromene-5,10-dione |
Dehydroaglaiastatin | 155595-93-0 | C31H28N2O6 | 524.573 | |
Dehydroadynerigenin digitaloside | 52628-62-3 | C30H42O8 | 530.66 | |
Dehydroacerogenin C | 152041-27-5 | C19H18O3 | 294.35 | |
Dehydroabietinsaeure | 1231-75-0 | C20H28O2 | 300.44 | (1R,4As,10aS)-7-Isopropyl-1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-1-carboxylic acid |
Dehydroabietinol | 3772-55-2 | C20H30O | 286.5 | [1R-(1alpha,4abeta,10aalpha)]-1,2,3,4,4a,9,10,10a-octahydro-7-isopropyl-1,4a-dimethylphenanthren-1-methanol |
Dehydroabietic acid | 1740-19-8 | C20H28O2 | ||
Decynium 22 | 977-96-8 | C23H23IN2 | 454.35 | 1-Ethyl-2-[(1-ethyl-2(1H)-quinolinylidene)methyl]quinolinium iodide |
DECYLUBIQUINONE | 55486-00-5 | C19H30O4 | 322.44 | 2,3-DIMETHOXY-5-METHYL-6-DECYL-1,4-BENZOQUINONE; DECYLUBIQUINONE |
Decyltrimethylammoniumchloride; 95% | 10108-87-9 | 235.84 | N-DECYLTRIMETHYLAMMONIUM CHLORIDE; DECYLTRIMETHYLAMMONIUM CHLORIDE; 95%; 1031; N,N,N-trimethyl-1-decanaminium chloride; N-Decyl-N,N,N-trimethylammonium chloride | |
Decyltrimethylammonium bromide | 2082-84-0 | C13H30BrN | 280.29 | n,n,n-trimethyldecylammonium bromide; N-DECYLTRIMETHYLAMMONIUM BROMIDE; DECYLTRIMETHYLAMMONIUM BROMIDE; ammonium,decyltrimethyl-,bromide; decyltrimethyl-ammoniubromide; n,n,n-trimethyl-1-decanaminiubromide; N,N,N-trimethyl-1-decanaminiumbromide; Trimethyl |
Decyldimethylsilane | 56318-71-9 | C12H28Si | 200.44 | |
Decyl Oleate | 3687-46-5 | C28H54O2 | 422.738 | Decyl 9-octadecenoate; Oleic acid, decyl ester |
decyl nitrate | 2050-78-4 | C10H21NO3 | 203.279 g/mol | |
Decyl Methyl Ether | 7289-52-3 | C11H24O | 172.31 | 1-Methoxydecane; Methyl Decyl Ether; Methyl n-Decyl Ether |
Decyl maltose neopentyl glycol | 1257852-99-5 | C43H80O22 | 949.08 | 2,2-Dioctylpropane-1,3-bis b-D-maltopyranoside; Decyl MNG |
Decyl glucoside | 68515-73-1 | D-Glucose decyl octyl ether, oligomeric; Capryl/Caprylyl Glycoside | ||
Decyl Glucose Neopentyl Glycol | 1423314-52-6 | C35H68O12 | 680.91 | 2,2-Dioctylpropane-1,3-bis b-D-glucopyranoside |
Decyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-glucopyranoside | 135198-04-8 | C24H41NO9 | 487.58 | |
Decyl 2-acetamido-2-deoxy-b-D-glucopyranoside | 147025-05-6 | C18H35NO6 | 361.47 | |
Decursinol angelate | 130848-06-5 | C19H20O5 | 328.36 | |
Decursinol | 23458-02-8 | C14H14O4 | 246.26 | (+)-Decursinol; (3S)-3-hydroxy-2,2-dimethyl-3,4-dihydropyrano[3,2-g]chromen-8-one |
Decursin | 5928-25-6 | C19H20O5 | 328.36 | 2-Butenoic acid, 3-methyl-, (7S)-7,8-dihydro-8,8-dimethyl-2-oxo-2H,6H-benzo[1,2-b:5,4-b']dipyran-7-yl ester (9CI); 2-Butenoic acid, 3-methyl-, 7,8-dihydro-8,8-dimethyl-2-oxo-2H,6H-benzo[1,2-b:5,4-b']dipyran-7-yl ester, (S)-; Crotonic acid, 3-methyl-, este |
Decursidate | 272122-56-2 | C18H18O6 | 330.3 | |
Dectaflur | 36505-83-6 | C18H37N.FH | 287.503 | |
Decoquinate-D5 | 1228182-55-5 | 6-Decyloxy-7-ethoxy-D5- 4-oxo-1,4-dihydro- quinoline-3-carboxylic acid ethyl ester | ||
Decoquinate | 18507-89-6 | C24H35NO5 | 417.54 | |
Decloxizini hydrochloride | 3733-63-9 | C21H28N2O2 | 340.45922;g/mol | Decloxizine; 3733-63-9; 2-(2-(4-Benzhydrylpiperazin-1-yl)ethoxy)ethanol; Hydroxydiethylphenamine; UCB1402; Decloxizine[INN] |
Decitabine Related Compound A (Mixture of Isomers) | 1019659-87-0 | C21H18Cl2O7 | 453.28 | |
Decitabine Impurity 6 | 78185-66-7 | C22H24O6 | 384.43 | alpha-D-Erythro-Pentopyranoside-Methyl-2-Deoxy-bis(4-methylbenzoate) |
Decitabine impurity 6 | 78185-67-8 | C22H24O6 | 384.43 | beta-D-Erythro-Pentopyranoside-Methyl-2-Deoxy-bis(4-methylbenzoate) |
Decitabine Impurity 4 | 6160-56-1 | C6H12O4 | 148.16 | Decitabine Impurity 4 |
Decitabine Impurity 4 | 17676-20-9 | C6H12O4 | 148.16 | Decitabine Impurity 4 |
Decitabine Impurity 3 | 17117-72-5 | C21H22O6 | 370.4 | rac-2-Deoxy-D-erythro-pentofuranose 3,5-Di-p-toluate; p-Toluic Acid 3,5-Diester with 2-Deoxy-D-erythro-pentofuranose |
Decitabine Impurity 2 (beta-Isomer) | 78185-65-6 | C22H24O6 | 384.43 | |
Decitabine Impurity 15 | 96761-00-1 | C5H8O3 | 116.12 | Decitabine Impurity 15; 1,4-Anhydro-2-deoxy-D-erythro-pent-1-enitol |
Decitabine Impurity 11 | 909402-26-2 | C9H13N3O5 | 243.22 | |
Decitabine Impurity 1 (alpha-Isomer) | 51255-17-5 | C6H12O4 | 148.16 | Decitabine Impurity 1 |
Decitabine | 2353-33-5 | C8H12N4O4 | 228.21 | Deoxycytidine, 5-aza-2'-deoxycytidine |
Decinnamoyltaxinine J | 84652-33-5 | C30H42O11 | 578.65 | |
Decinnamoyltaxagifine | 130394-69-3 | C28H38O12 | 566.60 | |
Dechloro Haloperidol | 3109-12-4 | C21H24FNO2 | 341.42 | 1-(4-Fluorophenyl)-4-(4-Hydroxy-4-Phenyl-1-Piperidyl)Butan-1-One; 1-(4-Fluorophenyl)-4-(4-hydroxy-4-phenyl-1-piperidinyl)-1-butanone; 4'-Fluoro-4-(4-hydroxy-4-phenylpiperidino)butyrophenone; Haloperidol impurity B; R 1838 |
Dechloro Griseofulvin | 3680-32-8 | C17H18O6 | 318.33 | 3',4,6-Trimethoxy-5'-Methyl-Spiro[Benzofuran-2,4'-Cyclohex-2-Ene]-1',3-Dione; 3',4,6-Trimethoxy-5'-Methyl-Spiro[Benzofuran-2,4'-Cyclohex-2-Ene]-1',3-Quinone; 7-Dechloro Griseofulvin:(1'S,6'R)-2',4,6-Trimethoxy-6'-methylspiro[benzofuran-2(3H),1'-[2]cyclohe |
Dechlorane 604 component a | 34571-16-9 | C13H4Br4Cl6 | 692.50486 | 1,2,3,4,7,7-Hexachloro-5-(tetrabromophenyl)bicyclo[2.2.1]hept-2-ene; 5-(Tetrabromophenyl)-1,2,3,4,7,7-hexachloro-2-norbornene; Hexachlorocyclopentadiene-tetrabromostyrene Adduct; |
Decernotinib | 944842-54-0 | C18H19F3N6O | 392.286 | Adelatinib; VX-509; VRT-831509; (2R)-2-methyl-2-[[2-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]amino]-N-(2,2,2-trifluoroethyl)butanamide |
Decatromicin B | 235097-64-0 | C45H56Cl2N2O10 | 855.9 | |
Decanedioic acid,3-hydroxy- | 73141-46-5 | C10H18 O5 | 218.25 | |
Decane,1,1,1,3,9,10-hexachloro- | 601523-26-6 | C10H16 Cl6 | 348.95 | 1,1,1,3,9,10-HEXACHLORODECANE |
DECANAL DIMETHYL ACETAL | 7779-41-1 | C12H26O2 | 202.34 | 1,1-Dimethoxydecane, Capraldehyde dimethyl acetal, DECANAL DIMETHYL ACETAL, Decanal DMA, Decane, 1,1-dimethoxy- |
Decamethyltetrasiloxane | 141-62-8 | C10H30O3Si4 | 310.68 | [(CH3)3SiOSi(CH3)2]2O; 1,1,1,3,3,5,5,7,7,7-Decamethyltetrasiloxane; CD3780; D3780; decamethyl-tetrasiloxan; DECAMETHYLETRASILOXANE |
Decamethylferrocene hexafluorophosphate | 54182-44-4 | |||
Decaglycerol decastearate | 39529-26-5 | C48H116O32 | 1205.41544 | |
Decaglycerol | 9041-07-0 | C30H62O21 | 758.7988 | |
Decafluoropent-2-ene | 72804-49-0 | C5F10 | 250.04 | DECAFLUOROPENT-2-ENE; Decafluoropent-2-ene99%; 1,1,1,2,3,4,4,5,5,5-DECAFLUORO-2-PENTENE |
Decafluorocyclohexanone | 1898-91-5 | C6F10O | 278.0476 | |
DECAFLUORO-4-(PENTAFLUOROETHYL)CYCLOHEXANESULFONIC ACID POTASSIUM SALT | 335-24-0 | C8F15KO3S | 500.22 | 1,2,2,3,3,4,5,5,6,6-decafluoro-4-(pentafluoroethyl)-cyclohexanesulfonicaci; DECAFLUORO-4-(PENTAFLUOROETHYL)CYCLOHEXANESULFONIC ACID POTASSIUM SALT; PERFLUORO-4-ETHYLCYCLOHEXANESULFONIC ACID POTASSIUM SALT; PERFLUORO-4-ETHYL-CYCLOHEXANE SULPHONIC ACID, POT |
Decaethylene Glycol Monodecyl Ether | 6540-99-4 | C32H66O11 | 626.87 | |
Decacyclene | 191-48-0 | C36H18 | 450.53 | DECACYCLENE; TRI-PERI-NAPHTHYLENEBENZENE; Diacenaphtheno[1,2-j:1',2'-l]fluoranthen; Diacenaphtho[1,2-j:1',2'-l]fluoranthene; Diacenaphtho[1,2-j:1,2-l]fluoranthene; diacenaphtho[1,2-j:1',2'-l]fluoranthene; benzo(a,a,a)triacenaphthylene; diacenaphtho[1,2-j: |
DECACHLOROBIPHENYL | 2051-24-3 | C12Cl10 | 498.66 | DECACHLOROBIPHENYL; BZ NO 209; BALLSCHMITER NO 209; 2,2',3,3',4,4',5,5',6,6'-DECACHLOROBIPHENYL; 2,2',3,3',4,4',5,5',6,6'-PCB; 1,1'-biphenyl,2,2',3,3',4,4',5,5',6,6'-decachloro |
Debromohymenialdisine | 75593-17-8 | C11H11N5O2 | 245.2 | DBH; SKF 108753 |
Deboxamet | 34024-41-4 | C12H14N2O3 | 234.254 | Deboxamet |
Debio-1347 | 1265229-25-1 | C20H16N6O | 356.389 | Debio-1347; Debio 1347; Debio1347; CH5183284; CH 5183284; CH-5183284; FF-284; FF284; FF 284. |
Debio 0932 | 1061318-81-7 | C22H30N6O2S | 442.58 | Debio0932; Debio 0932; CUDC-305; CUDC305; CUDC 305. |
Debenzoylgalloylpaeoniflorin | 262350-51-6 | C23H28O14 | 528.463 | 6'-O-Galloyldesbenzoylpaeoniflorin |
Deapi-platycodin D3 | 67884-05-3 | C58H94O29 | 1255.361 | 2beta,16alpha,23,24-Tetrahydroxy-3beta-(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyloxy)-5alpha-oleana-12-ene-28-oic acid 2-O-(4-O-beta-D-xylopyranosyl-alpha-L-rhamnopyranosyl)-alpha-L-arabinopyranosyl ester |
Deapio platycodin D | 78763-58-3 | C52H84O24 | Deapio-platycodin D | |
Deanol orotate | 1446-06-6 | C9H13N3O4 | 227.21722 | Deanol orotate; Dimethylaminoethanol orotate |
Deanol acetaminobenzoate | 3635-74-3 | C13H20N2O4 | 234.33 | Deanol acetaminobenzoate; 2-N,N-Dimethylammoniummethyn-1-ol-4-acetylaminobenzoate |
Deacetylsalannin | 1110-56-1 | C32H42O8 | 554.68 | 3-Deacetylsalannin |
Deacetylravidomycin | 88580-27-2 | C29H31NO8 | 521.6 | AY 26623 |
Deacetylpseudolaric acid C2 | 82508-36-9 | C20H24O7 | 376.4 | (1R,7S,8R,9R)-9-[(1E,3E)-4-Carboxy-1,3-pentadien-1-yl]-7-hydroxy-9-methyl-11-oxo-10-oxatricyclo[6.3.2.01,7]tridec-3-ene-4-carboxylic acid |
Deacetylpseudolaric acid A | 82508-37-0 | C20H26O5 | 346.4 | (2E,4E)-5-[(1R,7S,8R,9R)-7-Hydroxy-4,9-dimethyl-11-oxo-10-oxatricyclo[6.3.2.01,7]tridec-3-en-9-yl]-2-methyl-2,4-pentadienoic acid |
Deacetylorientalide | 1258517-59-7 | C19H22O7 | 362.378 | [(3aS,4S,5S,6E,10Z,11aR)-6-formyl-5-hydroxy-10-(hydroxymethyl)-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-4-yl] 2-methylprop-2-enoate |
Deacetylnimbinene | 78916-55-9 | C26H32O6 | 440.54 | 6-Deacetylnimbinene |
Deacetylnimbin | 18609-16-0 | C28H34O8 | 498.57 | Methyl-2-(furan-3-yl)-5-hydroxy-10-(2-methoxy-2-oxoethyl)-1,6,9a,10a-tetram ethyl-9-oxo-3,3a,4a,5,5a,6,9,9a,10,10a-decahydro-2H-cyclopenta[b]naphtho[2,3-d]furan- 6-carboxylate;6-Deacetylnimbin. |
Deacetyleupaserrin | 38456-39-2 | C20H26O6 | 362.422 | [(3aR,4R,6Z,8S,10E,11aR)-8-hydroxy-6,10-dimethyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-4-yl] (Z)-2-(hydroxymethyl)but-2-enoate |
Deacetylanisomycin | 27958-06-1 | C12H17NO3 | 223.3 | SA 3097D1 |
Deacetyl Linezolid | 168828-90-8 | C14H18FN3O3 | 295.31 | (5S)-5-(Aminomethyl)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxazolidinone; (-)-(S)-5-(Aminomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one; (S)-N-[[3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]amine; PNU 105868 |
Deacetyl ganoderic acid F | 100665-44-9 | C30H40O8 | 528.6 | Deacetyl ganoderic acid F; Ganoderic acid F, deacetyl-; (12beta)-12-Hydroxy-3,7,11,15,23-pentaoxolanost-8-en-26-oic acid |
ddTTP | 611-60-9 | C10H17N2O13P3 (free acid) | 466.17 (free acid) | 2',3'-Dideoxythymidine-5'-triphosphate, Lithium salt |
DDTTC | 20682-18-2 | C33H29IN2S2 | 644.633 | Dibenzocyanin 45; Naphtho[1, 1-ethyl-2-[7-(1-ethylnaphtho[1,2-d]thiazol-2(1H)-ylidene)-1,3,5-heptatrienyl]-, iodide |
DDR1-IN-1 dihydrochloride | 1780303-76-5 | C30H31F3N4O3.2HCl | 625.51 | N-[3-[(2,3-Dihydro-2-oxo-1H-indol-5-yl)oxy]-4-methylphenyl]-4-[(4-ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)benzamide dihydrochloride |
DDR1-IN-1 | 1449685-96-4 | C30H31F3N4O3 | 552.59 | DDR1-IN 1; DDR1-IN1 |
DC-120 | 1261080-40-3 | C18H18Cl2N6OS | 437.346 | DC-120; DC 120; DC120 |
Dasotraline hydrochloride | 675126-08-6 | C16H16Cl3N | 328.66 | (1R,4S)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-amine;hydrochloride; SEP-225,289; SEP225,289; SEP225,289; SEP-225289; SEP225289; SEP225289;; Dasotraline; Dasotraline HCl; Dasotraline hydrochloride |
Dasotraline | 675126-05-3 | C16H15Cl2N | 292.203 | (1R,4S)-trans-Norsertraline; Norsertraline, (1R,4S)-trans-; (1R,4S)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-amine |
D-Ascorbic acid | 10504-35-5 | C6H8 O6 | 176.12400 | |
Dasatinib N-Oxide | 910297-52-8 | C22H26ClN7O3S | 504 | N-[2-Chloro-6-methylphenyl]-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide N-Oxide |
Dasatinib Monohydrate | 863127-77-9 | C22H28ClN7O3S | 506.02 | BMS-354825 Monohydrate |
Dasatinib Impurity 5 | 1245157-85-0 | C24H28ClN7O3S | 530.04 | 2-(4-(6-((5-((2-Chloro-6-methylphenyl)carbamoyl)thiazol-2-yl)amino)-2-methylpyrimidin-4-yl)piperazin-1-yl)ethyl acetate |
Dasatinib Impurity 2 | 302964-24-5 | C11H10ClN3OS | 267.73 | 2-Amino-N-(2-chloro-6-methylphenyl)-5-thiazolecarboxamide |
Dasatinib hydrochloride | 854001-07-3 | C22H27Cl2N7O2S | 524.47 | BMS-354825 hydrochloride; Sprycel hydrochloride |
Dasatinib d8 | 1132093-70-9 | C22H18D8ClN7O2S | 496.05 | N-[2-Chloro-6-methylphenyl]-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl-d8]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide; BMS-354825-d8 |
Dasatinib Carboxylic Acid | 910297-53-9 | C22H24ClN7O3S | 501.99 | 4-[6-[[5-[[(2-Chloro-6-methylphenyl)amino]carbonyl]-2-thiazolyl]amino]-2-methyl-4-pyrimidinyl]-1-piperazineacetic Acid |
Dasatinib | 302962-49-8 | C22H26ClN7O2S | 488.01 | BMS-354825 |
dasabuvir | 1132935-63-7 | C26H27N3O5S | 493.578 | N-(6-(3-(tert-butyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamide |
DASA-58 | 1203494-49-8 | C19H23N3O6S2 | 453.53 | |
Darutoside | 59219-65-7 | C26H44O8 | 484.62 | Darutin |
Darusentan | 171714-84-4 | C22H22N2O6 | 410.426 | LU-135252; LU 135252; HMR-4005; (2S)-2-(4,6-dimethoxypyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid |
Darunavir-d9 | 1133378-37-6 | C27H28N3O7SD9 | 556.72 | [(1S,2R)-3-[[(4-Aminophenyl)sulfonyl](2-methylpropyl-d9)amino]-2-hydroxy-1-(phenyl-methyl)propyl]carabamic Acid (3R,3aS,6aR)-Hexahydrofuro[2,3-b]-furan-3-yl Ester; TMC-114-d9; UIC-94017-d9 |
Darunavir Ethanolate | 635728-49-3 | C27H37N3O7S·C2H5OH | 593.73 | Phosphonoformate |
Darunavir | 206361-99-1 | C27H37N3O7S | 547.67 | TMC-114; TMC 114; TMC114; Prezista |
Darodipine | 72803-02-2 | C19H21N3O5 | 371.39 | diethyl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate; darodipine; PY 108-068 |
Darinaparsin | 69819-86-9 | C12H22AsN3O6S | 411.305 | Darinaparsin; ZIO 101. |
Darifenacin-d5 | 133033-93-9 | C28H25N2O2D5 | 431.59 | |
Darapladib | 356057-34-6 | C36H38F4N4O2S | 666.77 | SB-480848 |
D-Arabonic acid-1,4-lactone | 2782-09-4 | C5H8O5 | 148.11 | D-Arabino-1,4-lactone |
D-Arabonic acid | 13752-83-5 | C5H10O6 | 166.13 | |
D-Arabinose-5-phosphate disodium salt | 89927-09-3 | C5H9Na2O8P | 274.07 | |
D-Arabinose-5-phosphate | 13137-52-5 | C5H11O8P | 230.11 | |
D-Arabinose phenylhydrazone | 28767-74-0 | C11H16N2O4 | 240.26 | |
D-Arabinose diethyldithioacetal | 1941-50-0 | C9H20O4S2 | 256.38 | |
D-Arabinose | 10323-20-3 | C5H10O5 | 150.13 | |
D-Arabinopyranosyl thiosemicarbazide | 262849-62-7 | C6H13N3O4S | 223.25 | D-Arabinose (aminothioxomethyl)hydrazone; N-D-arabinopyranosyl-hydrazinecarbothioamide |
D-Arabino-5-hexulosonic acid | 6812-01-7 | C6H10O7 | 194.14 | D-Tagaturonic acid; 5-Keto-L-galactonic acid |
D-Arabino-3-deoxyhexonic acid | 1518-59-8 | C6H12O6 | ||
D-arabinitol | 488-82-4 | C5H12O5 | 152.15 | D-Arabinitol |
D-Arabinaric acid dipotassium salt | 6703-05-5 | C5H6K2O7 | 256.29 | Dipotassium D-arabinarate; Dipotassium D-lyxarate |
Daptomycin-d5 Trifluoroacetic Acid Salt | 1356579-56-0 | C78H99F9N17O32D5 | 1967.77 | Ly-146032-d5 Trifluoroacetic Salt; Cidecin-d5 Trifluoroacetic Salt; Cubicin-d5 Trifluoroacetic Salt |
Daptomycin | 103060-53-3 | C72H101N17O26 | 1620.67 | LY 146032; LY-146032; LY146032; Daptomycin; Cidecin; Cubicin; |
DAPT | 208255-80-5 | C23H26F2N2O4 | 432.46 | |
Dapsone-d8 | 557794-38-4 | C12H4N2O2SD8 | 256.35 | 4,4'-Sulfonylbisbenzeneamine-D8; 4,4'-Sulfonylbis-benzen-2,3,5,6-d4-amine |
Dapsone-13C12 | 1632119-29-9 | 4,4'-Diaminodiphenyl-13C -sulfone | ||
Dapsone Impurity 5 | 27147-69-9 | C12H12N2O2S | 248.3 | 2,4'-Diaminophenyl Sulfone; 2,4'-Sulfonyldi-aniline; 2,4'-Diaminodiphenyl Sulfone; 2,4'-Diaminophenyl Sulfone; 4,2'-Bis(aminophenyl) Sulfone; 2-[(4-Aminophenyl)sulfonyl]-benzenamine |
Dapsone Impurity 4 | 7019-01-4 | C12H11NO2S | 233.29 | 4-Phenylsulfonylaniline; 4-(Phenylsulfonyl)benzenamine; p-(Phenylsulfonyl)aniline; 4-(Benzenesulfonyl)aniline; 4-(Benzenesulphonyl)phenylamine; 4-(Phenylsulfonyl)benzenamine; 4-Aminodiphenyl Sulfone; 4-Aminophenyl Phenyl Sulfone; 4-Phenylsulfonylaniline; |
Dapsone Impurity 3 | 25963-47-7 | C12H11NO3S | 249.29 | 4-Amino-4'-hydroxydiphenylsulfone; 4-[(4-Aminophenyl)sulfonyl]phenol; p-Sulfanilylphenol |
Dapsone Impurity 2 | 7146-68-1 | C12H10ClNO2S | 267.73 | 4-Amino-4'-chlorodiphenyl Sulfone; 4-[(4-Chlorophenyl)sulfonyl]benzenamine; p-[(p-Chlorophenyl)sulfonyl]aniline; 4-(4-Chlorobenzenesulfonyl)phenylamine; 4-Amino-4'-chlorodiphenyl Sulfone; 4-Aminophenyl 4-chlorophenyl Sulfone; NSC 23812; NSC 51990; p-(p-Ch |
Dapsone Impurity 1 | 80-00-2 | C12H9ClO2S | 252.72 | 4-Chlorophenyl Phenyl Sulfone; 4-Chlorodiphenyl Sulfone; 4-Chlorophenyl Phenyl Sulfone; NSC 404335; R 242; Sulfenon; Sulphenone; p-Chlorodiphenyl Sulfone; p-Chlorophenyl Phenyl Sulfone; p-Chlorophenyl Phenyl Sulfone; 1-Chloro-4-(phenylsulfonyl)benzene |
Dapsone Hydroxylamine | 32695-27-5 | C12H12N2O3S | 264.3 | N-Hydroxy-4,4'-sulfonyldi(aniline); N-Hydroxy-4,4'-sulfonyldi-aniline; 4-[(4-Aminophenyl)sulfonyl]-N-hydroxy-benzenamine |
Dapoxetine-d7 HCl | 1132642-56-8 | C21H17ClNOD7 | 348.93 | |
Dapansutrile | 54863-37-5 | C4H7NO2S | 133.2 | OLT1177; 3-methanesulfonylpropanenitrile |
Dapagliflozin Ortho Isomer | 2040305-05-1 | C21H25ClO6 | 408.87 | (2S,3R,4R,5S,6R)-2-(4-Chloro-3-(2-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
Dapagliflozin Impurity 9 | 1469910-70-0 | C21H25ClO6 | 408.87 | (1S)-1,4-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol; Dapagliflozin 1,4- Anhydro form; Dapagliflozin furanose isomer |
Dapagliflozin Impurity 3 | 1807632-95-6 | C21H25BrO6 | 453.32 | 4-Deschloro-4-bromo Dapagliflozin; (1S)-1,5-Anhydro-1-C-[4-bromo-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol |
Dapagliflozin Impurity 10 | 960404-86-8 | C21H25ClO7 | 424.88 | |
Dapagliflozin Impurity 1 | 1404477-10-6 | C15H12BrClO2 | 339.61 | 5-Bromo-2-chloro-2'-ethoxy Benzophenone; (5-Bromo-2-chlorophenyl)(2-ethoxyphenyl)methanone |
Dapagliflozin D5 | 1204219-80-6 | C21H10D5ClO6 | 413.90 | (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol-D5; BMS 512148-D5 |
Dapagliflozin (2S)-1,2-propanediol, hydrate | 960404-48-2 | C24H35ClO9 | 502.98 | Dapagliflozin propylene glycol hydrate |
Dapagliflozin | 461432-26-8 | C21H25ClO6 | 408.87 | (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol; BMS 512148 |
DAP-81 | 794466-17-4 | C25H20N6O4 | 468.464 | DAP 81; N-(4-((4-((2-benzoylphenyl)amino)-5-nitropyrimidin-2-yl)amino)phenyl)acetamide |
D-AP7 | 81338-23-0 | C7H16NO5P | 225.181 | Heptanoic acid, 2-amino-7-phosphono-, (2R)-; D-AP7; D(-)-2-Amino-7-phosphonoheptanoic acid; (2R)-2-amino-7-phosphonoheptanoic acid |
D-AP5 | 79055-68-8 | C5H12NO5P | 197.13 | D-(-)-2-Amino-5-phosphonopentanoic acid |
D-AP4 | 78739-01-2 | C4H10NO5P | 183.10 | D-(-)-2-Amino-4-phosphonobutyric acid |
Danshensu | 76822-21-4 | C9H10O5 | 198.17 | (R)-a,3,4-Trihydroxybenzenepropanoic acid; 3-(3',4'-Dihydroxyphenyl)-(2R)-lactic acid; Dan shen suan A; Salvianic acid A |
Danshenol C | 910856-25-6 | C21H20O4 | 336.38 | (1R,10R)-1,10-Dihydro-10-hydroxy-1,6-dimethyl-10-(2-oxopropyl)phenanthro[1,2-b]furan-11(2H)-one |
Danoprevir | 850876-88-9 | C35H46FN5O9S | 731.837 | RG7227, ITMN-191, RO5190591. |
Danofloxacin-D3 | 1217683-55-0 | 1-Cyclopropyl-6-fluoro-7- (5-methyl-D3-2,5-diaza-bicyclo-[2.2.1]hept-2-yl)- 4-oxo-1,4-dihydro-quino- line-3-carboxylic acid | ||
Danofloxacin Mesylate | 119478-55-6 | C19H20FN3O3.CH4O3S | 453.48 | CP-76136-27 |
Danmelittoside | 20633-72-1 | C15H22O10 | 362.33 | (2S,3R,4S,5S,6R)-2-[[(1S,4aS,5R,7aR)-4a,5-dihydroxy-7-(hydroxymethyl)-5,7a-dihydro-1H-cyclopenta[c]pyran-1-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol |
Danirixin | 954126-98-8 | C19H21ClFN3O4S | 441.9 | GSK1325756; N-(4-chloro-2-hydroxy-3-(3-piperidinylsulfonyl)phenyl)-N'-(3-fluoro-2-methylphenyl)urea |
Daniquidone | 67199-66-0 | C15H11N3O | 249.273 | Batracylin; Daniquidone |
Dandelion Extract | 84775-55-3 | 0 | TARAXACUM OFFICINALE (DANDELION) EXTRACT; Dandelion extract; Dandelion Root Extract; Unii-L9D1817A42 | |
Danaparoid sodium - Mixture of dermatan sulfate, heparan sulfate and chondroitin sulfate | 83513-48-8 | Mixture of dermatan sulfate, heparan sulfate and chondroitin sulfate | ||
DAN-1 EE hydrochloride | 1049720-51-5 | C20H20N2O2·HCl | 356.9 | 4-[[(3-amino-2-naphthalenyl)amino]methyl]-benzoic acid ethyl ester hydrochloride; Ethyl 4-[(3-amino-2-naphthyl)aminomethyl]benzoate hydrochloride |
Damulin B | 1202868-75-4 | C42H70O13 | 782.99 | |
Damulin A | 1202868-74-3 | C42H70O13 | 782.99 | |
Daminozide | 1596-84-5 | C6H12N2O3 | 160.17 | Alar; B 995; DMASA; SADH; Succinic Acid; Aminozide; Kylar; DIMG |
D-Amino Acid Oxidase Inhibitor | 39793-31-2 | C7H5NO2S | 167.2 | DAAO inhibitor; 4H-thieno[3,2-b]pyrrole-5-carboxylic acid |
DAMIANA LEAVES FLUID EXTRACT | 84696-52-6 | 0 | Turneradiffusa,ext.; DAMIANA LEAVES FLUID EXTRACT; Tumera diffusa extract; Damiana (turnera diffusa); Damiana (turnera diffusa) [leaf]; Einecs 283-657-8; Unii-rq2cfa7wwj | |
DAMGO | 78123-71-4 | C26H35N5O6 | 513.7 | [D-Ala2, NMe-Phe4, Gly-ol5]-enkephalin |
damascenone | 23696-85-7 | C13H18O | beta-Damascenone; 1-(2,6,6-Trimethyl-1,3-cyclohexadien-1-yl)-2-buten-1-one; 2-Buten-1-one, 1-(2,6,6-trimethyl-1,3-cyclohexadien-1-yl)-; Damascenone; Damascenone (natural); EINECS 245-833-2; FEMA No. 3420; 4-(2,6,6-Trimethylcyclohexa-1,3-dienyl)but-2-en-4- | |
DAMASCENINE | 483-64-7 | C10H13NO3 | 195.22 | METHYL 3-METHOXY-2-(METHYLAMINO)BENZOATE; DAMASCENINE; 3-Methoxy-2-(methylamino)benzoate (Damascenine); 2-(Methylamino)-3-methoxybenzoic acid methyl ester; 3-Methoxy-2-(methylamino)benzoic acid methyl ester; Methyldamascenine; Nigelline |
D-Altrose | 1990-29-0 | C6H12O6 | 180.16 | |
D-alpha-Tocopherol Succinate | 4345-03-3 | C33H54O5 | 530.79 | Vitamin E succinate; Alpha-Tocopheryl succinate; D-; 4-oxo-4-[[(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl]oxy]butanoic acid |
D-Allulose (D-Psicose) | 551-68-8 | C6H12O6 | 180.16 | D-Allulose; D-Ribo-2-hexulose; |
D-Allothreonine, N-[(1,1-dimethylethoxy)carbonyl]- (9CI) | 85979-33-5 | C9H17NO5 | 219.23498 | D-Allothreonine, N-[(1,1-dimethylethoxy)carbonyl]- (9CI) |
D-Allose-6-phosphate disodium salt hydrate | 82259-50-5 | C6H11O9PNa2 | 304.10 | |
D-Allose-6-phosphate disodium | 1161976-98-2 | C6H11O9PNa2 | 304.10 | |
Dacarbazine Related Compo | 63907-29-9 | C4HN5O | 135.08400 | |
Dacarbazine Impurity A | 4656-86-4 | C4H3N5O | 137.1 | 2-Azahypoxanthine; 3,7-Dihydro-4H-imidazo[4,5-d]-1,2,3-triazin-4-one; 1,5-Dihydro-4H-Imidazo[4,5-d]-1,2,3-triazin-4-one; 3,7-Dihydro-4H-imidazo[4,5-d]-v-triazin-4-one |
Dacarbazine | 891-98-6 | Biocarbazine; Dacarbazina; Dacarbazina Almirall; Dacarbazine - DTIC; Dakarbazin; Dimethyl (triazeno) imidazolecarboxamide; Dimethyl Triazeno Imidazol Carboxamide; Dimethyl Triazeno Imidazole Carboxamide; Imidazole Carboxamide Imidazole Carboxamide Dimethy | ||
Dacarbazine | 4342-03-4 | C6H10N6O | 182.18 | DTIC-Dome |
Dabuzalgron | 219311-44-1 | C12H16ClN3O3S | 317.79 | N-[6-chloro-3-(4,5-dihydro-1H-imidazol-2-ylmethoxy)-2-methyl-phenyl]me thanesulfonamide; Dabuzalgron |
Dabrafenib-d9 | 1423119-98-5 | C23H11F3N5O2S2D9 | 528.62 | N-[3-[5-(2-Amino-4-pyrimidinyl)-2-[1,1-di(methyl-d3)ethyl-2,2,2-d3]-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-benzenesulfonamide; GSK 2118436-d9; Tafinlar-d9 |
Dabrafenib Mesylate | 1195768-06-9 | C24H24F3N5O5S3 | 615.67 | N-(3-(5-(2-aminopyrimidin-4-yl)-2-(tert-butyl)thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide methanesulfonate; Dabrafenib mesylate; GSK 2118436B; GSK2118436B; GSK-2118436B; GSK2118436 Methane sulfonate salt; Brand name: Taflinar |
Dabrafenib | 1195765-45-7 | C23H20F3N5O2S2 | 519.56 | N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-benzenesulfonamide; Dabarefenib; GSK 2118436; Tafinlar |
DABMI | 87963-80-2 | C18H16N4O2 | 320.352 | 4-Dimethylaminophenylazophenyl-4'-maleimide |
Dabigatran Impurity M | 1422435-41-3 | C27H28N6O4 | 500.55 | Dabigatran Carboxamide Ethyl Ester |
Dabigatran Impurity K | 211915-00-3 | C33H39N7O5 | 613.72 | |
Dabigatran Impurity E | 1610758-21-8 | C35H43N7O5 | 641.76 | O-(2-Heptyl) Dabigatran Ethyl Ester; Ethyl 3-(2-(((4-(N-((Heptan-2-yloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate |
Dabigatran Impurity 9 HCl | 1408238-41-4 | C19H22ClN5O2 | 387.87 | |
Dabigatran Impurity 23 | 1637238-96-0 | C37H41N9O4 | 675.8 | |
Dabigatran Impurity 22 | 58906-62-0 | C7H13ClO2 | 164.63 | 3-Hexyl Chloroformate; Carbonochloridic Acid 1-Ethylbutyl Ester; Hexan-3-yl Carbonochloridate |
Dabigatran Impurity 21 | 265659-62-9 | C7H13ClO2 | 164.63 | |
Dabigatran Impurity 15 | 265659-61-8 | C7H13ClO2 | 164.63 | 2-Methylpentyl Chloroformate; Carbonochloridic Acid 2-Methylpentyl Ester |
Dabigatran Impurity 14 | 429659-01-8 | C19H22N4O5 | 386.41 | Ethyl 3-(4-(ethylamino)-3-nitro-N-(pyridin-2-yl)benzamido)propanoate |
Dabigatran Impurity 12 | 1422435-35-5 | C21H23N3O4 | 381.44 | |
Dabigatran Impurity 11 | 1422495-93-9 | C29H31N5O5 | 529.6 | |
Dabigatran Impurity 10 | 1422435-37-7 | C21H25ClN4O3 | 416.91 | |
Dabigatran ethyl ester hydrochloride | 211914-50-0 | C27H30ClN7O3 | 536.03 | Dabigatran Impurity O HCl; Dabigatran Ethyl Ester Hydrochloride Salt; Ethyl 3-[[2-[(4-carbamimidoylanilino)methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate hydrochloride |
Dabigatran ethyl ester | 429658-95-7 | C27H29N7O3 | 499.56 | |
Dabigatran ethyl AcOH Salt | 1188263-64-0 | C29H33N7O5 | 559.627 | Ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate acetate |
Dabigatran etexilate meslate | 593282-20-3 | C35H45N7O8S.CH3SO3H | 723.83900 | |
Dabigatran Etexilate Impurity 1 | 1610758-19-4 | C35H43N7O5 | 641.78 | |
Dabigatran etexilate | 211915-06-9 | C34H41N7O5 | 627.73 | Prazaxa; BIBR 1048; BIBR-1048 |
Dabigatran | 211914-51-1 | C25H25N7O3 | 471.51 | BIBR 953; BIBR953; BIBR-953 |
D-3-Cyclobutylalanine | 174266-00-3 | C7H13NO2 | 143.18362 | D-Cyclobutylalanine; D-3-Cyclobutylalanine |
D-346 | 76877-33-3 | C24H22N2O4 | 402.4 | 3-(4-Maleimidophenyl)-4-methyl-7-(diethylamino)coumarin; 7-Diethylamino-3-(4-maleimidophenyl)-4-methylcoumarin; 1-[4-[7-(diethylamino)-4-methyl-2-oxo-2H-1-benzopyran-3-yl]phenyl]-1H-pyrrole-2,5-dione |
D-3263 | 947257-66-1 | C21H31N3O3 | 373.497 | D-3263; EC D-3263 HCl; |
D-3 | 1967815-98-0 | C48H47N4O10P | 870.88 | |
D-[5-13C]fructose | 635325-97-2 | 13CC5H12O6 | 181.15 | |
D-[5-13C]arabinose | 139657-60-6 | 13CC4H10O5 | 151.12 | |
D-[3-2H]galactose | 478518-70-6 | C62HH11O6 | 181.16 | |
D-[3-2H]fructose | 53685-24-8 | C62HH11O6 | 181.17 | |
b-D-Ribopyranosyl amine | 85280-61-1 | C5H11NO4 | 149.15 | Propionic acid,3-dodecyloxy-,methyl ester; (2R,3R,4R,5R)-2-aminooxane-3,4,5-triol; 1-amino-1-deoxyribose; D-ribosylamine; ribosylamine |
Zopiclone-d4 | 1435933-78-0 | C17H13D4ClN6O3 | 392.84 | 4-Methyl-1-piperazine-carboxylic Acid 6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl Ester d4; RP-27267 d4; Amoban d4; Imovane d4 |
Zotarolimus | 221877-54-9 | C52H79N5O12 | 966.21 | A-179578; A 179578; A179578; ABT-578; ABT578; ABT 578 |
Z-VDVAD-FMK | 210344-92-6 | C32H46FN5O11 | 695.74 | Z-Val-Asp(OMe)-Val-Ala-Asp(OMe)-FMK; Z-Val-Asp(OMe)-Val-Ala-Asp(OMe)-Fluoromethylketone; methyl 5-fluoro-3-[2-[[2-[[4-methoxy-2-[[3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]-4-oxobutanoyl]amino]-3-methylbutanoyl]amino]propanoylamino]-4-oxopenta |
Zymosan A | 58856-93-2 | (C6H10O5)x | Variable | |
Zylofuramine | 3563-92-6 | C14H21NO | 219.326 | Zylofuramine; (1R)-N-ethyl-1-[(2R)-oxolan-2-yl]-2-phenylethanamine; (1R)-N-ethyl-1-[(2R)-oxolan-2-yl]-2-phenyl-ethanamine; ethyl-[(1R)-2-phenyl-1-[(2R)-tetrahydrofuran-2-yl]ethyl]amine |
Z-VAL-DL-ASP-FLUOROMETHYLKETONE | 582316-00-5 | C18H23FN2O6 | 382.38 | Z-VAL-DL-ASP-FLUOROMETHYLKETONE; Z-VD-FMK; Pentanoic acid,5-fluoro-3-[[(2S)-3-methyl-1-oxo-2-[[(phenylmethoxy)carbonyl]amino]butyl]amino]-4-oxo- |
Zosuquidar trihydrochloride | 167465-36-3 | C32H34Cl3F2N3O2 | 636.99 | LY 335979; LY-335979; D06387; RS-33295-198; Zosuquidar HCl |
Zosuquidar | 167354-41-8 | C32H31F2N3O2 | 527.60 | (2R)-anti-5-(3-(4-(10,11-difluoromethanodibenzo-suber-5-yl)piperazin-1-yl)2-hydroxypropoxy)quinoline trihydrochloride LY 335979 LY335979 RS 33295-198 RS-33295-198 zosuquidar trihydrochloride |
Zorubicin | 54083-22-6 | C34H35N3O10 | 645.665 | Zorubicin; RP-22050; rubidazone; Zorubicine. |
Zoliflodacin | 1620458-09-4 | C22H22FN5O7 | 487.40 | UNII-FWL2263R77; AZD-0914; FWL2263R77; Zoliflodacin; AZD0914; CHEMBL3544978; (2R,4S,4aS)-11-fluoro-2,4-dimethyl-8-((S)-4-methyl-2-oxooxazolidin-3-yl)-1,2,4,4a-tetrahydro-2'H,6H-spiro[isoxazolo[4,5-g][1,4]oxazino[4,3-a]quinoline-5,5'-pyrimidine]-2',4',6'(1 |
Zoleprodolol | 158599-53-2 | C17H25N3O5 | 351.40 | Zoleprodolol; Zoleprodolol [INN]; 1-(tert-butylamino)-3-[2-[(3-methoxy-1,2,4-oxadiazol-5-yl)methoxy]phenoxy]propan-2-ol; 1-(tert-butylamino)-3-{2-[(3-methoxy-1,2,4-oxadiazol-5-yl)methoxy]phenoxy}propan-2-ol; AC1L3230; MCULE-5529397605 |
Zolenzepine | 78208-13-6 | C19H24N6O2 | 368.43300 | |
Zoledronic acid | 165800-06-6 | C5H12N2O8P2 | 290.1 | Zoledronate monohydrate; CGP 42446 monohydrate; CGP42446A monohydrate; ZOL 446 monohydrate |
Zoledronic Acid | 118072-93-8 | C5H10N2O7P2 | 272.09 | Zoledronate; Zometa; Reclast; (1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid |
Zolazepam | 31352-82-6 | C15H15FN4O | 286.309 | Zolazepam; 4-(2-Fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo[3,4-e][1,4]diazepin-7(1H)-one; CL-716 |
Zolantidine dimaleate | 104076-39-3 | C22H27N3OS.2C4H4O4 | 613.68 | N-[3-[3-(1-Piperidinylmethyl)phenoxy]propyl]-2-benzothiazolamine dimaleate; SKF 95282 dimaleate |
Zofenopril Calcium Salt | 81938-43-4 | C44H44CaN2O8S4 | 897.17 | SQ26991; SQ 26991; SQ-26991; (4S)-N-[3-(benzoylsulfanyl)-2(s)-methylpropionyl]-4-(phenylsulfanyl)-l-proline calcium salt;[1(S),4(S)]-1-(3-Mercapto-2-methyl-1-oxopropyl)-4-phenyl-thio-L-proline-S-benzoyl Ester Calcium Salt;[(4S)-(2S)-3-(benzoylthio)-2-meth |
Zoalene-D5 | 1596379-06-4 | 2-Methyl-3,5-dinitrobenz- amide-D; Dinitolmide-D5 | ||
ZnPc | 14320-04-8 | |||
ZM447439 | 331771-20-1 | C29H31N5O4 | 513.59 | Code name: ZM447439 |
ZM336372 | 208260-29-1 | C23H23N3O3 | 389.45 | ZM-336372; ZM 336372 |
ZM323881 hydrochloride | 193000-39-4 | C22H19ClFN3O2 | 411.86 | ZM-323881 hydrochloride; ZM 323881 hydrochloride |
ZM323881 | 324077-30-7 | C22H19ClFN3O2 | 411.861 | ZM 323881; ZM-323881. |
ZM323881 | 193001-14-8 | C22H18FN3O2 | 375.4 | ZM 323881; ZM-323881 |
ZM306416 | 690206-97-4 | C16H13ClFN3O2 | 333.74 | ZM 306416; ZM-306416. |
ZM-230487 | 155944-23-3 | C24H26FNO4 | 411.47 | ZM-230487; ZM 230487; 1-Ethyl-6-((3-fluoro-5-(4-methoxy-3,4,5,6-tetrahydro-2H-pyran-4-yl)phenoxy)methyl)-2-quinolone; CHEMBL459236; Ici 230487 |
ZM 449829 | 4452-06-6 | C13H10O | 182.22 | 1-(2-Naphthalenyl)-2-propen-1-one; JAK3 inhibitor V |
ZM 39923 hydrochloride | 58753-54-1 | C23H25NO.HCl | 367.92 | 3-benzylisopropylamino-1-naphthalen-2-yl-propan-1-one hydrochloride; JAK3 Inhibitor IV |
ZM 39923 HCl | 1021868-92-7 | C23H25NO.HCl | 367.91 | ZM 39923 hydrochloride; JAK3 Inhibitor IV; 3-[benzyl(propan-2-yl)amino]-1-naphthalen-2-ylpropan-1-one hydrochloride |
ZM 39923 | 273727-89-2 | C23H25NO | 331.45 | 3-[benzyl(propan-2-yl)amino]-1-naphthalen-2-ylpropan-1-one 3-(benzyl(isopropyl)amino)-1-(naphthalen-2-yl)propan-1-one 273727-89-2 beta-(Isopropylbenzylamino)-2'-propionaphthone ZM39923 3-[benzyl(propan-2-yl)amino]-1-(naphthalen-2-yl)propan-1-one NCG |
ZM 306416 hydrochloride | 196603-47-1 | C16H13N3O2FCl.HCl | 370.21 | 4-[(4'-Chloro-2'-fluoro)phenylamino]-6,7-dimethoxyquinazoline hydrochloride |
ZM 260384 | 161229-62-5 | C15H11F4N3O4 | 373.26 | ZM 260384; AC1L53UP; SCHEMBL6369154; DTXSID90167090; HE092130; 2,2-bis(difluoromethyl)-6-nitro-4-(1-oxido-2H-pyridin-6-yl)-3H-1,4-benzoxazine |
ZM 241385 | 139180-30-6 | C16H15N7O2 | 337.34 | 4-(2-[7-Amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5]triazin-5-ylamino]ethyl)phenol |
ZM 226600 | 147695-92-9 | C16H14F3NO4S | 373.35 | N-(4-Phenylsulfonylphenyl)-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide |
Z-LLY-FMK | 133410-84-1 | C30H40FN3O6 | 557.66 | Calpain Inhibitor IV; Z-Leu-Leu-Tyr-FMK; Z-Leu-Leu-Tyr-Fluoromethylketone; benzyl N-[1-[[1-[[4-fluoro-1-(4-hydroxyphenyl)-3-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamate |
ZLJ-6 | 1051931-39-5 | C12H13N3O3S·CH3SO3H | 375.4 | |
ZIP (Scrambled) | 908012-18-0 | C90H154N30O17 | 1928.4 | Z-Pseudosubstrate inhibitory peptide (scrambled) |
Z-LEHD-FMK | 524746-03-0 | C34H44F4N6O12 | 804.74 | Caspase-9 Inhibitor; Methyl (4S)-5-[[(2S)-1-[[(3S)-5-fluoro-1-methoxy-1,4-dioxopentan-3-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-4-[[(2S)-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-5-oxopentanoate;2,2,2-trifluoroacetic acid |
ZLD1039 | 1826865-46-6 | C36H48N6O3 | 612.819 | 3-[Ethyl(tetrahydro-2H-pyran-4-yl)amino]-N-[(2,3,5,6,7,8-hexahydro-1-methyl-3-oxo-4-isoquinolinyl)methyl]-2-methyl-5-[6-(4-methyl-1-piperazinyl)-3-pyridinyl]-benzamide |
ZL0420 | 2229039-45-4 | C16H16N4O2 | 296.32 | 6-[(2-Amino-4-hydroxy-5-methylphenyl)diazenyl]-3,4-dihydro-1H-quinolin-2-one |
ZL006 | 1181226-02-7 | C14H11Cl2NO4 | 328.15 | |
ZK-Thiazolidinone | 891849-87-9 | C23H30F3N5O2S | 497.581 | TAL. |
ZK-90055 hydrochloride | 84638-81-3 | C16H23ClN2O4 | 342.82 | methyl 4-[2-(tert-butylamino)-1-hydroxyethyl]-7-hydroxy-1H-indole-2-carboxylate;hydrochloride; ZK-90055 (hydrochloride) |
ZK756326 (dihydrochloride) | 1780259-94-0 | C21H30Cl2N2O3 | 429.38 | 2-[2-[4-[(3-phenoxyphenyl)methyl]piperazin-1-yl]ethoxy]ethanol;dihydrochloride; 2-(2-(4-(3-phenoxybenzyl)piperazin-1-yl)ethoxy)ethanol; ZK 756326; ZK-756326; ZK756326; ZK756326 dihydrochloride |
ZK-304709 | 477588-78-6 | C13H16BrN5O3S | 402.27 | (S)-4-((5-bromo-4-((1-hydroxypropan-2-yl)amino)pyrimidin-2-yl)amino)benzenesulfonamide; |
ZK-261991 | 886563-25-3 | C24H25N7O2 | 443.5 | Benzamide, 2-[[[2-[[(dimethylamino)carbonyl]amino]-4-pyridinyl]methyl]amino]-N-(2- methyl-2H-indazol-6-yl)-; ZK261991; ZK-261991; ZK 261991; ZK-991; ZK 991 |
ZK200775 hydrate | 1255517-78-2 | C14H17F3N3O7P | 427.27 | Fanapanel hydrate; MPQX hydrate; ZK-200775 hydrate |
ZK200775 | 161605-73-8 | C14H15F3N3O6P | 409.25 | Fanapanel; MPQX; ZK-200775 |
ZK118182 isopropyl ester | 154927-31-8 | C23H37ClO5 | 429 | Propan-2-yl 2-[4-[5-chloro-2-(3-cyclohexyl-3-hydroxyprop-1-enyl)-3-hydroxycyclopentyl]but-2-enoxy]acetate |
ZK 93426 HYDROCHLORIDE | 89592-45-0 | C18H20N2O3.HCl | 348.82 | |
ZK 93426 hydrochloride | 1216792-30-1 | C18H20N2O3.HCl | 348.82 | 4-Methyl-5-(1-methylethoxy)-9H-pyrido[3,4-b]indole-3-carboxylic acid ethyl ester hydrochloride |
ZK 93423 HYDROCHLORIDE | 83910-44-5 | C23H22N2O4.HCl | 426.9 | |
ZK 93423 hydrochloride | 1216574-52-5 | C23H22N2O4.HCl | 426.9 | 4-(Methoxymethyl)-6-(phenylmethoxy)-9H-pyrido[3,4-b]indole-3-carboxylic acid ethyl ester hydrochloride |
ZK 756326 | 874911-96-3 | C21H28N2O3.2HCl | 429.38 | 2-[2-[4-[(3-phenoxyphenyl)methyl]-1-piperazinyl]ethoxy]ethanol dihydrochloride |
ZK 164015 | 177583-70-9 | C30H43NO4S | 513.73 | 2-(4-Hydroxyphenyl)-3-methyl-1-[10-(pentylsulfonyl)decyl]-1H-indol-5-ol |
ZJ 43 | 723331-20-2 | C12H20N2O7 | 304.3 | N-[[[(1S)-1-Carboxy-3-methylbutyl]amino]carbonyl]-L-glutamic acid; (2S)-2-[[(1S)-1-carboxy-3-methylbutyl]carbamoylamino]pentanedioic acid |
Zizyphus jujuba extract | 90045-99-1 | |||
Ziziphin | 73667-51-3 | C51H80O18 | 981.17 | |
Ziyuglycoside II | 35286-59-0 | C35H56O8 | 604.81 | (3beta)-3-(alpha-L-Arabinopyranosyloxy)-19-hydroxyurs-12-en-28-oic acid |
Ziyuglycoside I | 35286-58-9 | C41H66O13 | 766.95 | 3-O-alpha-L-Arabinopyranosylpomolic acid beta-D-glucopyranosyl ester |
ZIRCONYL NITRATE DIHYDRATE | 20213-65-4 | H4N2O9Zr | 267.26 | ZIRCONIUM(+4)NITRATE OXIDE DIHYDRATE; ZIRCONIUM NITRATE OXIDE DIHYDRATE; ZIRCONYL NITRATE DIHYDRATE; ZIRCONIUM OXYNITRATE DIHYDRATE; ZIRCONIUM OXYNITRATE, HYDROUS; ZIRCONIUM OXYNITRATE 2 HO |
Zirconyl chloride oCtahydrate | 13520-92-8 | ZroCl2.8(H2O) | 322.25 | dichlorooxozirconiumoctahydrate; dichlorooxo-zirconiuoctahydrate; Zirconiumoxychloride,octahydr; ZIRCONIUM(+4)CHLORIDE OXIDE OCTAHYDRATE; ZIRCONIUM(+4)OXYCHLORIDE OCTAHYDRATE; ZIRCONIUM CHLORIDE BASIC; ZIRCONIUM CHLORIDE OXIDE OCTAHYDRATE; ZIRCONIUM DICHL |
Zirconium,dichlorobis[(1,2,3,4,5-h)-1,2,3,4-tetramethyl-2,4-cyclopentadien-1-yl]- | 119445-90-8 | C18H26 Cl2 Zr | 404.53 | BIS(TETRAMETHYLCYCLOPENTADIENYL)ZIRCONIUM DICHLORIDE; Bis(tetramethylcyclopentadienyl)zirconiumdichloride,min.97%; Tris(dimethylamino)-2-methylimidazol zirconium; Bis(tetramethylcyclopentadienyl)zirconium dichloride, min. 97% |
Zirconium,dichloro[(1,2,3,4,5-h)-1-propyl-2,4-cyclopentadien-1-yl][(1,2,3,4,5-h)-1,2,3,4-tetramethyl-2,4-cyclopentadien-1-yl]- | 202001-05-6 | C17H24 Cl2 Zr | 390.5 | (N-PROPYLCYCLOPENTADIENYL)(TETRAMETHYLCYCLOPENTADIENYL)ZIRCONIUM DICHLORIDE |
Zirconium,[(dimethylsilylene)bis[(1,2,3,3a,7a-h)-1H-inden-1-ylidene]]dimethyl- | 146814-57-5 | C22H24 Si Zr | 407.74 | RAC-DIMETHYLSILYLBIS-(1-INDENYL)ZIRCONIUM(IV)DIMETHYL |
ZIP | 863987-12-6 | C90H154N30O17 | 1982.4 | Z-Pseudosubstrate inhibitory peptide |
Zinterol hydrochloride | 38241-28-0 | C19H26N2O4S | 414.95 | N-[5-[2-[(1,1-Dimethyl-2-phenylethyl)amino]-1-hydroxyethyl]-2-hydroxyphenyl]methanesulphonamide hydrochloride; Zinterol HCl; (+-)-Zinterol hydrochloride |
Zinterol hydrochloride | 37000-20-7 | C19H26N2O4S | 414.95 | N-[5-[2-[(1,1-Dimethyl-2-phenylethyl)amino]-1-hydroxyethyl]-2-hydroxyphenyl]methanesulphonamide hydrochloride |
Zingibroside R1 | 80930-74-1 | C42H66O14 | 795 | Ginsenoside Z-R1; 28-O-deglucosyl-chikusetsusaponin V |
Zingiberensis saponin I | 91653-50-8 | C51H82O22 | 1047.195 | Deltonin glucoside; Glucopyranosyl-(1-3)-deltonin; Beta-D-Glucopyranoside, (3beta,25R)-spirost-5-en-3-yl O-6-deoxy-alpha-L-mannopyranosyl-(1-2)-O-(O-beta-D-glucopyranosyl-(1-3)-beta-D-glucopyranosyl-(1-4))-, (S-(R*,R*))- |
ZINGIBERENE | 495-60-3 | C15H26 | ||
Zingerone | 122-48-5 | C11H14O3 | 194.23 | NSC 15335 |
Zinc-bis(2-hydroxy-3,5-bis(1-phenylethyl) benzoate | 53770-52-8 | C46H42O6Zn | Zinc-bis(2-hydroxy-3,5-bis(1-phenylethyl) benzoate; Zinc 3,5-bis(alpha-methylbenzyl)salicylate | |
Zidovudine Related Compound B | 25526-94-7 | C10H13ClN2O4 | 260.68 | 3'-Chloro-3'-deoxythymidine; USP Zidovudine Related Compound B |
Zidebactam | 1436861-97-0 | C13H21N5O7S | 391.40 | WCK5107;(1R,2S,5R)-7-oxo-2-(2-((R)-piperidine-3-carbonyl)hydrazine-1-carbonyl)-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate |
Zicronapine | 170381-16-5 | C22H27ClN2 | 354.92 | Zicronapine; UNII-QZV11V7G6A; 4-[(1R,3S)-6-chloro-3-phenyl-2,3-dihydro-1H-inden-1-yl]-1,2,2-trimethylpiperazine |
Zibotentan | 186497-07-4 | C19H16N6O4S | 424.435 | ZD4054. |
Z-Guggulsterone | 39025-23-5 | C21H28O2 | 312.45 | (Z)-Pregna-4,17(20)-diene-3,16-dione |
Zephirol Related Compound 5 | 57-09-0 | C19H42N.Br | 364.45 | CTAB; Cetrimonium bromide; NSC 32927; NSC-32927; NSC32927 |
Zephirol Related Compound 3 | 122-19-0 | C27H50N.Cl | 424.15 | N,N-Dimethyl-N-octadecylbenzenemethanaminium Chloride; Benzyldimethyloctadecylammonium Chloride; Algene SC 25; Carsoquat SDQ 25; Stebac; Triton CG 500; Varisoft SDC |
Zephirol Related Compound 2 | 122-18-9 | C25H46N.Cl | 395.33 | N-Hexadecyl-N,N-dimethylbenzenemethanaminium Chloride; Benzylhexadecyldimethylammonium Chloride; Acetoquate CDAC; Acinol; Banicol |
Zephirol Related Compound 1-d7 | 1219178-72-9 | C23H35ND7·Cl | 375.08 | N,N-Dimethyl-N-tetradecylbenzenemethanaminium-d7 Chloride; (Benzyl-d7)dimethyltetradecylammonium Chloride; Zephiramine-d7 Chloride |
Zephirol Related Compound 1 | 139-08-2 | C23H42NCl | 368.04 | N,N-Dimethyl-N-tetradecylbenzenemethanaminium Chloride; Benzyldimethyltetradecylammonium Chloride; Arquad DM 14B90; Cation M 2-100R; Cyncal; Dibactol; Myristalkonium Chloride; Zeph; Zephiramine; Zephiramine Chloride |
Zephirol | 139-07-1 | C21H38NCl | 339.99 | N-Dodecyl-N,N-dimethylbenzenemethanaminium Chloride; Benzododecinium Chloride; Benzyldimethyldodecylammonium Chloride; Catigene OM; Catinal CB 50; Catiogen PAN; Lauryldimethylbenzylammonium Chloride |
Zeorin | 22570-53-2 | C30H52O2 | 444.7 | 6alpha,22-Hopanediol |
ZEOLITE, TYPE: ZSM-5 | 308081-08-5 | 0 | Zeolite, type: ZSM-5 | |
ZEOLITE, HS-720, POTASSIUM FERRIERITE | 308066-04-8 | |||
ZEOLITE, HS-320, HYDROGEN Y | 308081-05-2 | |||
Zenarestat | 112733-06-9 | C17H11BrClFN2O4 | 441.64 | FR-74366;2-[3-[(4-bromo-2-fluorophenyl)methyl]-7-chloro-2,4-dioxoquinazolin-1-yl]acetic acid;FR74366;3-(2-Fluoro-4-bromobenzyl)-7-chloro-2,4(1H,3H)-dioxoquinazoline-1-acetic acid;3-[(4-Bromo-2-fluorophenyl)methyl]-7-chloro-3,4-dihydro-2,4-dioxo-1(2H)-quin |
Zelkovamycin | 221197-33-7 | C36H45N9O9S | 779.86 | (16E)-7-Acetyl-13-ethyl-16-ethylidene-4-[(7-methoxy-1H-indol-2-yl)methyl]-7,18,22-trimethyl-24-thia-3,6,9,12,15,18,21,26-octazabicyclo[21.2.1]hexacosa-1(25),23(26)-diene-2,5,8,11,14,17,20-heptone |
Zein | 9010-66-6 | |||
Zederone | 7727-79-9 | C15H18O3 | 246.3 | (1aR,4E,10aR)-1a,3,6,10a-Tetrahydro-1a,5,9-trimethyloxireno[4,5]cyclodeca[1,2-b]furan-10(2H)-one |
Zebularine 3'-CE phosphoramidite | 155831-90-6 | C45H61N4O8PSi | 845.04 | |
Zebularine | 3690-10-6 | C9H12N2O5 | 228.2 | NSC 309132; NSC309132; NSC-309132 |
Zeatin Riboside | 28542-78-1 | C15H21N5O5 | 351.36 | |
Zeatin | 13114-27-7 | C10H13N5O | 219.24 | ZEATIN MIXED ISOMERS-PLANT CELL CULTURE&; zeatin mixed isomers-plant cell culture tested; 2-Buten-1-ol, 2-methyl-4-(1H-purin-6-ylamino)-; Zeatin mixed isomers; ZEATIN mixed isomers (E/Z); Zeatin; 6-(4-Hydroxy-3-methylbut-2-enylamino)purine |
Zearalenone-13C18 solution | 911392-43-3 | 336.23 | Fully 13C-labelled Zearalenone | |
Zearalenone | 17924-92-4 | C18H22O5 | 318.37 | (3S,11E)-3,4,5,6,9,10-Hexahydro-14,16-dihydroxy-3-methyl-1H-2 -benzoxacyclotetradecin-1,7(8H)-dione; (-)-Zearalenone; Mycotoxin F 2; Toxin F2; Zenone; trans-Zearalenone |
Zearalanone | 5975-78-0 | C18H24O5 | 322.4 | (S)-Zearalanone, P 1502, Zanone |
Z-DEVD-FMK | 210344-95-9 | C30H41FN4O12 | 668.66 | Caspase-3 Inhibitor; Z-D(OMe)E(Ome)VD(OMe)-FMK; Caspase-3 Inhibitor II; methyl (4S)-5-[[(2S)-1-[[(3S)-5-fluoro-1-methoxy-1,4-dioxopentan-3-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-[[(2S)-4-methoxy-4-oxo-2-(phenylmethoxycarbonylamino)butanoyl]amino]-5-o |
WAY 207024 dihydrochloride | 872002-73-8 | C30H32N6.2HCl | 549.54 | 6-[[4-[2-[4-(1,1-Dimethylethyl)phenyl]-1H-benzimidazol-7-yl]-i-piperazinyl]methyl]-quinoxaline dihydrochloride |
WAY 181187 oxalate | 1883548-85-3 | C15H13ClN4O2S2.C2H2O4 | 470.91 | 1-[(6-Chloroimidazo[2,1-b]thiazol-5-yl)sulfonyl]-1H-indole-3-ethanamine oxalate |
WAY 170523 | 307002-73-9 | C33H31N3O7S | 613.68 | N-[2-[4-[[[2-[(Hydroxyamino)carbonyl]-4,6-dimethylphenyl](phenylmethyl)amino]sulfonyl]phenoxy]ethyl]-2-benzofurancarboxamide |
WAY 161503 hydrochloride | 276695-22-8 | C11H11Cl2N3O.HCl | 308.59 | 8,9-Dichloro-2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5(6H)-one hydrochloride |
WAY 150138 | 273388-09-3 | C22H18Cl2FN3O3S | 494.36 | 6-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-2-N,4-N-bis(prop-2-enyl)-1,3,5-triazine-2,4-diamine; Vectarion; Almitrin; Almitrina; Almitrinum; Almitrine |
WAY 127039-A-1 sodium salt | 1391052-54-2 | C15H9BrNNaO4 | 370.13 | 2-Amino-3-(4-bromobenzoyl)phenyloxoacetic acid |
Way 123398 | 138490-53-6 | C19H25N5O4S2 | 451.57 | N-methyl-N-(2-(methyl(1-methyl-1H-benzimidazol-2-yl)amino)ethyl)-4-((methylsulfonyl)amino)-Benzenesulfonamide |
WAY 100635 hydrochloride | 146714-97-8 | C25H34N4O2.3HCl | 531.947 | WAY 100635 trihydrochloride; N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-pyridin-2-ylcyclohexanecarboxamide trihydrochloride |
Viniferol D | 625096-18-6 | C42H32O9 | 680.7 | (3S,4S,4aR,5R,9bR,10S)-4-(3,5-Dihydroxyphenyl)-3,5,10-tris(4-hydr oxyphenyl)-3,4,4a,5,9b,10-hexahydro-11-oxabenzo[5,6]cyclohepta[1, 2,3,4-jkl]-as-indacene-2,6,8-triol |
Viniferin | 78690-98-9 | |||
Vinflunine Tartrate | 1201898-17-0 | C45H54F2N4O8.xC4H6O6 | 967.02 | N/A |
Vinblastine sulfate | 143-67-9 | C46H58N4O9.H2SO4 | 909.06 | cell pharm Brand of Vinblastine Sulfate; cellblastin; EG Labo Brand of Vinblastine Sulfate; Faulding Brand of Vinblastine Sulfate; Gastrozepin Brand of Vinblastine Sulfate; Gry Brand of Vinblastine Sulfate; Hexal Brand of Vinblastine Sulfate; Lemblastine; |
Vinblastine Impurity K | 71486-22-1 | C45H54N4O8 | 778.93 | vinorelbine; Exelbine; 71486-22-1; Vinorelbina; Vinorelbinum; UNII-Q6C979R91Y; CHEBI:480999; Q6C979R91Y; Navelbine; Nor-5'-anhydrovinblastine; Eunades; Vinorelbine (INN); Navelbine (TN); Ambap71486-22-1; HSDB 7665; ANX-530; SDP-012; Navelbinereg; HMS2090E |
Uvinul 4050 H | 124172-53-8 | C26H50N4O2 | 450.70100 | |
Uvinul 3030 | 178671-58-4 | C69H48N4O8 | 1061.14 | Uvinul3030; 178671-58-4; 2,2-Bis(((2-cyano-3,3-diphenylacryloyl)oxy)methyl)propane-1,3-diylbis(2-cyano-3,3-diphenylacrylate); UNII-P428PY6477; SCHEMBL124488; CTK8C1495 |
UVI-6976 | 390388-69-9 | |||
UVI 3003 | 847239-17-2 | C28H36O4 | 436.58 | 3-[4-Hydroxy-3-[5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-3-(pentyloxy)-2-naphthalenyl]phenyl]-2-propenoic acid; Compound 10e |
Uvedalin | 24694-79-9 | C23H28O9 | 448.47 | 5-Acetoxy-4-[[(2,3-dimethyloxiran-2-yl)carbonyl]oxy]-2,3,3a,4,5,8,9,11a-octahydro-10-methyl-3-methylene-2-oxocyclodeca[b]furan-6-carboxylic acid methyl ester |
Uvecryl P 36 | 85340-63-2 | C19H15ClO5 | 358.776 | |
Uvarigrin | 200563-11-7 | C37H68O6 | 608.94 | 4-[13,15-dihydroxy-15-[5-(1-hydroxytridecyl)oxolan-2-yl]pentadecyl]-2-methyl-2H-furan-5-one |
UNIL-088 | 473545-11-8 | C73H128N13O22P | 1570.86 | (1R,2R,E)-1-((2S,5S,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-11,17,26,29-tetraisobutyl-14,32-diisopropyl-1,7,10,16,20,23,25,28,31-nonamethyl-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2-yl)-2-methylhe |
Tropifexor | 1383816-29-2 | C29H25F4N3O5S | 603.589 | LJN-452; 2-[(1R,5S)-3-[[5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl]methoxy]-8-azabicyclo[3.2.1]octan-8-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid |
Tropicamide | 1508-75-4 | C17H20N2O2 | 284.35 | Ro 1-7683; Mydriacyl |
Tropenol hydrochloride | 99709-24-7 | C8H13NO.HCl | 175.66 | 8-Methyl-8-azabicyclo[3.2.1]oct-6-en-3-ol hydrochloride; Tropenol HCl*; Tropenol hydrochloride |
Trimagnesium phosphate | 7757-87-1 | Mg3O8P2 | 262.8577 | MAGNESIUM ORTHOPHOSPHATE TRIBASIC; MAGNESIUM PHOSPHATE; MAGNESIUM PHOSPHATE TRIBASIC; TRI-MAGNESIUM PHOSPHATE; "neutral""magnesiumphosphate; magnesiumphosphate(mg3(po4)2); magnesiumphosphate |
TRIM | 25371-96-4 | C10H7F3N2 | 212.17 | 1-(2-Trifluoromethylphenyl)imidazole; 1-[2-(Trifluoromethyl)phenyl]imidazole |
Trilostane | 13647-35-3 | C20H27NO3 | 329.43 | WIN 24540 |
Trilobatin 2'-acetate | 647853-82-5 | C23H26O11 | 478.5 | 1-Propanone, 1-[4-[(2-O-acetyl-b-D-glucopyranosyl)oxy]-2,6-dihydroxyphenyl]-3-(4-hydr oxyphenyl)- |
Trilithium phosphide | 12057-29-3 | Li3P | 51.796761 | trilithium phosphide; LITHIUM PHOSPHIDE; Trilithiophosphorus; Einecs 235-020-0; Lithium phosphide (li3p) |
Z-D-a-vinyl-Gly-OMe | 98854-91-2 | C13H15NO4 | 249.26200 | |
ZD8321 | 182073-77-4 | C18H28F3N3O5 | 423.43 | methyl N-[(2S)-3-methyl-1-oxo-1-[(2S)-2-[[(3S)-1,1,1-trifluoro-4-methyl-2-oxopentan-3-yl]carbamoyl]pyrrolidin-1-yl]butan-2-yl]carbamate; 1-(2-methoxycarbonyl-3-methylbutyryl)-N-(2-methyl-1-(trifluoroacetyl)propyl)pyrrolidine-2-carboxamide; ZD 8321; ZD-832 |
ZD-4190 | 413599-62-9 | C19H16BrFN6O2 | 459.27 | |
ZD 9379 | 170142-20-8 | C19H14ClN3O4 | 383.79 | 7-Chloro-2,3-dihydro-2-(4-methoxy-2-methylphenyl)pyridazino [4,5-b] quinoline-1,4,10(5H)trione |
ZD 7288 | 133059-99-1 | C15H21ClN4 | 292.81 | 4-Ethylphenylamino-1,2-dimethyl-6-methylaminopyrimidinium chloride; ICI D2788 |
ZD 7155 hydrochloride | 146709-78-6 | C26H26N6O.HCl | 474.99 | 5,7-Diethyl-3,4-dihydro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1,6-naphthyridin-2(1H)-one hydrochloride |
ZD 7114 hydrochloride | 129689-28-7 | C22H30N2O6.HCl | 454.95 | (S)-4-[2-Hydroxy-3-phenoxypropylaminoethoxy]-N-(2-methoxyethyl)phenoxyacetamide hydrochloride |
ZD 2079 | 178600-17-4 | C18H21NO4.HCl | 351.83 | 4-[2-[[(2R)-2-Hydroxy-2-phenylethyl]amino]ethoxy]-benzeneacetic acid hydrochloride; Talibegron hydrochloride; Talibegron HCl |
ZCZ 011 | 1998197-39-9 | C21H18N2O2S | 362.44 | 6-methyl-3-(2-nitro-1-(thiophen-2-yl)ethyl)-2-phenyl-1H-indole |
Z-Cyclopentyl-AP4 | 103439-17-4 | C6H12NO5P | 209.14 | cis-(±)-1-Amino-3-phosphonocyclopentane carboxylic acid |
ZCL278 | 587841-73-4 | C21H19BrClN5O4S2 | 584.888 | |
ZB716 | 1853279-29-4 | C32H48BF5O4S | 634.59 | fulvestrant-3-boronic acid |
Zaurategrast | 455264-31-0 | C26H25BrN4O3 | 521.41 | CDP-323 |
Zatosetron maleate | 123482-23-5 | C23H29ClN2O6 | 464.94 | (Z)-but-2-enedioic acid;5-chloro-2,2-dimethyl-N-[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]-3H-1-benzofuran-7-carboxamide; 5-chloro-2,3-dihydro-2,2-dimethyl-N-(8-methyl-8-azabicyclo(3.2.1)oct-3-yl)-7-benzofurancarboxamide; LY 277359; LY 277359 maleat |
Zatebradine hydrochloride | 91940-87-3 | C26H37ClN2O5 | 493.04 | Zatebradine HCl;UL-FS-49CL;UL-FS49;3-[3-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]propyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one hydrochloride;2H-3-Benzazepin-2-one, 3-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-1,3,4,5-tetrahydro-7,8-d |
Zatebradine | 85175-67-3 | C26H36N2O5 | 456.57 | 2H-3-Benzazepin-2-one,3-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-;Zatebradinum;Zatebradina;3-[3-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]propyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one;UL-FS49 |
Zarzissine | 160568-14-9 | C5H5N5 | 135.1 | 1H-Imidazo[4,5-d]pyridazin-2-amine |
Zardaverine | 101975-10-4 | C12H10F2N2O3 | 268.22 | |
Zaragozic acid A | 142561-96-4 | C35H46O14 | 690.7 | Squalestatin A, Squalestatin S1, L 694599 |
Zaprinast | 37762-06-4 | C13H13N5O2 | 271.28 | 2-(2-Propyloxyphenyl)-8-azapurin-6-one; 5-(2-propoxyphenyl)-2,3-dihydrotriazolo[4,5-d]pyrimidin-7-one |
ZAPA sulfate | 371962-01-5 | C4H6N2O2S.H2SO4 | 244.24 | (Z)-3-[(Aminoiminomethyl)thio]prop-2-enoic acid sulfate |
Zanubrutinib | 1691249-45-2 | C27H29N5O3 | 471.55 | BGB-3111; (7S)-2-(4-phenoxyphenyl)-7-(1-prop-2-enoylpiperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide |
Zanthobungeanine | 64190-94-9 | C16H17NO3 | 271.31 | 7-Methoxy-N-methylflindersine; 8-Methoxy-N-methylflindersine |
Zanamivir-13C, 15N2 | 1276528-62-1 | C12H20N4O7 | 335.29 | 5-Acetylamino-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy- D-glycero-D-galacto-non-2-enonic Acid-13C,15N2; GANA-13C,15N2; Zanamir-d3; 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-(acetyl-d3)neuraminic Acid-13C,15N2; 4-Guanidino-Neu5Ac2en-13C,15N2; Rel |
Zanamivir Azide Methyl Ester | 152178-79-5 | C12H18N4O7 | 330.29 | 5-(Acetylamino)-2,6-anhydro-4-azido-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic Acid Methyl Ester |
Zanamivir Amine Triacetate Methyl Ester | 139110-70-6 | C18H26N2O10 | 430.41 | methyl (2R,3R,4S)-3-acetamido-4-amino-2-[(1S,2R)-1,2,3-triacetyloxypropyl]-3,4-dihydro-2H-pyran-6-carboxylate |
Zanamivir | 139110-80-8 | C12H22N4O8 | 350.33 | Relenza; GG 167; 2,3-Didehydro-2,4-dideoxy-4-guanidine-N-acetyl-acetyl-D-neuraminic acid; 4-Guanidino-2,4-dideoxy-2,3-didehydro-N-acetylneuraminic acid; 5-Acetamino-2,6-anhydro-4-guanidino-3,4,5-trideoxy-D-galcto-non-enoic acid |
Zamifenacin fumarate | 127308-98-9 | C27H29NO3.C4H4O4 | 531.6 | (3R)-1-[2-(1-,3-Benzodioxol-5-yl)ethyl]-3-(diphenylmethoxy)piperidine fumarate |
Zamifenacin | 127308-82-1 | C27H29NO3 | 415.53 | UNII-Y88Q418Y7M;UK 76654; AC1MJ6I5;(3R)-3-benzhydryloxy-1-[2-(1,3-benzodioxol-5-yl)ethyl]piperidine;127308-98-9 (Zamifenacin fumarate) |
Zamicastat | 1080028-80-3 | C21H21F2N3OS | 401.48 | 4-[2-(Benzylamino)ethyl]-3-[(3R)-6,8-difluoro-3,4-dihydro-2H-chromen-3-yl]-1H-imidazole-2-thione;(R)-5-(2-(benzylamino)ethyl)-1-(6,8-difluorochroman-3-yl)-1,3-dihydro-2H-imidazole-2-thione |
Zaltoprofen | 74711-43-6 | C17H14O3S | 298.36 | 10,11-dihydro-alpha-methyl-10-oxodibenzo(b,f)thiepin-2-acetic acid; CN 100; CN-100; WY-21743 |
Zaltidine | 85604-00-8 | C8H10N6S | 222.27 | 2-[4-(2-methyl-1H-imidazol-5-yl)-1,3-thiazol-2-yl]guanidine;CP-57361;[4-(2-Methyl-1H-imidazol-4-yl)-2-thiazolyl]guanidine;Guanidine,[4-(2-methyl-1H-imidazol-4-yl)-2-thiazolyl]- |
Zaleplon-d5 | 1001083-56-2 | C17H10D5N5O | 310.37 | N-[3-(3-Cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethyl-d5-acetamide; CL-284846-d5; Sonata-d5 |
Zaleplon related compound A | 96605-66-2 | C15H20N2O2 | 260.34 | N-Ethyl-N-3-((3-dimethylamino-1-oxo-2-propenyl)phenyl)acetamide; N-[3-[3-(Dimethylamino)-1-oxo-2-propen-1-yl]phenyl]-N-ethyl-acetamide; 3-Dimethylamino-1-(3-N-ethyl-N-acetylaminophenyl)-2-propen-1-one; USP Zaleplon Related Compound A |
2',3'-Dideoxy-2',3'-didehydrocytidine | 7481-88-1 | C9H11N3O3 | 209.20 | ddddC; Dideoxycytidinene; 2',3'-Dideoxycytidinene |
zabofloxacin | 219680-11-2 | C19H20FN5O4 | ||
Z-7-tetradecen-2-one | 146955-45-5 | C14H26O | 210.35564 | (Z)-7-Tetradecen-2-one |
Z-360 | 209219-38-5 | C29H36N4O5 | 520.63 | Nastorazepide; 3-[[(3R)-1-cyclohexyl-5-(3,3-dimethyl-2-oxobutyl)-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]carbamoylamino]benzoic acid |
Z 944 | 1199236-64-0 | C19H27ClFN3O2 | 383.89 | 4-[[(3-Chloro-5-fluorobenzoyl)amino)methyl]-N-(1,1-dimethylethyl)-1-piperidineacetamide; N-((1-(2-(Tert-Butylamino)-2-oxoethyl)piperidin-4-yl)methyl)-3-chloro-5-fluorobenzamide |
YZ9 | 6093-71-6 | C12H10O5 | 234.2 | Ethyl 7-hydroxy-2-oxo-2H-1-benzopyran-3-carboxylate; 7-Hydroxycoumarin-3-carboxylic acid ethyl ester; 3-carbethoxy-7-hydroxycoumarin |
YYA-021 | 144217-65-2 | C18H27N3O2 | 317.43 | |
YW1159 | 2131223-69-1 | C19H14FN5O | 347.35 | Compound 3d; 1-(2-Fluorophenyl)-5-methyl-N-quinolin-2-yltriazole-4-carboxamide |
YW1128 | 2131223-64-6 | C20H17N5O | 343.38 | 5-Methyl-1-(2-methylphenyl)-N-quinolin-2-yltriazole-4-carboxamide |
Yunnanxane | 139713-81-8 | C31H46O9 | 562.69 | (2R,3S)-3-Hydroxy-2-methylbutanoic acid (3S,4aS,5S,6S,7S,11S,12aS)-3,5,11-tris(acetyloxy)-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-9,12a,13,13-tetramethyl-4-methylene-6,10-methanobenzocyclodecen-7-yl ester; Butanoic acid, 3-hydroxy-2-methyl-, 3,5,11-tris( |
Yunnandaphninine G | 1042143-83-8 | C30H47NO3 | 469.7 | (1S,2S,5S,8R)-2-Hydroxy-8-{2-[(1S,2R,3S,7R,10S,13S,14R)-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.02,13.03,7.07,12]hexadec-2-yl]ethyl}-1,5-dimethyl-6-oxabicyclo[3.2.1]octan-7-one |
Yunnancoronarin A | 162762-93-8 | C20H28O2 | 300.4 | 1-Naphthalenol,4-[(1E)-2-(3-furanyl)ethenyl]decahydro-4a,8,8-trimethyl-3-methylene-,(1R,4S,4aR,8aS)- |
Yunaconitoline | 259099-25-7 | C34H43NO10 | 625.715 | |
Yunaconitine | 70578-24-4 | C35H49NO11 | 659.76 | Guayewuanine B |
YUKA1 | 708991-09-7 | C13H16N4O2S | 292.36 | |
Yuehgesin C | 125072-68-6 | C17H22O5 | 306.4 | 8-(3-Ethoxy-2-hydroxy-3-Methylbutyl)-7-MethoxycouMarin |
Yucalexin P-17 | 119642-82-9 | C20H30O3 | 318.45 | [2S-(2alpha,4aalpha,4bbeta,6alpha,7alpha,10abeta)]-7-Ethenyl-1,4,4a,4b,5,6,7,9,10,10a-decahydro-2,6-dihydroxy-1,1,4a,7-tetramethyl-3(2H)-phenanthrenone; (2S,4aS,4bR,6S,7R,10aS)-2,6-dihydroxy-1,1,4a,7-tetramethyl-7-vinyl-1,4,4a,4b,5,6,7,9,10,10a-decahydrop |
Yubeinine | 157478-01-8 | C27H43NO3 | 429.645 | |
YTTRIUM TRIFLUOROACETATE HYDRATE | 37737-28-3 | C6H2F9O7Y | 445.97 | YTTRIUM TRIFLUOROACETATE HYDRATE; Yttrium(III) trifluoroacetate hydrate; trifluoroacetic acid, yttrium(III) salt |
Yomogin | 10-40-2 | C15H16O3 | 244.2857 | |
Xylose | 25990-60-7 | C5H10O5 | 150.13 | Xylose |
Yohimbine HCl | 65-19-0 | C21H26N2O3·HCl | 390.9 | |
Yohimbine | 146-48-5 | C21H26N2O3 | 354.45 | Yohimbine |
Yohimbic Acid | 522-87-2 | C20H24N2O3 | 340.42 | Yohimbinsaeure; Yohimbinic acid |
Yohimban-16-carboxylicacid,11,17-dimethoxy-18-[[(2E)-1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propen-1-yl]oxy]-,methyl ester, (3b,16b,17a,18b,20a)- | 24815-24-5 | C35H42 N2 O9 | 634.79 | RESCINNAMINE; RESERPININE; METHYL-3,4,5-TRIMETHOXYCINNAMOYL RESERPATE; METHYL RESERPATE-3,4,5-TRIMETHOXY CINNAMIC ACID ESTER; ANAPREL; 3,4,5-TRIMETHOXYCINNAMOYLRESERPATE |
Yoda 1 | 448947-81-7 | C13H8Cl2N4S2 | 355.27 | GlyT2-IN-1; 2-[5-[[(2,6-Dichlorophenyl)methyl]thio]-1,3,4-thiadiazol-2-yl]pyrazine; 2-[(2,6-dichlorophenyl)methylsulfanyl]-5-pyrazin-2-yl-1,3,4-thiadiazole |
YMU1 | 902589-96-2 | C17H22N4O4S | 378.45 | ethyl 4-[2-(4,6-dimethyl-3-oxo-[1,2]thiazolo[5,4-b]pyridin-2-yl)acetyl]piperazine-1-carboxylate |
YM758 | 312752-85-5 | C26H32FN3O4 | 469.55 | N-[2-[(3R)-3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-2-carbonyl)piperidin-1-yl]ethyl]-4-fluorobenzamide; YM 758; YM-758; YM758 cpd |
YM-53601 | 182959-33-7 | C21H21FN2O·HCl | 372.9 | YM 53601; YM53601; 2-[2-(1-Azabicyclo[2.2.2]octan-3-ylidene)-2-fluoroethoxy]-9H-carbazole hydrochloride |
YM-46303 | 171722-81-9 | C20H23ClN2O2 | 358.86 | 1-azabicyclo[2.2.2]octan-4-yl N-(2-phenylphenyl)carbamate;hydrochloride |
YM-201636 | 371942-69-7 | C25H21N7O3 | 467.48 | YM 201636; YM201636 |
YM-155 hydrochloride | 355406-09-6 | C20H19ClN4O3 | 398.84 | YM155 hydrochloride; YM 155 hydrochloride |
YM 976 | 191219-80-4 | C17H16ClN3O | 313.79 | 4-(3-Chlorophenyl)-1,7-diethylpyrido[2,3-d]pyrimidin-2(1H)-one |
YM 90K hydrochloride | 154164-30-4 | C11H7N5O4.HCl | 309.67 | 1,4-Dihydro-6-(1H-imidazol-1-yl)-7-nitro-2,3-quinoxalinedione hydrochloride |
YM 90709 | 163769-88-8 | C22H21N3O2 | 359.43 | 2,3-dimethoxy-6,6-dimethyl-5,6-dihydrobenzo(7,8)indolizino (2,3-b)quinoxaline |
YM 750 | 138046-43-2 | C31H36N2O | 452.63 | N-Cycloheptyl-N-(9H-fluoren-2-ylmethyl)-N'-(2,4,6-trimethylphenyl)urea; ACAT inhibitors, Yamanouchi |
YM 58483 | 223499-30-7 | C15H9F6N5OS | 421.32 | N-[4-[3,5-Bis(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-4-methyl-1,2,3-thiadiazole-5-carboxamide; Btp2; YM-58483; CRAC Channel Inhibitor, BTP2 |
Xylosidase, thermostable | 9025-53-0 | |||
Yangonin | 500-62-9 | C15H14O4 | 258.27 | 4-methoxy-6-[(E)-2-(4-methoxyphenyl)ethenyl]pyran-2-one; 4-methoxy-6-(beta-(p-anisyl)vinyl)-alpha-pyrone; |
Yangambin | 13060-14-5 | C24H30O8 | 446.5 | Lirioresinol B |
Yamogenin | 512-06-1 | C27H42O3 | 414.6 | (25S)-spirost-5-en-3beta-ol |
Wild Yam Extract | 90147-49-2 | 0 | Yam, Dioscorea villosa, ext.; DIOSCOREA VILLOSA (WILD YAM) ROOT EXTRACT; Dioscoreavillosaextract; WILDYAMROOTEXTRACT; WILDYAM(DIOSCOREAVILLOSA)EXTRACT | |
Yadanzioside P | 79439-84-2 | C34H46O16 | 710.72 | Bruceantinoside B; Picras-3-en-21-oic acid, 15-((3,4-dimethyl-1-oxo-2-pentenyl)oxy)-13,20-epoxy-3-(beta-D-glucopyranosyloxy)-11,12-dihydroxy-2,16-dioxo-, methyl ester, (11beta,12alpha,15beta(E))- |
Yadanzioside M | 101559-99-3 | C34H40O16 | 704.68 | |
Yadanzioside L | 99132-97-5 | C34H46O17 | 726.72 | Picras-3-en-21-oic acid, 13,20-epoxy-3-(beta-D-glucopyranosyloxy)-11,12-dihydroxy-15-((4-hydroxy-3,4-dimethyl-1-oxo-2-pentenyl)oxy)-2,16-dioxo-, methyl ester, (11beta,12alpha,15beta)- |
Yadanzioside K | 101559-98-2 | C36H48O18 | 768.76 | Picras-3-en-21-oicacid, 15-[[(2E)-4-(acetyloxy)-3,4-dimethyl-1-oxo-2-pentenyl]oxy]-13,20-epoxy-3-(b-D-glucopyranosyloxy)-11,12-dihydroxy-2,16-dioxo-, methyl ester, (11b,12a,15b)- (9CI) |
Yadanzioside I | 99132-95-3 | C29H38O16 | 642.60 | |
Yadanzioside G | 95258-17-6 | C36H48O18 | 768.76 | Picras-1-en-21-oic acid, 15-[(3,4-dimethyl-1-oxo-2-pentenyl)oxy]-13,20-epoxy-2-(.beta.-D-glucopyranosyloxy)-11,12-dihydroxy-3,16-dioxo-, (11.beta.,12.alpha.,15.beta.)- |
Yadanzioside F | 95258-11-0 | C29H38O16 | 642.60 | Picras-1-en-21-oic acid, 15-(acetyloxy)-11,12-dihydroxy-3,16-dioxo-13,20-epoxy-2-(beta-D-glucopyranosyloxy)-, methyl ester, (11-beta,12-alpha,15-beta)- |
Yadanzioside C | 95258-16-5 | C34H46O17 | 726.72 | Picras-1-en-21-oic acid, 13,20-epoxy-2-(.beta.-D-glucopyranosyloxy)-11,12-dihydroxy-15-[(4-hydroxy-3,4-dimethyl-1-oxo-2-pentenyl)oxy]-3,16-dioxo-, methyl ester, [11.beta.,12.alpha.,15.beta.(E)]- |
Yadanzioside A | 95258-15-4 | C32H44O16 | 684.68 | |
Y-33075 dihydrochloride | 173897-44-4 | C16H18Cl2N4O | 353.25 | 4-[(1R)-1-aminoethyl]-N-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzamide dihydrochloride; SNJ-1656; Y-3998 |
Y-33075 | 199433-58-4 | C16H16N4O | 280.32 | 4-[(1R)-1-aminoethyl]-N-(1H-pyrrolo[2,3-b]pyridin-4-yl)benzamide SNJ-1656 Y-39983 |
Y320 | 288250-47-5 | C27H29ClN6O2 | 505.019 | |
Y-29794 Tosylate | 146794-84-5 | C23H34N2OS2.C2H2O4 | 508.69 | [2-[8-(dimethylamino)octylsulfanyl]-6-propan-2-ylpyridin-3-yl]-thiophen-2-ylmethanone; oxalic acid; 2-(8-dimethylaminooctylthio)-6-isopropyl-3-pyridyl-2-thienyl ketone citrate; Y 29794; Y-29794; Y29794; Y-29794 OXALATE; 129184-48-1; CTK8F0584; HMS3268I17; |
Y-29794 Tosylate | 143984-17-2 | C30H42N2O4S3 | 590.86 | (2-((8-(dimethylamino)octyl)thio)-6-isopropylpyridin-3-yl)(thiophen-2-yl)methanone 4-methylbenzenesulfonate; Y 29794; Y-29794; Y29794; Y29794 tosylate; Y-29794 tosylate; Y 29794 tosylate. |
Y-29794 | 129184-48-1 | C23H34N2OS2 | 418.66 | |
Y-27632 2HCl | 129830-38-2 | C14H21N3O.2HCl | 320.26 | Y-27632 dihydrochloride; 4-[(1R)-1-aminoethyl]-N-pyridin-4-ylcyclohexane-1-carboxamide dihydrochloride |
Y27632 | 146986-50-7 | C14H21N3O | 247.34 | |
Y-27152 | 127408-30-4 | C21H22N2O4 | 366.41 | N-[(3S,4R)-6-Cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl]-N-(phenylmethoxy)acetamide |
Y-26763 | 127408-31-5 | C14H16N2O4 | 276.29 | N-[(3S,4R)-6-Cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl]-N-hydroxyacetamide |
Y16 | 429653-73-6 | C24H20N2O3 | 384.43 | |
Y15 | 4506-66-5 | C6H14Cl4N4 | 284.01 | 1,2,4,5-benzenetetramine tetrahydrochloride; Y15 hydrochloride; Y15 tetrahydrochloride; Y 15; Y-15 FAK Inhibitor 14 |
Y11 | 1086639-59-9 | C8H17BrN4O | 265.155 | Y-11; Y 11. |
Y 700 | 206884-98-2 | C16H17N3O3 | 299.32 | Niraxostat; 1-[3-cyano-4-(2,2-dimethylpropoxy)phenyl]pyrazole-4-carboxylic acid |
Y 134 | 849662-80-2 | C28H28N2O3S | 472.6 | [6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl]-[4-[4-(1-methylethyl)-1-piperazinyl]phenyl]methanone |
Xymenic acid | 557-58-4 | C18H30O2 | 278.43 g/mol | |
Xylyl dibutylbenzofuranone | 181314-48-7 | C24H30O2 | 350.49 | HP-136; XYLYL DIBUTYLBENZOFURANONE; 2(3H)-Benzofuranone, 5,7-bis(1,1-dimethylethyl)-3-hydroxy-, reaction products with o-xylene; Reaction product of 5,7-bis(1,1-dimetylethyl)-3-hydroxy-2(3H)-benzofuranone with o-xylene; 3,4-Dibutyl-5-(2,4-dimethylphenyl)b |
Xylotetraose Decaacetate | 67183-67-9 | C40H54O27 | 966.84 | |
XYLOTAXOL C, 7-(SH) | 90332-67-5 | C51H65NO18 | 980.06 | |
Xylopinine | 523-02-4 | C21H25NO4 | 355.43 | Norcoralydine; O-Methylgovanine; O,O-Dimethylgovadine |
Xylonic acid-1,4-lactone | 18423-66-0 | C5H8O5 | 148.114 | |
Xylometazoline HCl | 1218-35-5 | C16H24N2.HCl | 280.84 | N/A |
xylometazoline | 526-36-3 | C16H24N2 | 244.3752 | XYLOMETAZOLINE; 2-(4-TERT-BUTYL-2,6-DIMETHYL-BENZYL)-4,5-DIHYDRO-1H-IMIDAZOLE; AKOS BBS-00000259; 1h-imidazole,2-((4-(1,1-dimethylethyl)-2,6-dimethylphenyl)methyl)-4,5-dihydr; 2-(4-tert-butyl-2,6-dimethylbenzyl)-2-imidazolin; 2-(4-tert-Butyl-2,6-dimethylb |
XL999 | 705946-27-6 | C26H28FN5O | 445.532 | XL999; XL 999; XL-999; |
Xorphanol | 77287-89-9 | C23H31NO | 337.504 | |
X-NeuNAc | 160369-85-7 | C19H21BrClN2O9.Na | 559.72 | X-NANA.Na |
XMU-MP-1 | 2061980-01-4 | C17H16N6O3S2 | 416.5 | 4-[(5,10-Dimethyl-6-Oxo-6,10-Dihydro-5h-Pyrimido[5,4-B]thieno[3,2-E][1,4]diazepin-2-Yl)amino]benzenesulfonamide |
XMT-1107 | 1252797-29-7 | XMT-1107; XMT1107; XMT 1107; A poly(1-hydroxymethylethylene hydroxymethylformal) (Fleximer)-fumagillol conjugate. | ||
XMT-1001 | 1252797-26-4 | XMT-1001; XMT1001; XMT 1001; A poly(1-hydroxymethylethylene hydroxymethylformal) (Fleximer)-camptothecin conjugate. | ||
XMD8-92 | 1234480-50-2 | C26H30N6O3 | 474.55 | N/A |
XMD8-87 | 1234480-46-6 | C24H27N7O2 | 445.52 | 2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-11-methyl-5H-pyrimido[4,5-b][1,4]benzodiazepin-6-one; ACK1-B19; EX-A1296; XMD 8-87; XMD8-87; XMD-8-87; XMD 8-87; XMD887; XMD-887; XMD 887; ACK1-B19 |
XMD17-109 | 1435488-37-1 | C36H46N8O3 | 638.8 | XMD17 109 |
XMD16-5 | 1345098-78-3 | C23H24N6O2 | 416.48 | 2-[4-(4-hydroxypiperidin-1-yl)anilino]-11-methyl-5H-pyrimido[4,5-b][1,4]benzodiazepin-6-one; XMD-16-5; XMD 16-5; XMD165; XMD-165; XMD 165 |
XMC | 2655-14-3 | C10H13NO2 | 179.22 | XMC; XMC emulsion; XMC STANDARD; 3,5-dimethyl-phenomethylcarbamate; 3,5-Dimethylphenyl Methylcarbamate; 3,5-Dimethylphenyl N-methylcarbamate; 3,5-dimethylphenylmethylcarbamate; 3,5-dimethylphenyln-methylcarbamate |
XL888 | 1149705-71-4 | C29H37N5O3 | 503.64 | |
XL-647 | 781613-23-8 | C24H25Cl2FN4O2 | 491.39 | EXEL-7647; KD-019 |
XL647 | 874286-84-7 | C24H25Cl2FN4O2 | 491.388 | XL647; XL 647; XL-647; EXEL-7647; EXEL7647; EXEL7647; KD019; KD-019; KD 019. |
XL-418 | 871343-09-8 | C26H32BrF3N8O | 609.49 | 1-(3-(4-(3-bromo-1H-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl)-4-methyl-5-((2-(pyrrolidin-1-yl)ethyl)amino)phenyl)-4,4,4-trifluorobutan-1-one |
XL413 hydrochloride | 2062200-97-7 | C14H12ClN3O2·HCl | 326.18 | 8-Chloro-2-[(2S)-pyrrolidin-2-yl]-4aH-[1]benzofuro[3,2-d]pyrimidin-4-one hydrochloride |
XL413 | 1169558-38-6 | C14H12ClN3O2 | 289.72 | BMS-863233 |
XL388 | 1251156-08-7 | C23H22FN3O4S | 455.504 | |
XL228 | 898280-07-4 | C22H31N9O | 437.54 | XL-228; XL228; XL 228 |
XL147 | 956958-53-5 | C21H16N6O2S2 | 448.52 | N-[3-(2,1,3-Benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methylbenzenesulfonamide;SAR245408;N-[3-(Benzo[c][1,2,5]thiadiazol-5-ylaMino)quinoxalin-2-yl]-4-MethylbenzenesulfonaMide;PI3K inhibitorX |
XL019 | 945755-56-6 | C25H28N6O2 | 444.539 | (S)-N-(4-(2-((4-morpholinophenyl)amino)pyrimidin-4-yl)phenyl)pyrrolidine-2-carboxamide; XL-019 |
XL PI3K/mTOR inhibitor | 934529-30-3 | C31H29N5O6S | 599.66 | N-(3-(N-(3-((3,5-dimethoxyphenyl)amino)quinoxalin-2-yl)sulfamoyl)phenyl)-3-methoxy-4-methylbenzamide |
XL 765 | 1349796-36-6 | C31H29N5O6S | 599.662 | SAR 245409; N-[4-[[[3-[(3,5-Dimethoxyphenyl)amino]-2-quinoxalinyl]amino]sulfonyl]phenyl]-3-methoxy-4-methylbenzamide; N-(4-(N-(3-((3,5-Dimethoxyphenyl)amino)quinoxalin-2-yl)sulfamoyl)phenyl)-3-methoxy-4-methylbenzamide |
XK469 | 157435-10-4 | C17H13ClN2O4 | 344.751 | XK469; XK 469; XK-469. |
Xinomiline | 52832-91-4 | C5H10N2O | 114.147 | Xinomiline; UNII-3Q22EPG4O8; 52832-91-4; 4,4-dimethyl-5H-1,3-oxazol-2-amine; Xinomilina; Xinomilinum |
Ximelagatran | 192939-46-1 | C24H35N5O5 | 473.57 | N-[(1R)-1-Cyclohexyl-2-[(2S)-2-[[[[4-[(hydroxyamino)iminomethyl]phenyl]methyl]amino]carbonyl]-1-azetidinyl]-2-oxoethyl]glycine Ethyl Ester; Exanta; H 376/95; |
Xibornol | 13741-18-9 | C18H26O | 258.41 | 6-Isobornyl-3,4-xylenol; Bactacine |
Xeroboside | 117842-09-8 | C21H26O13 | 486.43 | Hymexelsin; AC1Q6BJD; AC1L4OV9; 6-methoxy-2-oxo-2h-chromen-7-yl 6-o-[3,4-dihydroxy-4-(hydroxymethyl)tetrahydrofuran-2-yl]hexopyranoside; 7-O-beta-Apiofuranosyl-(1SYM1746)-beta-glucopyranosylscopoletin; 7-[6-[[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy |
Xenopsin | 51827-01-1 | C47H73N13O10 | 980.16 | H-Pyr-Gly-Lys-Arg-Pro-Trp-Ile-Leu-OH; L-pyroglutamyl-glycyl-L-lysyl-L-arginyl-L-prolyl-L-tryptophyl-L-isoleucyl-L-leucine; (2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-6-amino-2-[[2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]acetyl]amino]hexanoyl]ami |
XENON TETRAFLUOROIDE OXIDE | 13774-85-1 | F4OXe | 223.28600 | |
Xenon tetrafluoride | 13709-61-0 | F4Xe | 207.3 | Xenontetrafluoride; 13709-61-0; tetrafluoroxenon; XeF4; Xenonfluoride(XeF4); xenon(4+)tetrafluoride |
Xenocyanine | 19764-90-0 | C29H29IN2 | 532.469 | |
Xenin 8 | 117442-28-1 | C51H79N15O9 | 1046.28 | Xenopsin-related peptide 1; XP-1 |
Xenin | 144092-28-4 | C139H224N38O32S | 2971.57 | H-Met-Leu-Thr-Lys-Phe-Glu-Thr-Lys-Ser-Ala-Arg-Val-Lys-Gly-Leu-Ser-Phe-His-Pro-Lys-Arg-Pro-Trp-Ile-Leu-OH; L-methionyl-L-leucyl-L-threonyl-L-lysyl-L-phenylalanyl-L-alpha-glutamyl-L-threonyl-L-lysyl-L-seryl-L-alanyl-L-arginyl-L-valyl-L-lysyl-glycyl-L-leucyl |
XEN907 | 912656-34-9 | C21H21NO4 | 351.40 | XEN-907;1'-pentylspiro[6H-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one |
XEN445 | 1515856-92-4 | C18H17F3N2O3 | 366.33 | |
XE 991 dihydrochloride | 122955-13-9 | C26H20N2O.2HCl | 449.37 | 10,10-bis(4-Pyridinylmethyl)-9(10H)-anthracenone dihydrochloride |
XE 991 | 122955-42-4 | C26H20N2O | 376.45 | XE-991; LS-190926; 10,10-bis(pyridin-4-ylmethyl)anthracen-9-one |
XDP | 29042-61-3 | C10H14N4O12P2(free acid) | 444.18 (free acid) | Xanthosine-5'-diphosphate, Sodium salt |
XD 14 | 1370888-71-3 | C20H27N3O5S | 421.51 | 4-Acetyl-N-[5-[(diethylamino)sulfonyl]-2-hydroxyphenyl]-3-ethyl-5-methyl-1H-pyrrole-2-carboxamide |
XCT 790 | 725247-18-7 | C23H13F9N4O3S | 596.42 | 3-[4-(2,4-Bis-trifluoromethylbenzyloxy)-3-methoxyphenyl]-2-cyano-N-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)acrylamide; (E)-3-[4-[[2,4-bis(trifluoromethyl)phenyl]methoxy]-3-methoxyphenyl]-2-cyano-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]prop-2-enamid |
WKYMVm | 187986-17-0 | C41H61N9O7S2 | 856.11 | WKYMVmamide, W-Peptide |
X-396 | 1365267-27-1 | C25H25Cl2FN6O3 | 547.412 | X-396. |
WZB 117 | 1223397-11-2 | C20H13FO6 | 368.31 | 3-Fluoro-1,2-phenylene bis(3-hydroxybenzoate) |
WZ-8040 | 1214265-57-2 | C24H25ClN6OS | 481.015 | WZ8040; WZ 8040. |
WZ4003 | 1214265-58-3 | C25H29ClN6O3 | 496.99 | N/A |
WZ-4002 | 1213269-23-8 | C25H27ClN6O3 | 494.98 | WZ4002; N-(3-(5-chloro-2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-yloxy)phenyl)acrylamide; WZ 4002 |
WZ4002 | 213269-23-8 | C25H27ClN6O3 | 494.99 | WZ4002; WZ-4002; WZ 4002. |
WZ-3146 | 1214265-56-1 | C24H25ClN6O2 | 464.954 | WZ3146; WZ 3146. |
WZ 811 | 55778-02-4 | C18H18N4 | 290.36 | N,N'-di-2-pyridinyl-1,4-benzenedimethanamine; WZ-811; WZ811 cpd |
WYE-687 | 1062161-90-3 | C28H32N8O3 | 528.617 | WYE 687; WYE687. |
WYE-354 | 1062169-56-5 | C24H29N7O5 | 495.54 | WYE354; WYE 354. |
WYE-28 | 1062172-60-4 | C30H34N8O5 | 586.6 | Methyl 4-[6-[4-[[4-(hydroxymethyl)phenyl]carbamoylamino]phenyl]-4-morpholin-4-ylpyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carboxylate |
WYE-23 | 1062169-46-3 | C26H32N8O4 | 520.6 | mTOR Inhibitor WYE-23; Methyl 4-[6-[4-(cyclopropylcarbamoylamino)phenyl]-4-morpholin-4-ylpyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carboxylate |
WYE-125132 | 1144068-46-1 | C27H33N7O4 | 519.606 | WYE-125132; WYE-125132; WYE-132; WYE132. |
WYE 687 dihydrochloride | 1702364-87-1 | C28H32N8O32HCl | 601.53 | N-[4-[4-(4-Morpholinyl)-1-[1-(3-pyridinylmethyl)-4-piperidinyl]-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-carbamic acid methyl ester dihydrochloride |
WYE 672 | 1221265-37-7 | C23H17F3N2O2S | 442.45 | 3-methyl-2-[4-(3-methylsulfonylphenyl)phenyl]-5-(trifluoromethyl)quinoxaline |
WY 45233 succinate | 448904-47-0 | C16H25NO2.C4H6O4 | 381.46 | 4-[2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol succinate; O-Desmethylvenlafaxine succinate; Ventab DXT; Desvenlafaxine succinate anhydrous |
WWL70 | 947669-91-2 | C27H23N3O3 | 437.5 | 4'-carbamoyl-[1,1'-biphenyl]-4-yl methyl(3-(pyridin-4-yl)benzyl)carbamate; WWL 70; WWL70; WWL-70. |
WWL229 | 1338575-28-2 | C16H22N2O5 | 322.4 | (4-Nitrophenyl) 2-(3-methoxypropyl)piperidine-1-carboxylate |
WWL123 | 1338575-41-9 | C28H24N2O3 | 436.5 | [3-(4-carbamoylphenyl)phenyl] N-methyl-N-[(3-phenylphenyl)methyl]carbamate |
WWL 123 | 1338574-83-6 | C28H24N2O3 | 436.5 | N-[[1,1'-Biphenyl]-3-ylmethyl)-N-methylcarbamic acid 4'-(aminocarbonyl)[1,1'-biphenyl]-4-yl ester |
WWL 113 | 947669-86-5 | C29H26N2O4 | 466.53 | 4'-[[[Methyl[[3-(4-pyridinyl)phenyl]methyl]amino]carbonyl]oxy]-[1,1'-biphenyl]-4-carboxylic acid ethyl ester |
WT-161 | 1206731-57-8 | C27H30N4O3 | 458.55 | (E)-8-(2-(4-(Diphenylamino)benzylidene)hydrazinyl)-N-hydroxy-8-oxooctanamide; WT161; WT 161 |
WKYMVM | 187986-11-4 | C41H61N9O7S2 | 856.11 | |
WK-X-34 | 908859-10-9 | C35H37N3O6 | 595.696 | |
WK88-1 | 958888-32-9 | C28H42N2O6 | 502.64 | |
Wittifuran X | 1309478-07-6 | C15H12O5 | 272.3 | 5-(6-Hydroxy-5-methoxy-2-benzofuranyl)-1,3-benzenediol |
Withaperuvin C | 81644-34-0 | C28H38O7 | 486.605 | (17S,22R)-6beta,14,17,20,22-Pentahydroxy-1-oxo-5beta-ergosta-2,4,24-triene-26-oic acid delta-lactone |
Withanolide S | 63139-16-2 | C28H40O8 | 504.62 | |
Withanolide C | 108030-78-0 | C28H39ClO7 | 523.063 | |
Withanolide B | 56973-41-2 | C28H38O5 | 454.6 | Lycium substance B |
Withanolide A | 32911-62-9 | C28H38O6 | 470.6 | |
Withaferin A | 5119-48-2 | C28H38O6 | 470.606 | 5,6-epoxy-4,22,27-trihydroxy-1-oxoergosta-2,24-dienoic acid delta-lactone; withaferin A; Withaferin A; Withaferine A; 5119-48-2; UNII-L6DO3QW4K5; NSC 273757; L6DO3QW4K5; CHEBI:69120; WITHAFERIN DERIV JPR, IOWA U. COMPOUND; NSC101088; BRN 1335150; NSC-1010 |
WITEPSOL | 56749-17-8 | WITEPSOL | ||
Hamamelis Virginiana Extract | 84696-19-5 | 0 | Witch hazel | |
WITCAMIDE (R) 511 EMULSIFIER | 80893-63-6 | |||
WINTER GREEN OIL | 68917-75-9 | C8H8O3 | 152.14700 | |
Windaus Ketone | 55812-80-1 | C19H32O | 276.464 | Ergocalciferol Impurity 1; Vitamin D2 Impurity 1; (1R,3aR,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-one |
Win-62005 | 152633-54-0 | C12H10N4O | 226.23 | 5-methyl-6-pyridin-4-yl-1,3-dihydroimidazo[4,5-b]pyridin-2-one; WIN 62005 |
WIN 64338 hydrochloride | 163727-74-0 | C45H68ClN4OP.HCl | 783.95 | (S)-4-[2-[Bis(cyclohexylamino)methyleneamino]-3-(2-naphthalenyl)-1-oxopropylamino]benzyl tributyl phosphonium chloride hydrochloride |
WIN 55212-2 mesylate | 131543-23-2 | C27H26N2O3.CH3SO3H | 522.61 | (R)-(+)-[2,3-DIHYDRO-5-METHYL-3-(4-MORPHOLINYLMETHYL)PYRROLO[1,2,3-DE]-1,4-BENZOXAZIN-6-YL]-1-NAPHTHALENYLMETHANONE MESYLATE;R(+)-[2,3-DIHYDRO-5-METHYL-3-[(MORPHOLINYL)METHYL]PYRROLO[1,2,3-DE]-1,4-BENZOXAZINYL]-(1-NAPHTHALENYL)METHANONE MESYLATE;R(+)-WIN |
Win 18446 | 1477-57-2 | C12H20Cl4N2O2 | 366.11 | N,N'-1,8-WIN 18446; WIN18446; WIN-18446; N,N'-1,8-Octanediylbis(2,2-dichloroacetamide); Fertilysin; Bis-Diamine; Fertilysine |
Wilsonine | 39024-12-9 | C20H25NO4 | 343.4 | C-Homoerythrinan, 1,2-didehydro-6,7-epoxy-3,15,16-trimethoxy-, (3alpha ,6xi)- |
Wilfortrine | 37239-48-8| | C41H47NO20 | Evonimine, 8-(acetyloxy)-O(sup 2)-deacetyl-8-deoxo-O(sup 2)-(3-furanylcarbonyl)-26-hydroxy-, (8-alpha)- | |
Wilfortrine | 37239-48-8 | C41H47NO20 | 873.814 | Evonimine, 8-(acetyloxy)-O(sup 2)-deacetyl-8-deoxo-O(sup 2)-(3-furanylcarbonyl)-26-hydroxy-, (8-alpha)- |
VO-Ohpic trihydrate | 476310-60-8 | C12H15N2O11V | 415.2 | VO-Ohpic trihydrate |
Vonoprazan Impurity 3 | 928325-41-1 | C17H15F2N3O2S | 363.39 | |
Vonoprazan Impurity 2 | 881733-36-4 | C17H16FN3O2S | 345.4 | |
Vonoprazan Impurity 14 | 881677-11-8 | C16H11FN2O3S | 330.34 | 1H-Pyrrole-3-carboxaldehyde, 5-(2-fluorophenyl)-1-(3-pyridinylsulfonyl)- |
Vonoprazan Impurity 1 | 881732-90-7 | C17H17N3O2S | 327.41 | N-methyl(5-phenyl-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methanamine fumarate salt |
Vonoprazan Fumarate | 1260141-27-2 | C17H16FN3O2S.C4H4O4 | 461.46 | TAK438; TAK-438; TAK 438 |
Vonoprazan Fumarate | 881681-01-2 | C17H16FN3O2S.C4H4O4 | 461.46 | TAK 438; TAK-438; 1-[5-(2-fluorophenyl)-1-pyridin-3-ylsulfonylpyrrol-3-yl]-N-methylmethanamine fumurate |
viquidil | 84-55-9 | C20H24N2O2 | 324.422 | |
VIQUALINE | 72714-74-0 | C20H26N2O | 310.43300 | |
Vipadenant | 442908-10-3 | C16H15N7O | 321.34 | BG-14; BIIB-014; BIIB14; CEB-4520; V2006; VER-11135; VER-A00-11; VER-A00049; VER-ADO-49; VR-2006 |
VIP(6-28)(human, rat, porcine, bovine) | 69698-54-0 | C126H207N37O34S | 2816.28 | H-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2; L-phenylalanyl-L-threonyl-L-alpha-aspartyl-L-asparagyl-L-tyrosyl-L-threonyl-L-arginyl-L-leucyl-L-arginyl-L-lysyl-L-glutaminyl-L-methionyl-L-alanyl-L-valyl-L |
Vinpocetine Impurity (Oxime) | 102341-40-2 | C19H23N3O | 309.41 | |
Vinpocetine Carboxylic Acid | 27773-65-5 | C20H22N2O2 | 322.41 | Apovincaminic Acid; (13aS,13bS)-13a-Ethyl-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylic acid; Apovincamin-22-oic acid; (3a,16a)-Eburnamenine-14-carboxylic acid |
Vinpocetine | 42971-09-5 | C22H26N2O2 | 350.45 | Cavinton; Ethyl apovincaminate |
Vinpocetine | 80038-06-8 | 0 | ||
Vaborbactam | 1360457-46-0 | C12H16BNO5S | 297.14 | RPX 7009; MP-7009; REBO-07; MP-7;Meropenem;2-((3R,6S)-2-hydroxy-3-(2-(thiophen-2-yl)acetamido)-1,2-oxaborinan-6-yl)acetic acid |
Vabicaserin hydrochloride | 887258-94-8 | C15H21ClN2 | 264.79 | Vabicaserin HCl; SCA 136; SCA-136; SCA136 |
Vabicaserin | 620948-93-8 | C15H20N2 | 228.33 | VABICASERIN; (6aS,9aR)-rel-(-)-1,2,3,4,6,6a,7,8,9,9a-Decahydrocyclopenta[4,5]pyrido[3,2,1-jk][1,4]benzodiazepine |
V-9302 | 1855871-76-9 | C34H38N2O4 | 538.68 | EX-A2965; (2S)-2-amino-4-[bis[[2-[(3-methylphenyl)methoxy]phenyl]methyl]amino]butanoic acid |
Uvarigranol C | 172104-04-0 | C23H24O7 | 412.43 | (5-benzoyloxy-2-ethoxy-1,6-dihydroxycyclohex-3-en-1-yl)methyl benzoate |
Uvarigranol B | 164204-79-9 | C23H22O8 | 426.42 | (6-acetyloxy-5-benzoyloxy-1,2-dihydroxycyclohex-3-en-1-yl)methyl benzoate |
Uzarigenin digitaloside | 61217-80-9 | C30H46O8 | 534.69 | 3beta-[(6-Deoxy-3-O-methyl-beta-D-galactopyranosyl)oxy]-14-hydroxy-5alpha,14beta-card-20(22)-enolide |
Tofetridine | 40173-75-9 | C15H21NO | 0 | Tofetridine; (-)-1,2,3,4,4a,5,6,10b-Octahydro-9-methoxy-10b-methylphenanthridine |
TNP-GTP | 612837-26-0 | C16H16N8O20P3 | 733.26 | 2',3'-O-Trinitrophenyl-guanosine-5'-triphosphate, Triethylammonium salt |
Tofacitinib Impurity Z | 477600-76-3 | C15H21N5O | 287.37 | 3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- |
Tofacitinib Impurity R | 479633-63-1 | C13H10ClN3O2S | 307.76 | 4-Chloro-7-tosyl-7h-pyrrolo[2,3-d]pyrimidine |
Tofacitinib Impurity P | 1252883-90-1 | C20H25N5 | 335.46 | N-((3S,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
Tofacitinib Impurity N | 1260614-73-0 | C13H19N5 | 245.33 | N-methyl-N-((3s,4s)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
Tofacitinib Impurity F | 384338-23-2 | C14H22N2 | 218.34 | |
Tofacitinib Impurity F | 477600-69-4 | C14H22N2 | ||
Tofacitinib Impurity E | 477600-70-7 | C14H22N2 | ||
Tofacitinib Citrate | 540737-29-9 | C22H28N6O8 | 504.5 | CP-690550 Citrate; 3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile citrate |
Tofacitinib | 477600-75-2 | C16H20N6O | 312.37 | Tasocitinib; 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile; CP-690550 |
TOFA | 54857-86-2 | C19H32O4 | 324.45 | 5-tetradecoxyfuran-2-carboxylic acid; 5-(tetradecyloxy)-2-furancarboxylic acid; 5-(tetradecyloxy)-2-furoic acid; RMI 14514; RMI-14514 |
Todralazine hydrochloride | 3778-76-5 | C11H12N4O2·HCl | 268.7 | Apirachol; Binazine; Ecarazine; Ethyl N-(phthalazin-1-ylamino)carbamate hydrochloride |
Tigogenin | 77-60-1 | C27H44O3 | 416.64 | (3beta,5alpha,17xi,25R)-spirostan-3-ol; (3beta,5alpha,25R)-spirostan-3-ol; (3beta,5alpha,8xi,9xi,14xi,25R)-spirostan-3-ol; (3beta,5alpha,25S)-spirostan-3-ol. |
TIGLYL CARNITINE, 95% | 64191-86-2 | C12H21NO4 | 243.29900 | |
Tigloylgomisin P | 69176-51-8 | C28H34O9 | 514.57 | Schizandrer B |
Tigloylgomisin H | 66069-55-4 | C28H36O8 | 500.59 | 2-Butenoic acid, 2-methyl-, (6S,7S,12aR)-5,6,7,8-tetrahydro-7-hydroxy-2,3,10,11,12-pentamethoxy-6,7-dimethyldibenzo(a,C)cycloocten-1-yl ester, (2E)- |
Wilforol C | 168254-95-3 | C30H48O4 | 472.7 | 3-Epihederagenol |
Wilfornine A | 345954-00-9 | C45H51NO20 | 925.89 | |
Wilforlide A acetate | 84104-80-3 | C32H48O4 | 496.732 | |
Wilforine | 11088-09-8 | C43H49NO18 | 867.85 | |
Wilforgine | 37239-47-7 | C41H47NO19 | 857.8 | (8alpha)-8-(Acetyloxy)-O2-deacetyl-8-deoxo-O2-(3-furanylcarbonyl)- evonimine Wilforgin |
Wilfordine | 37239-51-3 | C43H49NO19 | 883.853 | |
WIKI4 | 838818-26-1 | C29H23N5O3S | 521.595 | WIKI-4; 2-[3-[[4-(4-methoxyphenyl)-5-pyridin-4-yl-1,2,4-triazol-3-yl]sulfanyl]propyl]benzo[de]isoquinoline-1,3-dione |
Wighteone | 51225-30-0 | C20H18O5 | 338.4 | 3-(4-Hydroxyphenyl)-5,7-dihydroxy-6-(3-methyl-2-butenyl)-4H-1-benzopyran- 4-one;4',5,7-Trihydroxy-6-(3-methyl-2-butenyl)isoflavone;4',5,7-Trihydroxy-6-prenyl-isofla vone;5,7-Dihydroxy-3-(4-hydroxyphenyl)-6-(3-methyl-2-butenyl)-4H-1-benzopyran-4-on |
White spirit | 64742-88-7 | 0 | mediumaliphaticsolventnaphtha(petroleum); solventnaphtha(petroleum),mediumaliph.; Solventnaphtha,petroleum,mediumaliph.; PETROLEUM SPIRITS; MINERAL SPIRITS; STODDARD SOLVENT; VENICE TURPENTINE SUBSTITUTE; TURPENTINE SUBSTITUTE | |
White Beeswax | 8012-89-3 | Beeswax, bleached; Aquacer 560; BWS 30 | ||
WHI-P97 | 211555-05-4 | C16H13Br2N3O3 | 455.1 | 2,6-dibromo-4-[(6,7-dimethoxyquinazolin-4-yl)amino]phenol |
WHI-P258 | 21561-09-1 | C16H15N3O2 | 281.315 | 6,7-Dimethoxy-N-phenylquinazolin-4-amine |
WHI-P180 hydrochloride | 153437-55-9 | C16H16ClN3O3 | 333.77 | Janex 3 hydrochloride; WHI-P 180 hydrochloride |
WHI-P180 | 211555-08-7 | C16H15N3O3 | 297.31 | 3-[(6,7-dimethoxy-4-quinazolinyl)amino]-phenol; Janex 3; WHI-P 180 |
WHI-P154 | 211555-04-3 | C16H14BrN3O3 | 376.21 | JAK3 inhibitor II; WHI-P 154; 2-Bromo-4-[(6,7-dimethoxyquinazolin-4-yl)amino]phenol |
Willow Bark Extract | 84082-82-6 | White Willow Bark Extract | ||
WHEATGERMAMIDOPROPYL ETHYLDIMONIUM ETHOSULFATE | 115340-80-2 | |||
WEHI-539 | 1431866-33-9 | C31H29N5O3S2 | 583.73 | 5-[3-[4-(aminomethyl)phenoxy]propyl]-2-[(8E)-8-(1,3-benzothiazol-2-ylhydrazinylidene)-6,7-dihydro-5H-naphthalen-2-yl]-1,3-thiazole-4-carboxylic acid WEHI-539 1431866-33-9 CHEMBL3342187 WEHI539 DTXSID20744277 BDBM109236 BDBM50030764 ZINC100285165 |
WEHI-345 analogue | 1354825-62-9 | C23H25N7O | 415.49 | WEHI-345 (analog); SCHEMBL727021; CS-5569 |
WEHI-345 | 1354825-58-3 | C22H23N7O | 401.46 | WEHI-345; SCHEMBL10098386; CS-5045; HY-18937 |
Wedelolactone | 524-12-9 | C16H10O7 | 314.3 | 1,8,9-Trihydroxy-3-methoxy-6H-benzofuro[3,2-c][1]benzopyran-6-one; |
Wedelobatin B | 1589488-35-6 | C30H44O3 | 452.67 | |
Wedelobatin A | 1589488-34-5 | C30H46O3 | 454.68 | |
Wedeliatrilolactone A | 156993-29-2 | C23H32O9 | 452.5 | 6-O-Isobutyryltrilobolide; (8abeta)-4beta,5alpha-Diacetoxy-alpha-methylene-1alpha-(isobutyryloxy)-3beta,8beta-dihydroxy-4aalpha,8-dimethyldecahydronaphthalene-2beta-acetic acid 2,3-lactone |
Wedelialactone A | 175862-40-5 | C24H34O8 | 450.53 | |
WEB 2086 | 105219-56-5 | C22H22N5O2SCl | 455.96 | Apafant; 4-[3-[4[(2-Chlorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a]diazepin-2-yl]-1-oxopropyl]morpholine |
WDR5-0103 | 890190-22-4 | C21H25N3O4 | 383.44 | 3-[(3-Methoxybenzoyl)aMino]-4-(4-Methyl-1-piperazinyl)benzoic Acid Methyl Ester;Methyl 3-(3-methoxybenzamido)-4-(4-methylpiperazin-1-yl)benzoate;WD-Repeat Protein 5-0103 |
WCA-80 | 35430-88-7 | |||
WB 4101 hydrochloride | 2170-58-3 | C19H23NO5.HCl | 381.86 | 2-(2,6-Dimethoxyphenoxyethyl)aminomethyl-1,4-benzodioxane hydrochloride |
WAY-600 | 1062159-35-6 | C28H30N8O | 494.603 | WAY 600; WAY600. |
WAY-316606 | 915759-45-4 | C18H19F3N2O4S2 | 448.475 | WAY 316606; 5-(phenylsulfonyl)-N-(piperidin-4-yl)-2-(trifluoromethyl)benzenesulfonamide |
WAY-262611 | 1123231-07-1 | C20H22N4 | 318.42 | |
WAY-255348 | 872141-23-6 | C16H14FN3O | 283.306 | WAY255348; WAY 255348. |
WAY-200070 | 440122-66-7 | C13H8BrNO3 | 306.11 | 4-(7-bromo-5-hydroxy-3H-1,3-benzoxazol-2-ylidene)cyclohexa-2,5-dien-1-one; Br-ERb-041; WAY 200070; WAY 20070-3; WAY-200070; WAY-200070-3; WAY200070; WAY200070-3 |
WAY181187 | 554403-49-5 | C15H13ClN4O2S2 | 380.86 | WAY-181187;2-(1-((6-Chloroimidazo(2,1-b)(1,3)thiazol-5-yl)sulfonyl)-1H-indol-3-yl)ethylamine;SAX-187;SAX187 |
WAY-161503 | 75704-24-4 | C11H11Cl2N3O | 272.1 | WAY 161503; WAY161503; 8,9-Dichloro-2,3,4,4A-tetrahydro-1H-pyrazino[1,2-A]quinoxalin-5(6H)-one hydrochloride |
WAY-126299A | 169626-43-1 | C22H19N2NaO3S | 414.45 | WAY-126299A; WAY 126299A; 2-Naphthaleneacetamide, 6-(2-benzothiazolylmethoxy)-N-hydroxy-N,alpha-dimethyl-, sodium salt, (S)-; 2-Naphthaleneacetamide, 6-(2-benzothiazolylmethoxy)-N-hydroxy-N,alpha-dimethyl-, sodium salt, (alphaS)- |
WAY-100635 maleate | 634908-75-1 | C29H38N4O6 | 538.64 | (Z)-but-2-enedioic acid;N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-pyridin-2-ylcyclohexanecarboxamide; |
WAY-100635 | 162760-96-5 | C25H34N4O2 | 422.56 | N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-pyridin-2-ylcyclohexanecarboxamide cyclohexanecarboxamide, N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-2-pyridinyl- N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamid |
WAY100635 | 1092679-51-0 | C25H34N4O2.C4H4O4 | 538.64 | N/A |
WAY 629 hydrochloride | 57756-44-2 | C15H18N2.HCl | 262.78 | 1,2,3,4,8,9,10,11-Octahydro[1,4]diazepino[6,7,1-jk]carbazole hydrochloride |
WAY 316606 hydrochloride | 1781835-02-6 | C18H19F3N2O4S2.HCl | 484.94 | 5-(Phenylsulfonyl)-N-4-piperidinyl-2-(trifluoromethyl)benzene sulfonamide hydrochloride |
WAY 267464 dihydrochloride | 1432043-31-6 | C32H35N7O4.2HCl | 654.59 | N-[[4-[(4,10-Dihydro-1-methylpyrazolo[3,4-b][1,5]benzodiazepin-5(1H)-yl)carbonyl]-2-methylphenyl]methyl]-4-[(3,5-dihydroxyphenyl)methyl]-1-piperazinecarboxamide dihydrochloride |
VX-787 | 1629869-44-8 | C20H19F2N5O2 | 399.40 | VX-787; VX 787; VX787; JNJ-872; JNJ 872; JNJ872; VRT-0928787; VRT 0928787; VRT0928787;pimodivir; (2S,3S)-3-((5-Fluoro-2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl)amino)bicyclo[2.2.2]octane-2-carboxylic Acid |
WAY 213613 | 868359-05-1 | C16H13BrF2N2O4 | 415.19 | N-[4-(2-Bromo-4,5-difluorophenoxy)phenyl]-L-asparagine; (2S)-2-amino-4-[4-(2-bromo-4,5-difluorophenoxy)anilino]-4-oxobutanoic acid |
WAY 208466 dihydrochloride | 1207064-61-6 | C17H18FN3O2S.2HCl | 420.33 | 3-[(-3-Fluorophenyl)sulfonyl]-N,N-dimethyl-1H-pyrrolo[2,3-b]pyridine-1-ethanamine dihydrochloride |
VU 0357017 hydrochloride | 1135242-13-5 | C18H27N3O3.HCl | 369.89 | ethyl4-[2-[(2-methylbenzoyl)amino]ethylamino]piperidine-1-carboxylate;hydrochloride;VU0357017Hydrochloride;1135242-13-5;VU0357017;4-[[2-[(2-Methylbenzoyl)amino]ethyl]amino]-1-piperidinecarboxylicAcidEthylEsterHydrochloride |
VU 0285683 | 327056-22-4 | C14H7FN4O | 266.23 | 3-Fluoro-5-[3-(2-pyridinyl)-1,2,4-oxadiazol-5-yl]-benzonitrile |
VU 0255035 | 1135243-19-4 | C18H20N6O3S2 | 432.52 | N-[3-Oxo-3-[4-(4-pyridinyl)-1-piperazinyl]propyl]-2,1,3-benzothiadiazole-4-sulfonamide |
VU 0238429 | 1160247-92-6 | C17H12F3NO4 | 351.28 | 1-(4-Methoxybenzyl)-5-trifluoromethoxyisatin; 1-[(4-methoxyphenyl)methyl]-5-(trifluoromethoxy)indole-2,3-dione |
VU 0155069 | 1130067-06-9 | C26H27ClN4O2 | 462.98 | N-[(1S)-2-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]-1-methylethyl-2-naphthalenecarboxamide |
VU 0155041 sodium salt | 1259372-69-4 | C14H14Cl2NNaO3 | 338.16 | cis-2-[[(3,5-Dichlorophenyl)amino]carbonyl]cyclohexanecarboxylic acid sodium salt |
VU 0155041 | 1093757-42-6 | C14H15Cl2NO3 | 316.18 | cis-2-[[(3,5-Dichlorophenyl)amino]carbonyl]cyclohexanecarboxylic acid; (1R,2S)-2-[(3,5-dichlorophenyl)carbamoyl]cyclohexane-1-carboxylic acid |
VU 0134992 | 755002-90-5 | C20H31BrN2O2 | 411.38 | 2-(2-Bromo-4-isopropylphenoxy)-N-(2,2,6,6-tetramethylpiperidin-4-yl)acetamide |
VU 0029767 | 326001-01-8 | C21H21N3O3 | 363.41 | 2-(4-ethoxyanilino)-N'-[(Z)-(2-oxonaphthalen-1-ylidene)methyl]acetohydrazide |
VMY-1-103 | 1209002-43-6 | C34H42ClN9O4S | 708.279 | VMY1-103; VMY 1-103. |
VK3-OCH3 | 255906-59-3 | C14H14O3S | 262.3 | Vitamin K3-OCH3; 2-(2-methoxyethylthio)-3-methylnaphthalene-1,4-dione; 2-(2-Methoxyethylthio)-3-methyl-1,4-naphthoquinone |
VJ115 | 929256-79-1 | C23H24N2O | 344.45 | VJ 115; VJ-115. |
Vitronectin from rat plasma | 83380-82-9 | Serum spreading factor | ||
Vitexolide D | 1788090-69-6 | C20H30O3 | 318.45 | 12-Hydroxy-8(17),13-labdadien-16,15-olide; 4-[(1S)-2-[(1S,4aS,8aS)-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-1-hydroxyethyl]-2H-furan-5-one |
Vitexin-4-rhamnoside | 32426-34-9 | |||
Undecyl b-D-maltopyranoside | 253678-67-0 | C23H44O11 | 496.59 | Undecyl 4-O-a-D-glucopyranosyl-b-D-glucopyranoside |
Undecyl b-D-glucopyranoside | 70005-86-6 | C17H34O6 | 334.45 | |
Undecyl a-D-maltopyranoside | 168037-13-6 | C23H44O11 | 496.59 | Undecyl 4-O-a-D-glucopyranosyl-a-D-glucopyranoside |
Undecyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-glucopyranose | 173725-24-1 | C25H43NO9 | 501.61 | |
Undecyl 2-acetamido-2-deoxy-b-D-glucopyranoside | 152914-68-6 | C19H37NO6 | 375.5 | |
UNDECETH-5 | 34398-01-1 | (C2H4O)n.C11H24O | UNDECETH-5; Poly(oxy-1,2-ethanediyl), .alpha.-undecyl-.omega.-hydroxy-; POLY(OXY-1,2-ETHANDIYL),ALPHA-UNDECYL-OMEGA-HYDROXY; 2-ethanediyl), .alpha.-undecyl-.omega.-hydroxy-Poly(oxy-1; alpha-undecyl- omega -hydroxy-poly(oxy-2-ethanediyl); Polyethylene glyc | |
TRIISONONYL TRIMELLITATE | 53894-23-8 | C36H60O6 | 588.86 | 1,2,4-Benzenetricarboxylicacid,triisononylester; triisononyltrimellitate,mixtureofisomers; TRIISONONYL TRIMELLITATE; triisononyl benzene-1,2,4-tricarboxylate; TRIISONONYL TRIMELLITATE MIXTURE OF &; TINTM; Triisononylbenzol-1,2,4-tricarboxylat; Trimelli |
tri-isobutyl phosphate | 126-71-6 | C12H27O4P | 266.32 | PHOSPHORIC ACID TRIISOBUTYL ESTER; isobutylphosphate; Phosphoricacid,tris(2-methylpropyl)ester; TRIISOBUTYL PHOSPHATE; TIBP; TRIS-ISOBUTYLPHOSPHATE; Triisobutylphosphat; Tris(2-methylpropyl) phosphate |
Triisobutyl citrate | 63133-75-5 | C18H32O7 | 360.44248 | triisobutyl citrate; Citric acid triisobutyl ester |
TRIETHYLAMMONIUM ACETATE | 5204-74-0 | C8H19NO2 | 161.24 | Aceticacid,compd.withN,N-diethylethanamine(1:1); aceticacid:triethylamine2m:2mconcen-trate; Ethanamine,N,N-diethyl-,acetate; triethylammonium; TEAA; TRIETHYLAMINE ACETATE |
Triethylamine-n-oxide | 2687-45-8 | C6H15NO | 117.19 | TRIETHYLAMINE N-OXIDE; triethylamine-n-oxidemoistcrystals; N,N-Diethylethanamine N-oxide; N,N-diethylethanamine oxide |
TRIETHYLAMINE HYDROBROMIDE 99% | 636-70-4 | C6H16BrN | 182.1 | |
Triethyl-a-cyclodextrin | 145454-97-3 | C72H132O30 | 1477.80 | Hexakis-(2,3,6-tri-O-ethyl)-a-cyclodextrin |
Trazodone Impurity C | 1263278-77-8 | C19H22ClN5O | 371.87 | |
Trazodone Impurity B | 62337-66-0 | C19H23N5O | 337.43 | 2-[3-(4-Phenyl-1-piperazinyl)propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one |
Trazodone Impurity A | 55290-68-1 | C19H22ClN5O2 | 387.87 | 2-[3-[4-(3-Chlorophenyl)-1-oxido-1-piperazinyl]propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one |
Trazodone hydrochloride | 25332-39-2 | C19H23Cl2N5O | 408.32 | Trazodone HCl; Desyrel; Molipaxin; 2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one hydrochloride |
Trazodone | 19794-93-5 | C19H22ClN5O | 371.86 | 8-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-6,8,9-triazabicyclo[4.3.0]nona-2,4,9-trien-7-one;desyrel;trazon;TRAZODONE;trialodine;Trazodone Hydrochloride 2-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl]-1,2,4-tri;Trazodone (base and/or unspecified salts) |
Traxoprodil mesylate | 188591-67-5 | C20H25NO3.CH4O3S | 423.52 | CP 101606 mesylate; 1-[(1S,2S)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]-4-phenylpiperidin-4-ol mesylate |
Traxillaside | 149415-62-3 | C28H36O12 | 564.59 | (3R,4R)-3-[[3-methoxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl]-4-[(3,4,5-trimethoxyphenyl)methyl]oxolan-2-one |
TP-10 | 898563-00-3 | C26H19F3N4O | 460.45 | 2-{4-[4-Pyridin-4-yl-1-(2,2,2-trifluoro-ethyl)-1H-pyrazol-3-yl]-phenoxymethyl}-quinoline;Substituted pyrazole, 13;2-[[4-[4-pyridin-4-yl-1-(2,2,2-trifluoroethyl)pyrazol-3-yl]phenoxy]methyl]quinoline |
TP-0903 | 1341200-45-0 | C24H30ClN7O2S | 516.06 | TP-0903; TP 0903; TP0903 |
TP0427736 | 864374-00-5 | C14H10N4S2 | 298.4 | TP 0427736; TP-0427736; 6-[5-(4-methyl-1,3-thiazol-2-yl)-1H-imidazol-4-yl]-1,3-benzothiazole |
TP 064 | 2080306-20-1 | C28H34N4O2 | 458.6 | N-Methyl-N-((2-(1-(2-(methylamino)ethyl)piperidin-4-yl)pyridin-4-yl)methyl)-3-phenoxybenzamide |
TP 003 | 628690-75-5 | C23H16F3N3O | 407.39 | 2',4-Difluoro-5'-[8-fluoro-7-(1-hydroxy-1-methylethyl)imidazo[1,2-a]-pyridin-3-yl]-[1,1'-biphenyl]-2-carbonitrile |
Tozasertib | 639089-54-6 | C23H28N8OS | 464.59 | MK-0457; VX-680; VE-465. |
Way 100289 | 136013-69-9 | C20H27N3O3 | 357.45 | 2-(cyclopropylmethoxy)-N-((8-methyl-8-azabicyclo[3.2.1]octan-3-yl)carbamoyl)benzamide |
Way 100252 | 129041-16-3 | C26H25NO2 | 383.49 | 4-(bis(naphthalen-1-ylmethyl)amino)butanoic acid |
WAY 100135 dihydrochloride | 149055-79-8 | C24H33N3O2.2HCl | 468.46 | WAY 100135 hydrochloride; 3-[4-(2-Methoxyphenyl)piperazin-1-yl]-2-phenyl-N-tert-butyl-propanamide dihydrochloride; N-tert-Butyl-3-(4-(2-methoxyphenyl)-piperazin-1-yl)-2-phenylpropanamide dihydrochloride |
Way 100135 | 133025-23-7 | C24H33N3O2 | 395.54 | N-(tert-butyl)-3-(4-(2-methoxyphenyl)piperazin-1-yl)-2-phenylpropanamide;(S)-WAY 100135 dihydrochloride(149007-54-5) |
Watanipidine monohydrochloride | 116308-56-6 | C41H43ClN4O6 | 723.26 | 5-O-[2-[4-(4-benzhydrylpiperazin-1-yl)phenyl]ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;hydrochloride; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-(4-(4-(diphenylmethyl)-1-piper |
WARFARIN-S | 37341-99-4 | C33H28N4O6S | 608.66400 | |
Warfarin-d6 | 1261395-69-0 | C19H10D6O4 | 314.36 | |
Warfarin sodium | 129-06-6 | C19H15NaO4 | 330.31 | Aldocumar; Athrombin; Coumadan Sodico; Coumadin; Coumadin Sodium; Coumadine; Coumafene Sodium; Dimantil; Farin; Marevam; Marevan; Orfarin; Panwarfin; Prothromadin; Ratsul Soluble ;Simarc 2 ; Sodium coumadin; Sodium Warfarin; [[2-Oxo-3-(3-oxo-1-phenylbutyl |
Warfarin Impurity 1 | 55901-61-6 | C13H14O | 186.26 | |
Warangalone | 4449-55-2 | C25H24O5 | 404.5 | Scandenone; 2H,6H-Benzo[1,2-b:5,4-b']dipyran-6-one, 5-hydroxy-7-(4-hydroxyphenyl)-2,2-dimethyl-10-(3-methyl-2-butenyl)- |
Walsuronoid B | 942582-15-2 | C26H30O6 | 438.53 | |
Walsuralactam A | 1370556-82-3 | C26H31NO5 | 437.536 | |
Walrycin B | 878419-78-4 | C14H10F3N5O2 | 337.26 | |
Wallicoside | 88797-59-5 | C61H98O26 | 1247.43 | |
Wallichinine | 125292-97-9 | C22H26O5 | 370.439 | 4-[2-(3,4-Dimethoxyphenyl)-1-methylethenyl]-4,5-dimethoxy-2-(2-propenyl)-2,5-cyclohexadien-1-one; 4-[(E)-1-(3,4-dimethoxyphenyl)prop-1-en-2-yl]-4,5-dimethoxy-2-prop-2-enylcyclohexa-2,5-dien-1-one |
WAGLIOL (PROPYLENE GLYCOL DICAPRYLATE | 68583-51-7 | C39H70O8-- | 666.96800 | |
VX-561 | 1413431-07-8 | C24H19D9N2O3 | 401.267 | CTP-656; N-(2-(tert-butyl)-5-hydroxy-4-(2-(methyl-d3)propan-2-yl-1,1,1,3,3,3-d6)phenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide; d9-ivacaftor |
VX-222 (VCH-222, Lomibuvir) | 1026785-59-0 | C25H35NO4S | 445.61 | N/A |
VX-166 | 800408-39-3 | C22H21F4N3O8 | 531.41 | (S)-3-((S)-2-(3-((methoxycarbonyl)amino)-2-oxopyridin-1(2H)-yl)butanamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid |
VX-148 | 297730-05-3 | C23H25N5O4 | 435.476 | VX148; VX 148. |
VX-11e | 896720-20-0 | C24H20Cl2FN5O2 | 500.35 | |
VULM 1457 | 228544-65-8 | C25H27N3O3S | 449.57 | N-[2,6-bis(1-Methylethyl)phenyl]-N'-[4-[(4-nitrophenyl)thio]phenyl]urea |
VUF10460 | 1028327-66-3 | C15H19N5 | 269.34 | 4-(4-methylpiperazin-1-yl)-6-phenylpyrimidin-2-amine; |
VUF 8430 dihydrobromide | 100130-32-3 | C4H11N5S.2HBr | 323.05 | 2-[(Aminoiminomethyl)amino]ethyl carbamimidothioic acid ester dihydrobromide; S-(2-guanidylethyl)-isothiourea; S,2-Guanidinoethylisothiuronium bromide hydrobromide |
VUF 5681 dihydrobromide | 639089-06-8 | C11H19N3.2HBr | 355.11 | 4-[3-(1H-Imidazol-4-yl)propyl]piperidine dihydrobromide |
VUF 5574 | 280570-45-8 | C21H17N5O2 | 371.39 | N-(2-Methoxyphenyl)-N'-[2-(3-pyrindinyl)-4-quinazolinyl]-urea; 1-(2-Methoxyphenyl)-3-(2-(pyridin-3-yl)quinazolin-4-yl)urea |
VUF 11222 | 1414376-84-3 | C25H31BrIN | 552.33 | 2'-Bromo-N-[[(1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl]methyl]-N,N-dimethyl-[1,1'-biphenyl]-4-methanaminium iodide |
VUF 11207 fumarate | 1785665-61-3 | C27H35FN2O4.C4H4O4 | 586.65 | N-[(2E)-3-(2-Fluorophenyl)-2-methyl-2-propen-1-yl]-3,4,5-trimethoxy-N-[2-(1-methyl-2-pyrrolidinyl)ethyl]benzamide fumarate |
VUF 10166 | 155584-74-0 | C13H15ClN4 | 262.74 | 2-Chloro-3-(4-methyl-1-piperazinyl)quinoxaline |
VU6001221 | 2002495-17-0 | C20H26ClN3O3 | 391.89 | VU 6001221; VU-6001221 |
VU-0483605 | 1623101-11-0 | C20H10Cl3N3O3 | 446.67 | CHEMBL3628116; VU0483605; AOB6248; SYN5042; 3-chloro-N-[3-chloro-4-(4-chloro-1,3-dioxoisoindol-2-yl)phenyl]pyridine-2-carboxamide |
VU0467154 | 1451993-15-9 | C17H15F3N4O3S2 | 444.45 | 5-Amino-3,4-dimethyl-N-[[4-(trifluoromethylsulfonyl)phenyl]methyl]thieno[2,3-c]pyridazine-6-carboxamide |
VU0364572 trifluoroacetate salt | 1240514-89-9 | C21H31N3O3·CF3COOH | 487.5 | VU0364572 TFA salt; ethyl 4-[(3R)-3-[(2-methylbenzoyl)amino]piperidin-1-yl]piperidine-1-carboxylate;2,2,2-trifluoroacetic acid |
VU0359595 | 1246303-14-9 | C25H29BrN4O2 | 497.4 | CID-53361951; ML-270; (1R,2R)-N-[(2S)-1-[4-(5-Bromo-2-oxo-3H-benzimidazol-1-yl)piperidin-1-yl]propan-2-yl]-2-phenylcyclopropane-1-carboxamide |
VU-0240551 | 893990-34-6 | C16H14N4OS2 | 342.43 | N-(4-Methyl-2-thiazolyl)-2-[(6-phenyl-3-pyridazinyl)thio]acetamide;VU 0240551 |
VU0152100 | 409351-28-6 | C18H19N3O2S | 341.43 | VU0152100 |
VU0071063 | 333415-38-6 | C18H22N4O2 | 326.4 | 7-[(4-tert-butylphenyl)methyl]-1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione |
VU0029251 | 330819-85-7 | C10H11N3S2 | 237.3 | 10-methylsulfanyl-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(12),2(6),8,10-tetraen-12-amine |
VU 6008667 | 2092923-21-0 | C24H17ClF2N2O2 | 438.85 | |
VU 591 hydrochloride | 1315380-70-1 | C16H12N6O5.HCl | 404.76 | 6-Nitro-2-[(6-nitro-1H-benzimidazol-2-yl)methoxymethyl]-1H-benzimidazole hydrochloride |
VU 590 dihydrochloride | 1783987-83-6 | C24H32N4O7.2HCl | 561.46 | 7,13-Bis[(4-nitrophenyl)methyl]-1,4,10-trioxa-7,13-diazacyclopentadecane dihydrochloride |
VU 29 | 890764-36-0 | C22H16N4O3 | 384.39 | N-(1,3-Diphenyl-1H-pyrazolo-5-yl)-4-nitrobenzamide; DPAP; VU-29; 4-nitro-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide |
VU 1545 | 890764-63-3 | C22H15FN4O3 | 402.38 | N-[1-(2-Fluorophenyl)-3-phenyl-1H-pyrazol-5-yl]-4-nitrobenzamide |
VU 10010 | 633283-39-3 | C17H16ClN3OS | 345.85 | 3-Amino-N-[(4-chlorophenyl)methyl]-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide |
VU 0650991 | 488097-06-9 | C16H11ClF6N4O2 | 440.73 | GLP-1R Antagonist 1; 7-(4-Chlorophenyl)-5,8-dihydro-1,3-dimethyl-5,5-bis(trifluoromethyl)pyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione |
VU 0469650 hydrochloride | 1443748-47-7 | C22H28N4O.HCl | 400.94 | 3-[(3R)-3-Methyl-4-(tricyclo[3.3.1.13,7]dec-1-ylcarbonyl)-1-piperazinyl]-2-pyridinecarbonitrile hydrochloride |
VU 0463271 | 1391737-01-1 | C19H18N4OS2 | 382.5 | N-Cyclopropyl-N-(4-methyl-2-thiazolyl)-2-[(6-phenyl-3-pyridazinyl)thio]acetamide |
VU 0422288 | 1630936-95-6 | C17H11Cl2N3O2 | 360.19 | N-[3-Chloro-4-[(5-chloro-2-pyridinyl)oxy]phenyl]-2-pyridinecarboxamide; ML 396 |
VU 0409551 | 1363281-27-9 | C20H17FN2O3 | 352.37 | JNJ46778212;(4-fluorophenyl)(2-(phenoxymethyl)-6,7-dihydrooxazolo[5,4-c]pyridin-5(4H)-yl)methanone |
VU 0409106 | 1276617-62-9 | C15H11FN4O2S | 330.34 | 3-Fluoro-N-(4-methyl-2-thiazolyl)-5-(5-pyrimidinyloxy)benzamide |
VU 0365114 | 1208222-39-2 | C22H14F3NO3 | 397.35 | 1-[(1,1'-Biphenyl)-4-ylmethyl]-5-(trifluoromethoxy)-1H-indole-2,3-dione; 1-[(4-phenylphenyl)methyl]-5-(trifluoromethoxy)indole-2,3-dione |
VU 0364770 | 61350-00-3 | C12H9ClN2O | 232.67 | |
VU 0364739 hydrochloride | 1244640-48-9 | C26H27FN4O2.HCl | 482.98 | N-[2-[1-(3-Fluorophenyl)-4-oxo-1,3,8-triazaspiro[4.5]dec-8-yl]ethyl]-2-naphthalenecarboxamide |
VU 0364439 | 1246086-78-1 | C18H13Cl2N3O3S | 422.28 | |
VU 0361737 | 1161205-04-4 | C13H11ClN2O2 | 262.693 | |
VU 0360223 | 1274859-33-4 | C15H9FN2S | 268.31 | 3-Fluoro-5-(2-methyl-5-benzothiazolyl)-benzonitrile |
VU 0360172 hydrochloride | 1309976-62-2 | C18H15FN2O.HCl | 330.78 | N-Cyclobutyl-6-[2-(3-fluorophenyl)ethynyl]-3-pyridinecarboxamide hydrochloride |
VU 0357121 | 433967-28-3 | C17H17F2NO2 | 305.32 | |
VTP-27999 Hydrochloride | 1264191-73-2 | C26H42Cl2N4O5 | 561.54 | VTP27999 Hydrochloride; VTP 27999 Hydrochloride |
VTP-27999 2,2,2-trifluoroacetate | 1013937-63-7 | C28H42ClF3N4O7 | 639.1 | |
VTP-27999 | 942142-51-0 | C26H41ClN4O5 | 525.08 | |
VT-ME6 | 1353880-00-8 | C25H44IN | 484.54 | Dimethyl-[4-(4-octyl-phenyl)-cyclohexyl]-propyl-ammonium iodide |
VT-464 racemate | 1375603-36-3 | C18H17F4N3O3 | 399.34 | VT-464; CHEMBL3264610; CS-3139; UNII-8S5OIN36X4 component ZBRAJOQFSNYJMF-SFHVURJKSA-N |
VT-464 R enantiomer | 1375603-38-5 | C18H17F4N3O3 | 399.34 | VT-464 (R enantiomer); CS-3140; UNII-8S5OIN36X4 component ZBRAJOQFSNYJMF-GOSISDBHSA-N |
VT-464 | 1610537-15-9 | C18H17F4N3O3 | 399.34 | (1S)-1-[6,7-bis(difluoromethoxy)naphthalen-2-yl]-2-methyl-1-(2H-triazol-4-yl)propan-1-ol VT-464 CHEMBL3264610 CS-3139 HY-15996 UNII-8S5OIN36X4 component ZBRAJOQFSNYJMF-SFHVURJKSA-N 1610537-15-9 1H-1,2,3-Triazole-5-methanol, alpha-(6,7-bis(difluorom |
VT-1161 | 1340593-59-0 | C23H16F7N5O2 | 527.40 | VT 1161; VT1161; Oteseconazole |
1,2,3-Trithiane-4-pentanoic acid | 1204245-29-3 | C8H14O2S3 | 238.4 | 6,8-Epitrithiooctanoic acid |
Vortioxetine-d8 | 2140316-62-5 | C18H14N2SD8 | 306.5 | 1-[2-[(2,4-Dimethylphenyl)thio]phenyl]piperazine-d8; 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine-d8 |
Vortioxetine Impurity 6 | 1293489-74-3 | C18H22N2S | 298.45 | |
VS-5584 | 1246560-33-7 | C17H22N8O | 354.418 | |
VRX-806 | 1004523-72-1 | C24H18BrClN4O3S | 557.85 | VRX806;AR-806;AR806;RDEA-806;RDEA806;4-[[2-[[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-1,2,4-triazol-3-yl]sulfanyl]acetyl]amino]-3-chlorobenzoic acid |
VRT-043198 | 244133-31-1 | C22H29ClN4O6 | 480.946 | VRT-043198; VRT043198; VRT 043198 |
VR23 | 1624602-30-7 | C19H16ClN5O6S | 477.88 | VR23; VR-23; VR 23. |
Vps34-PIK-III | 1383716-40-2 | C17H17N7 | 319.36 | 4-(cyclopropylmethyl)-5-[2-(pyridin-4-ylamino)pyrimidin-4-yl]pyrimidin-2-amine; PIK-III; VPS34-IN2; VPS34-IN 2; VPS34-IN-2 |
VPS34-IN1 | 1383716-33-3 | C21H24ClN7O | 425.91 | VPS34IN1; VPS34 IN1; VPS34-IN1. |
VPS34 inhibitor 1 | 1383716-46-8 | C21H25N7O | 391.47 | 1-[[4-(cyclopropylmethyl)-5-[2-(pyridin-4-ylamino)pyrimidin-4-yl]pyrimidin-2-yl]amino]-2-methylpropan-2-ol; Compound 19, PIK-III analogue; Compound 19, PIK-III analogue |
VPC 23019 | 449173-19-7 | C17H29N2O5P | 372.4 | [(2R)-2-amino-3-(3-octylanilino)-3-oxopropyl] dihydrogen phosphate; 2-Amino-N-(3-octylphenyl)-3-(phosphonooxy)-propanamaide; |
VPA-985 | 168079-32-1 | C27H21ClFN3O2 | 473.94 | N-[3-Chloro-4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)-ylcarbonyl)phenyl]-5-fluoro-2-methylbenzamide;Lixivaptan; VPA-985 |
VP-14637 | 235106-62-4 | C25H22N10O3 | 510.5 | VP 14637; VP14637; 2-[[2-Hydroxy-5-[(E)-(5-methyltetrazol-1-yl)iminomethyl]phenyl]-(4-hydroxyphenyl)methyl]-4-[(E)-(5-methyltetrazol-1-yl)iminomethyl]phenol |
VP/EICOSENE COPOLYMER | 28211-18-9 | C26H49NO | 391.6734 | VP/EICOSENE COPOLYMER; PVP/EICOSENECOPOLYMER; 2-Pyrrolidinone, 1-ethenyl-, polymer with 1-eicosene; polyvinylpyrrolidone-eicosene copolymer; POLY(VINYLPYRROLIDONE/1-EICOSENE); 2-Pyrrolidinone, 1-ethenyl-, polymer with 1-eicosene 1-Eicosene, polymer with 1 |
Voxtalisib (XL-765) | 934493-76-2 | C13H14N6O | 270.296 | XL-765; XL 765; XL765; SAR245409; SAR-245409; SAR 245409; Voxtalisib. |
Vortioxetine Impurity 4 | 1293489-77-6 | C18H22N2S | 298.45 | 4-Desmethyl 3-Methyl Vortioxetine; 1-[2-[(2,3-dimethylphenyl)thio]phenyl]-piperazine |
Vortioxetine Impurity 3 | 508233-82-7 | C17H20N2S | 284.43 | |
Vortioxetine Impurity 20 | 1446750-99-7 | C14H22N4 | 246.36 | 1,2-Bis(piperazin-1-yl)benzene |
Vortioxetine Impurity 2 | 1293489-69-6 | C17H20N2S | 284.43 | |
Vortioxetine Impurity 19 | 1429908-35-9 | C18H22N2OS | 314.45 | 1-[2-[(2,4-diMethylphenyl)sulfinyl]phenyl]- Piperazine |
Vortioxetine Impurity 18 | 13616-83-6 | C16H18S2 | 274.45 | Disulfide,bis(2,4-dimethylphenyl) |
Vortioxetine Impurity 16 | 16704-47-5 | C14H14S | 214.33 | DIMETHYLDIPHENYLSULFIDE |
Vortioxetine Impurity 14 | 1240670-85-2 | C28H34N4S | 458.67 | |
Vortioxetine Impurity 13 | 1011-13-8 | C10H13BrN2 | 241.13 | 1-(2-BROMOPHENYL)PIPERAZINE |
Vortioxetine Impurity 1 | 1293489-71-0 | C17H20N2S | 284.43 | |
Vortioxetine HBr | 960203-27-4 | C18H22N2S·HBr | 379.36 | Lu AA21004 |
Vortioxetine | 508233-74-7 | C18H22N2S | 298.448 | Lu AA 21004; Lu AA21004 |
Vorozole | 129731-10-8 | C16H13ClN6 | 324.76800 | |
Vorinostat Impurity 1 | 866824-87-5 | C28H37N3O5 | 495.62 | |
Vorinostat Amination Derivative | 1160823-16-4 | C15H23N3O3 | 293.37 | p-Aminomethyl Vorinostat; N1-[4-(Aminomethyl)phenyl]-N8-hydroxy-octanediamide |
Vorinostat | 149647-78-9 | C14H20N2O3 | 264.33 | Suberoylanilide Hydroxamic Acid; N-Hydroxy-N'-phenyloctanediamide; SAHA; Zolinza |
Voriconazole Related Compound A | 182230-43-9 | C16H14F3N5O | 349.32 | (2RS,3RS)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol |
Voriconazole Impurity E | 5872-08-2 | C10H16O4S | 232.30 | (±)-7,7-Dimethyl-2-oxo-bicyclo[2.2.1]heptane-1-methanesulfonic Acid; (±)-2-Oxo-10-bornanesulfonic Acid; (RS)-10-Camphorsulfonic Acid; (±)-Camphor-10-sulfonic Acid; (±)-Camphorsulfonic acid; 2-Oxo-10-bornanesulfonic Acid; DL-Camphorsulfonic Acid; ({(1RS,4S |
Voriconazole Impurity C | 137234-88-9 | C6H7FN2 | 126.13 | 4-Ethyl-5-fluoropyrimidine |
Voriconazole Impurity B | 182369-73-9 | C16H15F2N5O | 331.33 | 2RS,3SR)-2-(2,4-Difluorophenyl)-3-pyrimidin-4-yl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol; Desfluoro Voriconazole; Voriconazole USP Related Compound D |
Voriconazole Impurity 8 | 239807-03-5 | C16H14F3N5O | 349.32 | |
Voriconazole Impurity 7 | 239807-04-6 | C16H14F3N5O | 349.32 | |
Voriconazole Impurity 3 | 188416-28-6 | C6H5BrClFN2 | 239.48 | 6-(1-Bromoethyl)-4-chloro-5-fluoropyrimidine |
Voriconazole Impurity 1 | 137234-87-8 | C6H7FN2O | 142.13 | 6-Ethyl-5-fluoro-4-hydroxypyrimidine; 6-Ethyl-5-fluoropyrimidin-4(1H)-one |
Voriconazole | 137234-62-9 | C16H14F3N5O | 349.31 | Vfend; UK-109496; (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol |
Voreloxin Hydrochloride | 175519-16-1 | C18H20ClN5O4S | 437.9 | Voreloxin Hydrochloride |
Voreloxin | 175414-77-4 | C18H19N5O4S | 401.44 | SNS 595; SNS-595; SNS595; SPC-595; SPC595; SPC 595; AG-7352; AG 7352; AG7352; Voreloxin; Vosaroxin. |
Vorasidenib | 1644545-52-7 | C14H13ClF6N6 | 414.74 | AG-881; 6-(6-chloropyridin-2-yl)-2-N,4-N-bis[(2R)-1,1,1-trifluoropropan-2-yl]-1,3,5-triazine-2,4-diamine |
Virustomycin A | 84777-85-5 | C48H71NO14 | 886.08 | AM 2604A |
Voglibose | 83480-29-9 | C10H21NO7 | 267.28 | 3,4-Dideoxy-[2-hydroxy-1-(hydroxyethyl)ethyl] amino-1-C-(hydroxynethyl)-1,2,3,4-cyclohexaneterol; 3,4-Dideoxy-4-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-C-(hydroxymethyl)-D-epiinositol |
Vorapaxar Sulfate | 705260-08-8 | C29H35FN2O8S | 590.66 | SCH530348; SCH 530348, SCH-530348; Vorapaxar sulfate. |
Vorapaxar | 618385-01-6 | C29H33FN2O4 | 492.58 | N-[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(1E)-2-[5-(3-Fluorophenyl)-2-pyridinyl]ethenyl]dodecahydro-1-methyl-3-oxonaphtho[2,3-c]furan-6-yl]carbamic Acid Ethyl Ester Sulfate; Sch 530348; |
Vonoprazan | 881681-00-1 | C17H16FN3O2S | 345.39 | TAK-438 free base;TAK438 free base;Takecab;1-[5-(2-Fluorophenyl)-1-[(pyridin-3-yl)sulfonyl]-1H-pyrrol-3-yl]-N-methylmethanamine;1H-Pyrrole-3-methanamine,5-(2-fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl) |
Vomifoliol | 23526-45-6 | C13H20O3 | 224.3 | (1S)-1-Hydroxy-1-[(1E,3R)-3-hydroxy-1-butenyl]-2,6,6-trimethyl-2-cyclohexene-4-one; (6S,9R)-vomifoliol |
Vomicine | 125-15-5 | C22H24N2O4 | 380.44 | 12-Hydroxy-N-methylpseudostrychinine;4-Hydroxy-19-methyl-16,19-secostrychinidine-10,16-dione;Strychnicine |
Volvaltrate B | 1181224-13-4 | C27H41ClO11 | 577.06 | Valtrate J |
Volvalerenic acid A | 1247014-34-1 | C15H22O2 | 234.33 | Madolin P |
Volkensin | 91933-11-8 | |||
Voleneol | 70389-88-7 | C15H26O2 | 238.4 | 1beta,6alpha-Dihydroxyeudesm-4(15)-ene;Eudesm-4(15)-ene-1beta,6alpha-diol; (1S,2S,4aR,5R,8aS)-2-Isopropyl-4a-methyl-8-methylenedecahydro-1,5 -naphthalenediol |
Volasertib | 755038-65-4 | C34H50N8O3 | 618.827 | Volasertib; BI-6727; BI6727; BI 6727. |
Vofopitant Dihydrochloride | 168266-51-1 | C21H23F3N6O2HCl | 505.37 | Vofopitant dihydrochloride; 3-Piperidinamine, N-[[2-methoxy-5-[5-(trifluoro-methyl)-1H-tetrazol-1-yl]phenyl]methyl]-2-phenyl-, dihydrochloride, (2S,3S)-;3-Piperidinamine, N-[[2-methoxy-5-[5-(trifluoromethyl)-1H-tetrazol-1-yl]phenyl]methyl]-2-phenyl-, dihy |
Vobasan-17-oic acid,4-demethyl-3-oxo-, methyl ester | 2673-40-7 | C20H22N2O3 | Perivin; 5-Ethylidene-2,3,4,5,6,7,8,9-octahydro-8-oxo-2,6-methano-1H-azecino[5,4-b]indole-14-carboxylic acid methyl ester; 4-Demethyl-3-oxovobasan-17-oic acid methyl ester; Vobassan-17-oic acid, 4-demethyl-3-oxo-, methyl ester. | |
Voafinidine | 180059-77-2 | C20H28N2O2 | 328.456 | |
Voacangine | 510-22-5 | C22H28N2O3 | 368.48 | (-)-Voacangine; Carbomethoxyibogaine; 12-Methoxyibogamine-18-carboxylic acid methyl ester |
Voacamine | 3371-85-5 | C43H52N4O5 | 704.90 | NSC 82591; Voacanginine |
Vitexin-4''-O-glucoside | 178468-00-3 | C27H30O15 | 594.5 | 4''-O-Glucosylvitexin; Vitexin 4''-O-glucoside |
Vitexin 2''-O-p-coumarate | 59282-55-2 | C30H26O12 | 578.526 | [(2S,3R,4S,5S,6R)-2-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl] 3-(4-hydroxyphenyl)prop-2-enoate |
Vitexin 2''-O-(4'''-O-acetyl)rhamnoside | 80537-98-0 | C29H32O15 | 620.56 | |
Vitexdoin A | 1186021-77-1 | C19H18O6 | 342.4 | |
Viteralone | 87440-75-3 | C15H14O3 | 242.3 | (S)-5,6,7,8-Tetrahydro-4,5-dimethyl-8-oxonaphtho[2,3-b]furan-3-carboxaldehyde; (5S)-4,5-Dimethyl-8-oxo-5,6,7,8-tetrahydronaphtho[2,3-b]furan-3-c arbaldehyde |
Vitedoin A | 819861-40-0 | C20H20O6 | 356.37 | (3R,4S)-6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-5-methoxy-3,4-dihydronaphthalene-2-carbaldehyde |
VitaminE | 1406-18-4 | C29H50O2 | 430.71 | naturalvitaminee; RAC-ALPHA-TOCOPHEROL; VITAMIN E (DL-FORM); (TOCOPHEROL); TOCOPHEROL, ALPHA-DL-; 5,7,8-TRIMETHYLTOCOL; (+/-)-ALPHA-TOCOPHEROL; (+/-)-ALPHA-TOCOFEROL |
Vitamin U | 3493-12-7 | C6H14NO2·Cl | 199.7 | Methylmethioninesulfonium chloride; Merastom; Cabagin-U; S-methylmethionine; (3-amino-3-carboxypropyl)-dimethylsulfanium chloride |
Vitamin K5 hydrochloride | 130-24-5 | C11H11NOHCl | 209.68 | 4-AMINO-2-METHYL-1-NAPHTHOL HYDROCHLORIDE; 2-METHYL-4-AMINO-1-NAPHTHOL HCL; 2-METHYL-4-AMINO-1-NAPHTHOL HYDROCHLORIDE; VITAMIN K5; VITAMIN K5 HYDROCHLORIDE; 4-hydroxy-3-methyl-1-naphthylammonium chloride; 2-Methyl-4-amino-1-hydroxynaphthalenehydrochloride |
Vitamin K4 | 573-20-6 | C15H14O4 | 258.27 | Menadiol diacetate; Acetomenaphthone; Kapilin; (4-acetyloxy-3-methylnaphthalen-1-yl) acetate |
Vitamin E Related Compound 1 | 119-98-2 | C26H44O2 | 388.64 | rac-Tocol; 2-Methyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydrochromen-6-ol |
VITAMIN E NICOTINATE | 16676-75-8 | C35H53NO3 | 535.8 | VitaminENicotinate; Renascin; TOCOPHERYLNICOTINATE; tocopherolnicotinate; 16676-75-8; (R)-2,5,7,8-Tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-ylnicotinate |
Vitamin E Nicotinate | 51898-34-1 | C35H53NO3 | 535.80 | DL-alpha-Tocopherol nicotinate; Vitamin E nicotinic acid ester; (R)-2,5,7,8-Tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-yl nicotinate |
VITAMIN E LINOLEATE | 36148-84-2 | C47H80O3 | 693.13600 | |
Vitamin E Impurity D (Mixture of Z and E isomers) | 37570-32-4 | C32H54O3 | 486.79 | |
Vitamin E Acetate | 7695-91-2 | C31H52O3 | 472.75 | 3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-yl acetate; [2r-[2r*(4r*,8r*)]]-3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2h-1-benzopyran-6-ol acetate; ALPHA-TOCOPHERYL ACETATE; ALPHA-TOCOPHERYLIS ACETAS; (+ |
Vitamin E | 2074-53-5 | C29H50O2 | 430.71 | Rac-alpha-Tocopherol; Vitamin E (DL-form); Tocopherol, alpha-DL-; [2theta(4theta,8theta)]-(+/-)-yl); 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-,[2R*(4R*,8R*)]-(+-)-2H-1-Benzopyran-6-ol; Alpha-Tocopherolum; (+/-)-alpha-Tocopherol |
Vitamin D5 | 71761-06-3 | C29H48O | 412.7 | (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol; 24R-methylcalciol; Vitamin D5; UNII-0W2I161LCL; 71761-06-3; (5Z,7E)-9,10-Secostigmasta-5, |
Vitamin D4 | 511-28-4 | C28H46O | 398.66 | |
Vitamin D3 Sulfate | 10529-43-8 | C27H44O4S | 464.70 | Cholecalciferol sulfate; AC1O5U9F; 9,10-Secocholesta-5,7,10(19)-trien-3-ol, hydrogen sulfate, (3beta,5Z,7E)-; [(1R,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecycloh |
Vitamin D3 | 67-97-0 | C27H44O | 384.64 | Vitamin D3; Colecalciferol |
Vitamin D2 b-D-glucuronide sodium salt | 85701-30-0 | C34H51NaO7 | 594.75 | (3b,5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-yl b-D-glucopyranosiduronic acid monosodium salt |
Vitamin D2 (Ergocalciferol) | 50-14-6 | C28H44O | 396.65 | Vitamin D2; Calciferol; Viosterol; Deltalin |
Vitamin C | 50-81-7 | C6H8O6 | 176.12 | L-ascorbic acid; Vitamine C; ascorbate. |
Vitamin B6 | 8059-24-3 | C8H10NO5P | 231.14 | 2-Methyl-3-hydroxy-4,5-dihydroxymethylpyridine; (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate |
Vitamin B2 Aldehyde | 59224-04-3 | C17H18N4O6 | 374.353 | |
Vitamin B12 | 68-19-9 | C63H88CoN14O14P | 1355.37 | Cyanocobalamin; Vitamin B12; Docigram; NSC 80365; NSC-80365; NSC80365; Norethisterone |
Vitamin A Impurity C (retro-Vitamin A) | 16729-22-9 | C20H30O | 286.46 | all-trans-Retro Retinol; 4,14-retro-Retinol; retro-Vitamin A; Retroretinol; all-trans-Retroretinol; all-trans-retro- Vitamin A |
Vitamin A Impurity B (Anhydro-Vitamin A) | 1224-78-8 | C20H28 | 268.45 | all-trans-Anhydro Retinol; (6E)-6-[(2E,4E,6E)-3,7-Dimethyl-2,4,6,8-nonatetraen-1-ylidene]-1,5,5-trimethylcyclohexene; Anhydroretinol; Anhydrovitamin A; Anhydrovitamin A1; R368; Anhydroretinol; all-trans-Anhydroretinol; trans-Anhydrovitamin A |
Vitamin A | 11103-57-4 | C20H30O | ROIDEX; Vitamin A Retinol; 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-nona-2,4,6,8-tetraen-1-ol; Aquasol A; Vitamin A; Water-soluble vitamin A | |
Visnagin | 82-57-5 | C13H10O4 | 230.2 | 5-METHOXY-2-METHYL-FURANOCHROMONE; 4-methoxy-7-methylfuro[3,2-g]chromen-5-one |
Vismodegib-d4 | 1450990-33-6 | C19H10Cl2N2O3SD4 | 425.33 | GDC 0449-d4; 2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)-benzamide-d4 |
Vismodegib | 879085-55-9 | C19H14Cl2N2O3S | 421.292 | GDC-0449; Erivedge; 2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide |
Virstatin | 88909-96-0 | C16H13NO4 | 283.3 | Isodibut; 4-(1,3-Dioxo-1H,3H-benzo[de]isoquinolin-2-yl)-butyric acid; 4-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)butanoic acid |
Virosine B | 1052228-70-2 | C13H17NO3 | 235.283 | |
Virodhamine trifluoroacetate | 1415264-56-0 | C22H37NO2·CF3CO2H | 461.56 | O-(2-Aminoethyl)-5Z,8Z,11Z,14Z-eicosatetraenoate trifluoroacetate |
Viroallosecurinine | 1857-30-3 | C13H15NO2 | 217.26 | (7R,9R)-Securinan-11-one;Alkaloid PN-A |
Viridiol | 23820-80-6 | C20H18O6 | 354.4 | NSC 658706 |
VIRIDIFLOROL | 552-02-3 | C15H26O | ||
Viridicatumtoxin | 39277-41-3 | C30H31NO10 | 565.6 | NSC 159628 |
Viridicatol | 14484-44-7 | C15H11NO3 | 253.25 | 3-hydroxy-4-(3-hydroxyphenyl)-1H-quinolin-2-one |
Viridicatin | 129-24-8 | C15H11NO2 | 237.3 | 2,3-dihydroxy-4-phenylquinoline |
Virginiamycin S1 | 23152-29-6 | C43H49N7O10 | 823.9 | Staphylomycin S, PA 114B2, 899, A1745Z3B, Factor S |
Virginiamycin B | 3131-03-1 | C45H54N8O10 | 866.96 | Ostreogrycin B, Pristinamycin IA, Streptogramin B, Syncothrecin B1, Synergistin B, Vernamycin Balpha, Virginiamycin 1A, NSC 125176, 14725-1, PA 114B, RP 12535 |
Virginiamycin | 11006-76-1 | C28H35N3O7 (for M1), C43H49N7O10 (for S1) | 1349.5 | Cebin V, Eskalin V, Eskamicin, Stafac, Stephylomycin, Mikamycin, Ostreogrycin, Patricin, Pristinamycin, Streptogramin, Vernamycin. |
Virgatic acid | 14356-51-5 | C30H46O4 | 470.694 | Vergatic acid; Momordic acid |
Vinorine | 34020-07-0 | C21H22N2O2 | 334.42 | (17R,19E)-1,2,19,20-Tetradehydro-1-demethylajmalan-17-ol 17-acetate |
Vinblastine Impurity J | 61988-79-2 | C47H61N4O9.I | 952.93 | Vinblastine Methiodide; 6'-Methylvincaleukoblastinium Iodide; 1H-Indolizino[8,1-cd]carbazole Vincaleukoblastinium Deriv.; 2H-3,7-Methanoazacycloundecino[5,4-b]indole Vincaleukoblastinium Deriv.; (3R,5S,7S,9S)-9-((3aR,3a1R,4R,5S,5aR,10bR)-4-Acetoxy-3a-ethy |
Vinblastine Impurity C | 18172-50-4 | C45H56N4O9 | 796.97 | N-Desmethyl Vinblastine; 1-Demethyl-vincaleukoblastine; N-Deformylleurocristine; N-Deformylvincristine |
Vinblastine Impurity B | 61936-68-3 | C46H58N4O10 | 827 | (5S,7S,9S)-9-((3aR,3a1R,4R,5S,5aR,10bR)-4-acetoxy-3a-ethyl-5-hydroxy-8-methoxy-5-(methoxycarbonyl)-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indolizino[8,1-cd]carbazol-9-yl)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-1,2,3,4,5,6,7,8,9,10-decahydro-3,7-methan |
Vinblastine | 865-21-4 | C46H58N4O9 | 810.97 | |
Vinaginsenoside R8 | 156042-22-7 | C48H82O19 | 963.15 | |
Vina-ginsenoside R4 | 156009-80-2 | C48H82O19 | 963.15 | |
Vinaginsenoside R3 | 156012-92-9 | C48H82O17 | 931.15 | |
Viminol | 21363-18-8 | C21H31ClN2O | 362.937 g/mol | |
Villosolside | 99933-30-9 | C16H26O9 | 362.372 | |
Villosol | 60077-62-5 | C23H20O7 | 408.4 | |
Villosin C | 160927-81-1 | C20H24O6 | ||
Villosin | 160598-92-5 | C20H28O2 | 300.4 | 8(17),11,13-Labdatrien-16,15-olide |
Vildagliptin-d7 | 1133208-42-0 | C17H18D7N3O2 | 310.4 | (2S)-1-[2-[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-2-pyrrolidine-2,3,3,4,4,5,5-d7-carbonitrile |
Vildagliptin Impurity B | 1036959-23-5 | C24H33N5O3 | 439.56 | Vildagliptin Impurity 2; (2S,2'S)-1,1'-[[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)imino]bis(1-oxo-2,1-ethanediyl)]bis-2-pyrrolidinecarbonitrile |
Vildagliptin Impurity E | 1789703-37-2 | C17H25N3O2 | 303.4 | Vildagliptin Cyclo Imidamide; 2-(3-Hydroxyadamantan-1-yl)-1-iminohexahydropyrrolo[1,2-a]pyrazin-4(1H)-one |
Vildagliptin Impurity A | 565453-39-6 | C17H27N3O3 | ||
Vildagliptin Impurity 3 Trifluoroacetate | 565453-41-0 | C17H26N2O4. C2HF3O2 | 436.43 | Vildagliptin Carboxy Acid Metabolite Trifluoroacetate |
Vildagliptin Carboxylic Acid Metabolite | 565453-40-9 | C17H26N2O4 | 322.405 | N-(3-Hydroxytricyclo[3.3.1.1~3,7~]decan-1-yl)glycyl-L-proline |
Vildagliptin | 274901-16-5 | C17H25N3O2 | 303.406 | LAF237; LAF 237; LAF-237; Galvus; NVP-LAF 237; Zomelis; Xiliarx; Jalra; DSP 7238; DSP-7238; DSP7238; Vildagliptin; Zomelis |
Vilazodone Impurity C | 1622425-52-8 | C26H27N5O3 | 457.54 | Vilazodone N-Oxide; 5-[4-[4-(5-Cyano-1H-indol-3-yl)butyl]-4-oxido-1-piperazinyl]-2-benzofurancarboxamide |
Vilazodone Hydrochloride | 163521-08-2 | C26H28ClN5O2 | 477.99 | EMD 68843; SB 659746A; EMD-68843; EMD68843; SB-659746A; SB659746A |
Vilazodone D8 | 1794789-93-7 | C26H19N5O2D8 | 449.59 | EMD 515259-d8; HY-14261S; [2H8]-5-[4-[4-(5-Cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-2-benzofurancarboxamide; 5-[4-[4-(5-Cyano-1H-indol-3-yl)butyl]-1-(piperazinyl-d8)]-2-benzofurancarboxamide; 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-2,2,3,3,5,5,6,6-octadeut |
Vilazodone Carboxy Acid | 163521-19-5 | C26H26N4O3 | 442.52 | 5-[4-[4-(5-Cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-2-benzofurancarboxylic Acid |
Vilazodone | 163521-12-8 | C26H27N5O2 | 441.52 | EMD 68843; SB 659746A; EMD-68843; EMD68843; SB-659746A; SB659746A |
Vilaprisan | 1262108-14-4 | C27H29F5O4S | 544.58 | UNII-IN59K53GI9; IN59K53GI9; BAY1002670;(8S,11R,13S,14S,17S)-17-hydroxy-13-methyl-11-(4-methylsulfonylphenyl)-17-(1,1,2,2,2-pentafluoroethyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one |
Vidupiprant | 1169483-24-2 | C28H27Cl2FN2O6S | 609.49 | 2-[4-[4-(tert-butylcarbamoyl)-2-[(2-chloro-4-cyclopropylphenyl)sulfonylamino]phenoxy]-5-chloro-2-fluorophenyl]aceticacid;VIDUPIPRANT;UNII-61OTZ32XNC;CHEMBL1951575;AMG853;1169483-24-2 |
viF 549-carboxylic acid | 1355043-65-0 | C32H41BrN2O2 | 565.59 | 2-[3-[1-(5-Carboxypentyl)-3,3-dimethyl-1,3-dihydro-indol-2-ylidene]-propenyl]-3,3-dimethyl-1-propyl-3H-indolium bromide |
Vilanterol Trifenatate | 503070-58-4 | C24H33Cl2NO5.C20H16O2 | 774.776 | (R)-4-(2-((6-(2-((2,6-dichlorobenzyl)oxy)ethoxy)hexyl)amino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol 2,2,2-triphenylacetate; GW-642444; GW642444; GW-642444; GW 642444X; Vilanterol; Vilanterol trifenatate |
Vidofludimus | 717824-30-1 | C20H18FNO4 | 355.36 | SC12267, 4SC-101 |
Vidarabine monohydrate | 24356-66-9 | C10H13N5O4·H2O | 285.26 | Spongoadenosine monohydrate; Vira-A monohydrate; (2R,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol hydrate |
Victoxinine | 39965-06-5 | C17H29NO | 263.425 | (4aalpha,8aalpha)-Decahydro-8-methyl-9-methylene-5beta-isopropyl-4beta,8beta-methanoisoquinoline-2-ethanol |
victoria pure blue bo | 2390-60-5 | C33H40ClN3 | 514.15 | 5-cyclohexadien-1-ylidene]-n-ethyl-ylene]-chloride; abcolvictoriabluebo; AizenVictoriaPureBlueBOH; BasicbrilliantblueBO; C.1.BasicBlue7(42595); C.I.Basicblue7 |
Vardenafil Related Compound (2-(2-Ethoxyphenyl)-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one) | 224789-21-3 | C17H20N4O2 | 312.37 | 2-(2-Ethoxyphenyl)-5-methyl-7-propyl-imidazo[5,1-f][1,2,4]triazin-4(1H)-one |
Vicagrel | 1314081-53-2 | C18H18ClNO4S | 379.87 | CHEMBL2042273; SCHEMBL12438770; ZINC84654546; AJ-126334; methyl (2S)-2-(2-acetyloxy-6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)-2-(2-chlorophenyl)acetate |
Vicriviroc maleate | 599179-03-0 | C32H42F3N5O6 | 649.7 | 1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]-4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methyl-1-piperazinyl]-4-methyl-piperidine (2Z)-2-butenedioate (1:1) |
Vicriviroc Malate | 541503-81-5 | C28H38F3N5O2.C4H6O5 | 667.72 | (4,6-dimethylpyrimidin-5-yl)-[4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl]methanone; 2-hydroxybutanedioicacid; VicrivirocMalate; 541503-81-5; S2004_Selleck; MolPort-016-633-267 |
Vicriviroc | 306296-47-9 | C28H38F3N5O2 | 533.64 | SCH-D; Sch-D compound; Sch 417690; UNII-TL515DW4QS; SCH-417690; (4,6-dimethylpyrimidin-5-yl)-[4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl]methanone |
Vicenin-3 | 59914-91-9 | C26H28O14 | 564.50 | 6-beta-D-Glucopyranosyl-8-beta-D-xylopyranosylapigenin; 6-C-Glucosyl-8-C-xylosylapigenin; Vicenin III; 6-C-beta-D-Glucopyranosyl-8-C-beta-D-xylopyranosylapigenin; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan |
Vicenin-2 | 23666-13-9 | C27H30O15 | 5,7-Dihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one | |
Viburnumoside | 2222365-74-2 | C26H38O8 | 478.58 | |
Viburgenin | 211506-71-7 | C30H50O5 | 490.73 | (+)-Viburgenin |
Vibunazole | 80456-55-9 | 309.79 | ||
Vibsanin C | 74690-89-4 | C25H36O5 | 416.56 | 3-Methyl-2-butenoic acid [2-[5-hydroxy-2-methyl-2-(4-methyl-3-pentenyl)-6-oxo-7-(2-oxopropyl)-4-cyclohepten-1-yl]vinyl] ester |
Vibralactone L | 1623786-67-3 | C14H20O4 | 252.31 | ethyl 5-methyl-2-[(5-oxo-2H-furan-3-yl)methyl]hex-4-enoate |
Vibralactone K | 1623786-66-2 | C12H18O3 | 210.273 | (3aR,4R,5S,6aS)-4-hydroxy-5-(3-methylbut-2-enyl)-1,3a,4,5,6,6a-hexahydrocyclopenta[c]furan-3-one |
Vibralactone D | 1251748-32-9 | C12H18O3 | 210.273 | (1S,5R,6S)-6-hydroxy-5-(3-methylbut-2-enyl)-3-oxabicyclo[3.2.1]octan-4-one |
Vibralactone B | 1093230-95-5 | C12H16O4 | 224.256 | (1beta)-2alpha-Prenyl-3beta-hydroxy-5beta-(hydroxymethyl)-6-oxabicyclo[3.1.0]hexane-2-carboxylic acid 2,3-lactone |
vibo-Quercitol | 488-76-6 | C6H12O5 | 164.16 | Viburnitol; vibo-Quercitol |
VIBEGRON | 1190389-15-1 | C26H28N4O3 | 444.54 | (6S)-N-[4-[[(2S,5R)-5-[(R)-hydroxy(phenyl)methyl]pyrrolidin-2-yl]methyl]phenyl]-4-oxo-7,8-dihydro-6H-pyrrolo[1,2-a]pyrimidine-6-carboxamide,MK 4618 |
Vialinin A | 858134-23-3 | C34H26O8 | 562.57 | 1,1'-(4,4'',5',6'-Tetrahydroxy[1,1':4',1''-terphenyl]-2',3'-diyl) benzeneacetic acid ester; Ganbajunin C |
Vernakalant Impurity 8 ((3R,1'S,2'R)-Isomer) | 795282-27-8 | C20H31NO4 | 349.47 | |
VH 298 | 2097381-85-4 | C27H33N5O4S | 523.65 | (2S,4R)-1-((S)-2-(1-cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide; EX-A1505 |
VH 032-linker 9 | 2341796-83-4 | C26H37N5O5S·2HCl | 604.59 | (2S,4R)-1-((S)-2-(2-(2-Aminoethoxy)acetamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide dihydrochloride |
VH 032-linker 8 | 2341796-77-6 | C29H43N5O4S·2HCl | 630.67 | (2S,4R)-1-((S)-2-(7-Aminoheptanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide dihydrochloride |
VH 032-linker 7 | 2341796-73-2 | C25H35N5O4S·2HCl | 574.56 | (2S,4R)-1-((S)-2-(3-Aminopropanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide dihydrochloride |
VH 032-linker 4 | 2140807-42-5 | C32H46N4O9S | 662.79 | (S)-15-((2S,4R)-4-Hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamoyl)pyrrolidine-1-carbonyl)-16,16-dimethyl-13-oxo-4,7,10-trioxa-14-azaheptadecanoic acid |
VH 032-linker 12 | 2341796-76-5 | C28H41N5O6S·2HCl | 648.64 | (2S,4R)-1-((S)-2-(2-(2-(2-Aminoethoxy)ethoxy)acetamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide |
VH 032-linker 11 | 2341796-80-1 | C31H47N5O4S·HCl | 658.72 | (2S,4R)-1-((S)-2-(9-Aminononanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide dihydrochloride |
VH 032-linker 10 | 2341796-75-4 | C33H51N5O4S·2HCl | 686.78 | (2S,4R)-1-((S)-2-(11-Aminoundecanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide dihydrochloride |
VH 032-linker 1 | 2376990-24-6 | C30H45N5O7S·2HCl | 692.69 | (2S,4R)-1-((S)-14-amino-2-(tert-butyl)-4-oxo-6,9,12-trioxa-3-azatetradecan-1-oyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide dihydrochloride |
VH 032 phenol-linker 2 | 2376990-28-0 | C30H45N5O5S·2HCl | 660.7 | (2S,4R)-1-((S)-2-Acetamido-3,3-dimethylbutanoyl)-N-(2-((6-aminohexyl)oxy)-4-(4-methylthiazol-5-yl)benzyl)-4-hydroxypyrrolidine-2-carboxamide dihydrochloride |
VH 032 phenol-linker 1 | 2376990-26-8 | C28H41N5O5S·2HCl | 632.64 | (2S,4R)-1-((S)-2-Acetamido-3,3-dimethylbutanoyl)-N-(2-(4-aminobutoxy)-4-(4-methylthiazol-5-yl)benzyl)-4-hydroxypyrrolidine-2-carboxamide dihydrochloride |
Vestipitant | 334476-64-1 | C24H28F7N3O4S | 491.44 | GW597599; GW 597599; GW-597599; Vestipitant |
Vestinol(R) INB | 670241-72-2 | |||
Vesnarinone | 81840-15-5 | C22H25N3O4 | 395.45 | Arkin;Piteranometozine;OPC 8212;6-[4-(3,4-Dimethoxybenzoyl)-1-piperazinyl]-3,4-dihydro-2(1H)-quinolinone;3,4-Dihydro-6-(4-(3,4-dimethoxybenzoyl)-1-piperazinyl)-2(1h)-quinolinone |
Verucerfont | 885220-61-1 | C22H26N6O2 | 406.49 | GSK561679; GSK561679A; NBI-77860; 3-(4-methoxy-2-methylphenyl)-2,5-dimethyl-N-[(1S)-1-(3-methyl-1,2,4-oxadiazol-5-yl)propyl]pyrazolo[1,5-a]pyrimidin-7-amine |
Vernakalant Impurity 7 ((3R,1'R,2'S)-Isomer) | 795282-29-0 | C20H31NO4 | 349.47 | |
Vernakalant Impurity 5 ((3R,1'S,2'S)-Isomer) HCl | 795281-93-5 | C20H31NO4. HCl | 385.93 | |
Vernakalant Impurity 4 ((3S,1'S,2'R)-Isomer) | 795282-28-9 | C20H31NO4 | 349.47 | |
Vernakalant Impurity 3 ((3S,1'R,2'S)-Isomer) | 795282-30-3 | C20H31NO4 | 349.47 | |
Vernakalant Impurity 2 ((3S,1'R,2'R)-Isomer) HCl | 795281-99-1 | C20H31NO4. HCl | 385.93 | |
Vernakalant Impurity 1 ((3S,1'S,2'S)-Isomer) HCl | 795282-00-7 | C20H31NO4. HCl | 385.93 | |
Vernakalant ((3R,1'R,2'R)-Isomer) HCl | 748810-28-8 | C20H32NO4Cl | 385.93 | RSD1235, RSD-1235, RSD 1235, Vernakalant HCl, Kynapid, Brinavess; D06665;(3R)-1-[(1R,2R)-2-[2-(3,4-Dimethoxyphenyl)ethoxy]cyclohexyl]-3-pyrrolidinol monohydrochloride;RSD 1235 hydrochloride;Vernakalant ((3R,1'R,2'R)-Isomer) HCl |
Vernakalant | 794466-70-9 | C20H31NO4 | 349.47 | Brinavess;RSD1235;(3R)-1-[(1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]pyrrolidin-3-ol |
Verlukast | 120443-16-5 | C26H27ClN2O3S2 | 515.09 | 3-[[(R)-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl][[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]-propanoic Acid; L 668019; MK 679; R-(-)-MK 571; |
Verinurad | 1352792-74-5 | C20H16N2O2S | 348.42 | Verinurad; UNII-12WJ62D047; Verinurad [INN]; SCHEMBL12070797; 12WJ62D047 |
Vericiguat | 1350653-20-1 | C19H16F2N8O2 | 426.39 | BAY 10-21189;methyl (4,6-diamino-2-(5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-5-yl)carbamate |
Vercirnon | 698394-73-9 | C22H21ClN2O4S | 444.93 | 4-(2-((4-(tert-butyl)phenyl)sulfonamido)-5-chlorobenzoyl)pyridine 1-oxide; GSK1605786; GSK 1605786; GSK-1605786; CCX282B; CCX 282B; CCX-282b; CCX282-B |
Verbenacine | 717901-03-6 | C20H30O3 | 318.50 | (3alpha,4alpha)-3-Hydroxykaur-15-en-18-oic acid |
Verbascotetraose | 1111-08-6 | C24H42O21 | 666.58 | a-D-Galactopyranosyl-(1-6)-a-D-galactopyranosyl-(1-6)-a-D-galactopyranosyl-(1-6)-D-glucose; D-Glucose, a-D-galactopyranosyl-(1-6)-a-D-galactopyranosyl-(1-6)-a-D-galactopyranosyl-(1-6)- |
Verbascose | 546-62-3 | C30H52O26 | 828.72 | |
Veratrosine | 475-00-3 | C33H49NO7 | 571.75 | Veratramine 3-glycoside |
VERATRINE SULFATE | 15585-38-3 | C36H53NO15S | 771.87 | VERATRINE SULFATE |
Veratramine | 60-70-8 | C27H39NO2 | 409.6 | NSC17821; NSC23880 |
Verapamil Impurity O | 959011-16-6 | C27H38N2O4 | 454.61 | a-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-a-propyl-benzeneacetonitrile |
Verapamil Impurity L | 14046-55-0 | C12H16O3 | 208.26 | 1-(3,4-Dimethoxyphenyl)-2-methyl-1-propanone; 1-(3,4-Dimethoxyphenyl)-2-methylpropanone; 2-Methyl-1-(3,4-dimethoxyphenyl)-1-propanone; 3,4-Dimethoxyphenyl Isopropyl Ketone; 3',4'-Dimethoxyisobutyrophenone; NSC 63844; 3',4'-Dimethoxy-2-methyl-propiophenone |
Vasopressin-d5 | 1356383-11-3 | C46H60N15O12S2D5 | 1089.28 | Arginine Vasopressin-d5; 19-Amino-13-(benzyl-d5)-7-(carbamoylmethyl)-4-[2-[[1-[(carbamoylmethyl)carbamoyl]-4-guanidinobutyl]carbamoyl]-1-pyrrolidinylcarbonyl]-16-p-hydroxybenzyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloeicosane-10-propio |
Venetoclax D8 | 1257051-06-1 | C45H42D8ClN7O7S | 876.5 | 4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-[3-nitro-4-({[(2,2,3,3,5,5,6,6-D8)oxan-4-yl]methyl}amino)benzenesulfonyl]-2-{1H-pyrrolo[2,3-b]pyridin-5-yloxy}benzamide |
venetoclax | 1257044-40-8 | C45H50ClN7O7S | 868.44 | Venclexta; ABT-199 |
Vemurafenib-d7 | 1365986-73-7 | C23H11D7ClF2N3O3S | 496.97 | N-[3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluorophenyl]propane-1-sulfonamide; PLX4032 |
Vemurafenib | 918504-65-1 | C23H18ClF2N3O3S | 489.92 | PLX4032, RG7204 |
VELVETONE | 68555-94-2 | C15H24O | 220.36 | (* Alt. CAS #) CAS: 72117-72-7; dimethyl alpha-ionone, 1-Penten-3-one, 2-methyl-1-(2,2,6-trimethylcyclohexenyl)-, DIMETHYL IONONE, Dimethylionone, VELVETONE |
Velutin | 25739-41-7 | C17H14O6 | 314.3 | 4',5-Dihydroxy-3',7-dimethoxyflavone |
Velusetrag | 866933-46-2 | C25H36N4O5S | 504.65 | UNII-J4VNV64ARB; TD-5108; TD 5108; J4VNV64ARB; GTPL8425;N-[(1R,5S)-8-[(2R)-2-hydroxy-3-[methyl(methylsulfonyl)amino]propyl]-8-azabicyclo[3.2.1]octan-3-yl]-2-oxo-1-propan-2-ylquinoline-3-carboxamide |
VELTONAL | 68555-62-4 | C14H22O | 206.32 | 2-Butenal, 2-methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-, 2-Methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-2-butenal, VELTONAL |
Velpatasvir | 1377049-84-7 | C49H54N8O8 | 883.01 | GS-5816; GS 5816; GS5816 |
Velneperit | 342577-38-2 | C17H24F3N3O3S | 407.45 | S-2367; N-[5-(Trifluoromethyl)pyridin-2-yl]-trans-4-(tert-butylsulfonylamino)cyclohexane-1-carboxamide; |
Vellosimine | 6874-98-2 | C19H20N2O | 292.4 | 4-ethyl-4-phenyl-piperidine-2,6-dione; 2,6-Piperidinedione,4-ethyl-4-phenyl |
Veliparib | 912444-00-9 | C13H16N4O | 244.298 | (R)-2-(2-methylpyrrolidin-2-yl)-1H-benzo[d]imidazole-4-carboxamide; ABT888; ABT-888; ABT 888; Veliparib |
Veledimex S enantiomer | 1093131-03-3 | C27H38N2O3 | 438.6 | N'-(3,5-dimethylbenzoyl)-N'-[(3S)-2,2-dimethylhexan-3-yl]-2-ethyl-3-methoxybenzohydrazide; Veledimex (S enantiomer) |
Veledimex racemate | 755013-59-3 | C27H38N2O3 | 438.6 | N'-(3,5-dimethylbenzoyl)-N'-(2,2-dimethylhexan-3-yl)-2-ethyl-3-methoxybenzohydrazide; Veledimex (racemate) |
Veledimex | 1093130-72-3 | C27H38N2O3 | 438.61 | INXN-1001;INXN1001;RG-115932;RG115932;N'-(3,5-dimethylbenzoyl)-N'-[(3R)-2,2-dimethylhexan-3-yl]-2-ethyl-3-methoxybenzohydrazide;(R)-N'-(3,5-dimethylbenzoyl)-N'-(2,2-dimethylhexan-3-yl)-2-ethyl-3-methoxybenzohydrazide |
VEL-0230 | 221144-20-3 | C14H24NNaO5 | 309.338 | VEL-0230; VEL 0230; VEL0230; NC-2300; NC2300. |
VEGFR2 Kinase Inhibitor II | 288144-20-7 | C17H15BrN2O | 343.2 | (Z)-5-Bromo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylene)-1,3-dihydroindol-2-one |
VEGFR Tyrosine Kinase Inhibitor II | 269390-69-4 | C19H16ClN3O | 337.8 | N-(4-Chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide |
Vedroprevir | 1098189-15-1 | C45H60ClN7O9S | 910.52 | (1R,2R)-N-[[(1alpha,3beta,5alpha)-Bicyclo[3.1.0]hex-3-yloxy]carbonyl]-3-methyl-L-valyl-(4R)-4-[[8-chloro-2-[2-[(1-methylethyl)amino]-4-thiazolyl]-7-[2-(4-morpholinyl)ethoxy]-4-quinolinyl]oxy]-L-prolyl-1-amino-2-ethyl-cyclopropanecarboxylic acid;GS9451;GS- |
Vedolizumab | 943609-66-3 | C6528H10072N1732O2042S42 | 146836.67 | Entyvio |
Vedaprofen-D3 | 1185054-34-5 | 2-(4-Cyclohexyl- naphthalen-1-yl)- propionic acid-D3 | ||
Vedaprofen | 71109-09-6 | C19H22O2 | 282.383 | 2-(4-Cyclohexylnaphthalen-1-yl)-propionic acid |
Vecuronium Bromide | 50700-72-6 | C34H57N2O4.Br | 637.73 | Norcuron |
VE-821 | 1232410-49-9 | C18H16N4O3S | 368.41 | VE821; VE 821. |
VDM 11 | 313998-81-1 | C27H39NO2 | 409.61 | (5Z,8Z,11Z,14Z)-N-(4-Hydroxy-2-methylphenyl)-5,8,11,14-eicosatetraenamide; N-(4-Hydroxy-2-methylphenyl)arachidonylamide |